#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Cell-specific histone modification maps link schizophrenia risk to the neuronal epigenome Risk variants for schizophrenia affect more than 100 genomic loci, yet cell- and tissue-specific roles underlying disease liability remain poorly characterized.
1-1	0-13	Cell-specific	_
1-2	14-21	histone	_
1-3	22-34	modification	_
1-4	35-39	maps	_
1-5	40-44	link	_
1-6	45-58	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-7	59-63	risk	_
1-8	64-66	to	_
1-9	67-70	the	_
1-10	71-79	neuronal	_
1-11	80-89	epigenome	_
1-12	90-94	Risk	_
1-13	95-103	variants	_
1-14	104-107	for	_
1-15	108-121	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-16	122-128	affect	_
1-17	129-133	more	_
1-18	134-138	than	_
1-19	139-142	100	_
1-20	143-150	genomic	_
1-21	151-155	loci	_
1-22	156-157	,	_
1-23	158-161	yet	_
1-24	162-167	cell-	_
1-25	168-171	and	_
1-26	172-187	tissue-specific	_
1-27	188-193	roles	_
1-28	194-204	underlying	_
1-29	205-212	disease	_
1-30	213-222	liability	_
1-31	223-229	remain	_
1-32	230-236	poorly	_
1-33	237-250	characterized	_
1-34	251-252	.	_

Text=We have generated for two cortical areas implicated in psychosis, dorsolateral prefrontal cortex and anterior cingulate cortex, 157 reference maps from neuronal, neuronal-depleted and bulk tissue chromatin for two histone marks associated with active promoters and enhancers, H3-trimethyl-lysine 4 (H3K4me3) and H3-acetyl-lysine 27 (H3K27ac).
2-1	253-255	We	_
2-2	256-260	have	_
2-3	261-270	generated	_
2-4	271-274	for	_
2-5	275-278	two	_
2-6	279-287	cortical	_
2-7	288-293	areas	_
2-8	294-304	implicated	_
2-9	305-307	in	_
2-10	308-317	psychosis	_
2-11	318-319	,	_
2-12	320-332	dorsolateral	_
2-13	333-343	prefrontal	_
2-14	344-350	cortex	_
2-15	351-354	and	_
2-16	355-363	anterior	_
2-17	364-373	cingulate	_
2-18	374-380	cortex	_
2-19	381-382	,	_
2-20	383-386	157	_
2-21	387-396	reference	_
2-22	397-401	maps	_
2-23	402-406	from	_
2-24	407-415	neuronal	_
2-25	416-417	,	_
2-26	418-435	neuronal-depleted	_
2-27	436-439	and	_
2-28	440-444	bulk	_
2-29	445-451	tissue	_
2-30	452-461	chromatin	_
2-31	462-465	for	_
2-32	466-469	two	_
2-33	470-477	histone	_
2-34	478-483	marks	_
2-35	484-494	associated	_
2-36	495-499	with	_
2-37	500-506	active	_
2-38	507-516	promoters	_
2-39	517-520	and	_
2-40	521-530	enhancers	_
2-41	531-532	,	_
2-42	533-552	H3-trimethyl-lysine	_
2-43	553-554	4	_
2-44	555-556	(	_
2-45	557-564	H3K4me3	_
2-46	565-566	)	_
2-47	567-570	and	_
2-48	571-587	H3-acetyl-lysine	_
2-49	588-590	27	_
2-50	591-592	(	_
2-51	593-600	H3K27ac	_
2-52	601-602	)	_
2-53	603-604	.	_

Text=Differences between neuronal and neuronal-depleted chromatin states were the major axis of variation in histone modification profiles followed by substantial variability across subjects and cortical areas.
3-1	605-616	Differences	_
3-2	617-624	between	_
3-3	625-633	neuronal	_
3-4	634-637	and	_
3-5	638-655	neuronal-depleted	_
3-6	656-665	chromatin	_
3-7	666-672	states	_
3-8	673-677	were	_
3-9	678-681	the	_
3-10	682-687	major	_
3-11	688-692	axis	_
3-12	693-695	of	_
3-13	696-705	variation	_
3-14	706-708	in	_
3-15	709-716	histone	_
3-16	717-729	modification	_
3-17	730-738	profiles	_
3-18	739-747	followed	_
3-19	748-750	by	_
3-20	751-762	substantial	_
3-21	763-774	variability	_
3-22	775-781	across	_
3-23	782-790	subjects	_
3-24	791-794	and	_
3-25	795-803	cortical	_
3-26	804-809	areas	_
3-27	810-811	.	_

Text=Thousands of significant histone quantitative trait loci (hQTLs) were identified in neuronal and neuronal-depleted samples.
4-1	812-821	Thousands	_
4-2	822-824	of	_
4-3	825-836	significant	_
4-4	837-844	histone	_
4-5	845-857	quantitative	_
4-6	858-863	trait	_
4-7	864-868	loci	_
4-8	869-870	(	_
4-9	871-876	hQTLs	_
4-10	877-878	)	_
4-11	879-883	were	_
4-12	884-894	identified	_
4-13	895-897	in	_
4-14	898-906	neuronal	_
4-15	907-910	and	_
4-16	911-928	neuronal-depleted	_
4-17	929-936	samples	_
4-18	937-938	.	_

Text=Risk variants for schizophrenia, depressive symptoms and neuroticism were significantly overrepresented in neuronal H3K4me3 and H3K27ac landscapes.
5-1	939-943	Risk	_
5-2	944-952	variants	_
5-3	953-956	for	_
5-4	957-970	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-5	971-972	,	_
5-6	973-983	depressive	_
5-7	984-992	symptoms	_
5-8	993-996	and	_
5-9	997-1008	neuroticism	_
5-10	1009-1013	were	_
5-11	1014-1027	significantly	_
5-12	1028-1043	overrepresented	_
5-13	1044-1046	in	_
5-14	1047-1055	neuronal	_
5-15	1056-1063	H3K4me3	_
5-16	1064-1067	and	_
5-17	1068-1075	H3K27ac	_
5-18	1076-1086	landscapes	_
5-19	1087-1088	.	_

Text=Our PsychENCODE and CommonMind sponsored resource highlights the critical role of cell-type specific signatures at regulatory and disease-associated non-coding sequences in the human frontal lobe.
6-1	1089-1092	Our	_
6-2	1093-1104	PsychENCODE	_
6-3	1105-1108	and	_
6-4	1109-1119	CommonMind	_
6-5	1120-1129	sponsored	_
6-6	1130-1138	resource	_
6-7	1139-1149	highlights	_
6-8	1150-1153	the	_
6-9	1154-1162	critical	_
6-10	1163-1167	role	_
6-11	1168-1170	of	_
6-12	1171-1180	cell-type	_
6-13	1181-1189	specific	_
6-14	1190-1200	signatures	_
6-15	1201-1203	at	_
6-16	1204-1214	regulatory	_
6-17	1215-1218	and	_
6-18	1219-1237	disease-associated	_
6-19	1238-1248	non-coding	_
6-20	1249-1258	sequences	_
6-21	1259-1261	in	_
6-22	1262-1265	the	_
6-23	1266-1271	human	_
6-24	1272-1279	frontal	_
6-25	1280-1284	lobe	_
6-26	1285-1286	.	_

Text=METHODS Brains All tissue donors of the present study were from the Human Brain Collection Core (HBCC) at the National Institutes of Health.
7-1	1287-1294	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
7-2	1295-1301	Brains	_
7-3	1302-1305	All	_
7-4	1306-1312	tissue	_
7-5	1313-1319	donors	_
7-6	1320-1322	of	_
7-7	1323-1326	the	_
7-8	1327-1334	present	_
7-9	1335-1340	study	_
7-10	1341-1345	were	_
7-11	1346-1350	from	_
7-12	1351-1354	the	_
7-13	1355-1360	Human	_
7-14	1361-1366	Brain	_
7-15	1367-1377	Collection	_
7-16	1378-1382	Core	_
7-17	1383-1384	(	_
7-18	1385-1389	HBCC	_
7-19	1390-1391	)	_
7-20	1392-1394	at	_
7-21	1395-1398	the	_
7-22	1399-1407	National	_
7-23	1408-1418	Institutes	_
7-24	1419-1421	of	_
7-25	1422-1428	Health	_
7-26	1429-1430	.	_

Text=None of the brains had known neurological or psychiatric disease.
8-1	1431-1435	None	_
8-2	1436-1438	of	_
8-3	1439-1442	the	_
8-4	1443-1449	brains	_
8-5	1450-1453	had	_
8-6	1454-1459	known	_
8-7	1460-1472	neurological	_
8-8	1473-1475	or	_
8-9	1476-1487	psychiatric	_
8-10	1488-1495	disease	_
8-11	1496-1497	.	_

Text=All brains had undergone a detailed neuropathological exam (incl.
9-1	1498-1501	All	_
9-2	1502-1508	brains	_
9-3	1509-1512	had	_
9-4	1513-1522	undergone	_
9-5	1523-1524	a	_
9-6	1525-1533	detailed	_
9-7	1534-1551	neuropathological	_
9-8	1552-1556	exam	_
9-9	1557-1558	(	_
9-10	1559-1563	incl	_
9-11	1564-1565	.	_

Text=Bielschowsky stain) and were considered normal by histopathology.
10-1	1566-1578	Bielschowsky	_
10-2	1579-1584	stain	_
10-3	1585-1586	)	_
10-4	1587-1590	and	_
10-5	1591-1595	were	_
10-6	1596-1606	considered	_
10-7	1607-1613	normal	_
10-8	1614-1616	by	_
10-9	1617-1631	histopathology	_
10-10	1632-1633	.	_

Text=Demographics of the brain cohort, and toxicology and neuropathology reports are summarized Table S1.
11-1	1634-1646	Demographics	_
11-2	1647-1649	of	_
11-3	1650-1653	the	_
11-4	1654-1659	brain	_
11-5	1660-1666	cohort	_
11-6	1667-1668	,	_
11-7	1669-1672	and	_
11-8	1673-1683	toxicology	_
11-9	1684-1687	and	_
11-10	1688-1702	neuropathology	_
11-11	1703-1710	reports	_
11-12	1711-1714	are	_
11-13	1715-1725	summarized	_
11-14	1726-1731	Table	_
11-15	1732-1734	S1	_
11-16	1735-1736	.	_

Text=Sample size: No statistical methods were used to pre-determine sample sizes but our sample sizes exceeded those reported in previous publications focused on cell-type specific histone profiling in human brain (references) by several-fold.
12-1	1737-1743	Sample	_
12-2	1744-1748	size	_
12-3	1749-1750	:	_
12-4	1751-1753	No	_
12-5	1754-1765	statistical	_
12-6	1766-1773	methods	_
12-7	1774-1778	were	_
12-8	1779-1783	used	_
12-9	1784-1786	to	_
12-10	1787-1800	pre-determine	_
12-11	1801-1807	sample	_
12-12	1808-1813	sizes	_
12-13	1814-1817	but	_
12-14	1818-1821	our	_
12-15	1822-1828	sample	_
12-16	1829-1834	sizes	_
12-17	1835-1843	exceeded	_
12-18	1844-1849	those	_
12-19	1850-1858	reported	_
12-20	1859-1861	in	_
12-21	1862-1870	previous	_
12-22	1871-1883	publications	_
12-23	1884-1891	focused	_
12-24	1892-1894	on	_
12-25	1895-1904	cell-type	_
12-26	1905-1913	specific	_
12-27	1914-1921	histone	_
12-28	1922-1931	profiling	_
12-29	1932-1934	in	_
12-30	1935-1940	human	_
12-31	1941-1946	brain	_
12-32	1947-1948	(	_
12-33	1949-1959	references	_
12-34	1960-1961	)	_
12-35	1962-1964	by	_
12-36	1965-1977	several-fold	_
12-37	1978-1979	.	_

Text=Antibodies, ChIP-Seq library preparation and sequencing Nuclei were extracted from approximately 300mg aliquots of frozen frontal (dorsolateral prefrontal and anterior cingulate gyrus) cortex tissue, immunotagged with Anti-NeuN-Alexa488 (Cat #MAB377X, EMD Millipore) antibody which robustly stains human cortical neuron nuclei for subsequent fluorescence-activated nuclei sorting.
13-1	1980-1990	Antibodies	_
13-2	1991-1992	,	_
13-3	1993-2001	ChIP-Seq	_
13-4	2002-2009	library	_
13-5	2010-2021	preparation	_
13-6	2022-2025	and	_
13-7	2026-2036	sequencing	_
13-8	2037-2043	Nuclei	_
13-9	2044-2048	were	_
13-10	2049-2058	extracted	_
13-11	2059-2063	from	_
13-12	2064-2077	approximately	_
13-13	2078-2083	300mg	_
13-14	2084-2092	aliquots	_
13-15	2093-2095	of	_
13-16	2096-2102	frozen	_
13-17	2103-2110	frontal	_
13-18	2111-2112	(	_
13-19	2113-2125	dorsolateral	_
13-20	2126-2136	prefrontal	_
13-21	2137-2140	and	_
13-22	2141-2149	anterior	_
13-23	2150-2159	cingulate	_
13-24	2160-2165	gyrus	_
13-25	2166-2167	)	_
13-26	2168-2174	cortex	_
13-27	2175-2181	tissue	_
13-28	2182-2183	,	_
13-29	2184-2196	immunotagged	_
13-30	2197-2201	with	_
13-31	2202-2220	Anti-NeuN-Alexa488	_
13-32	2221-2222	(	_
13-33	2223-2226	Cat	_
13-34	2227-2228	#	_
13-35	2229-2236	MAB377X	_
13-36	2237-2238	,	_
13-37	2239-2242	EMD	_
13-38	2243-2252	Millipore	_
13-39	2253-2254	)	_
13-40	2255-2263	antibody	_
13-41	2264-2269	which	_
13-42	2270-2278	robustly	_
13-43	2279-2285	stains	_
13-44	2286-2291	human	_
13-45	2292-2300	cortical	_
13-46	2301-2307	neuron	_
13-47	2308-2314	nuclei	_
13-48	2315-2318	for	_
13-49	2319-2329	subsequent	_
13-50	2330-2352	fluorescence-activated	_
13-51	2353-2359	nuclei	_
13-52	2360-2367	sorting	_
13-53	2368-2369	.	_

Text=Next, chromatin of sorted nuclei was digested with micrococcal nuclease and subsequently pulled down with anti-histone antibodies, followed by library preparation and sequencing.
14-1	2370-2374	Next	_
14-2	2375-2376	,	_
14-3	2377-2386	chromatin	_
14-4	2387-2389	of	_
14-5	2390-2396	sorted	_
14-6	2397-2403	nuclei	_
14-7	2404-2407	was	_
14-8	2408-2416	digested	_
14-9	2417-2421	with	_
14-10	2422-2433	micrococcal	_
14-11	2434-2442	nuclease	_
14-12	2443-2446	and	_
14-13	2447-2459	subsequently	_
14-14	2460-2466	pulled	_
14-15	2467-2471	down	_
14-16	2472-2476	with	_
14-17	2477-2489	anti-histone	_
14-18	2490-2500	antibodies	_
14-19	2501-2502	,	_
14-20	2503-2511	followed	_
14-21	2512-2514	by	_
14-22	2515-2522	library	_
14-23	2523-2534	preparation	_
14-24	2535-2538	and	_
14-25	2539-2549	sequencing	_
14-26	2550-2551	.	_

Text=Two histone antibodies, anti-H3K4me3 (Cat #9751BC, lot 7; Cell Signaling, Danvers, MA) and anti-H3K27ac (Cat #39133, Lot #01613007; Active Motif, Carlsbad, CA) were used for immunoprecipitation.
15-1	2552-2555	Two	_
15-2	2556-2563	histone	_
15-3	2564-2574	antibodies	_
15-4	2575-2576	,	_
15-5	2577-2589	anti-H3K4me3	_
15-6	2590-2591	(	_
15-7	2592-2595	Cat	_
15-8	2596-2597	#	_
15-9	2598-2604	9751BC	_
15-10	2605-2606	,	_
15-11	2607-2610	lot	_
15-12	2611-2612	7	_
15-13	2613-2614	;	_
15-14	2615-2619	Cell	_
15-15	2620-2629	Signaling	_
15-16	2630-2631	,	_
15-17	2632-2639	Danvers	_
15-18	2640-2641	,	_
15-19	2642-2644	MA	_
15-20	2645-2646	)	_
15-21	2647-2650	and	_
15-22	2651-2663	anti-H3K27ac	_
15-23	2664-2665	(	_
15-24	2666-2669	Cat	_
15-25	2670-2671	#	_
15-26	2672-2677	39133	_
15-27	2678-2679	,	_
15-28	2680-2683	Lot	_
15-29	2684-2685	#	_
15-30	2686-2694	01613007	_
15-31	2695-2696	;	_
15-32	2697-2703	Active	_
15-33	2704-2709	Motif	_
15-34	2710-2711	,	_
15-35	2712-2720	Carlsbad	_
15-36	2721-2722	,	_
15-37	2723-2725	CA	_
15-38	2726-2727	)	_
15-39	2728-2732	were	_
15-40	2733-2737	used	_
15-41	2738-2741	for	_
15-42	2742-2761	immunoprecipitation	_
15-43	2762-2763	.	_

Text=Antibody specificity was tested using peptide binding assays and immunoblotting of nuclear extracts from human postmortem cortical tissue.
16-1	2764-2772	Antibody	_
16-2	2773-2784	specificity	_
16-3	2785-2788	was	_
16-4	2789-2795	tested	_
16-5	2796-2801	using	_
16-6	2802-2809	peptide	_
16-7	2810-2817	binding	_
16-8	2818-2824	assays	_
16-9	2825-2828	and	_
16-10	2829-2843	immunoblotting	_
16-11	2844-2846	of	_
16-12	2847-2854	nuclear	_
16-13	2855-2863	extracts	_
16-14	2864-2868	from	_
16-15	2869-2874	human	_
16-16	2875-2885	postmortem	_
16-17	2886-2894	cortical	_
16-18	2895-2901	tissue	_
16-19	2902-2903	.	_

Text=A commercially available histone H3 peptide array (Cat #16–667; Millipore) containing 46 peptides representing 46 different histone H3 posttranslational modifications was used as previously described.
17-1	2904-2905	A	_
17-2	2906-2918	commercially	_
17-3	2919-2928	available	_
17-4	2929-2936	histone	_
17-5	2937-2939	H3	_
17-6	2940-2947	peptide	_
17-7	2948-2953	array	_
17-8	2954-2955	(	_
17-9	2956-2959	Cat	_
17-10	2960-2961	#	_
17-11	2962-2968	16–667	_
17-12	2969-2970	;	_
17-13	2971-2980	Millipore	_
17-14	2981-2982	)	_
17-15	2983-2993	containing	_
17-16	2994-2996	46	_
17-17	2997-3005	peptides	_
17-18	3006-3018	representing	_
17-19	3019-3021	46	_
17-20	3022-3031	different	_
17-21	3032-3039	histone	_
17-22	3040-3042	H3	_
17-23	3043-3060	posttranslational	_
17-24	3061-3074	modifications	_
17-25	3075-3078	was	_
17-26	3079-3083	used	_
17-27	3084-3086	as	_
17-28	3087-3097	previously	_
17-29	3098-3107	described	_
17-30	3108-3109	.	_

Text=All procedures were performed as described in the recent PsychENCODE methods paper, providing a detailed description of the protocol.
18-1	3110-3113	All	_
18-2	3114-3124	procedures	_
18-3	3125-3129	were	_
18-4	3130-3139	performed	_
18-5	3140-3142	as	_
18-6	3143-3152	described	_
18-7	3153-3155	in	_
18-8	3156-3159	the	_
18-9	3160-3166	recent	_
18-10	3167-3178	PsychENCODE	_
18-11	3179-3186	methods	_
18-12	3187-3192	paper	_
18-13	3193-3194	,	_
18-14	3195-3204	providing	_
18-15	3205-3206	a	_
18-16	3207-3215	detailed	_
18-17	3216-3227	description	_
18-18	3228-3230	of	_
18-19	3231-3234	the	_
18-20	3235-3243	protocol	_
18-21	3244-3245	.	_

Text=For each cell-type specific ChIP-assay, a minimum of 400,000 sorted neuronal (NeuN+) or neuron-depleted/non-neuronal (NeuN−) nuclei was required as starting material.
19-1	3246-3249	For	_
19-2	3250-3254	each	_
19-3	3255-3264	cell-type	_
19-4	3265-3273	specific	_
19-5	3274-3284	ChIP-assay	_
19-6	3285-3286	,	_
19-7	3287-3288	a	_
19-8	3289-3296	minimum	_
19-9	3297-3299	of	_
19-10	3300-3307	400,000	_
19-11	3308-3314	sorted	_
19-12	3315-3323	neuronal	_
19-13	3324-3325	(	_
19-14	3326-3331	NeuN+	_
19-15	3332-3333	)	_
19-16	3334-3336	or	_
19-17	3337-3365	neuron-depleted/non-neuronal	_
19-18	3366-3367	(	_
19-19	3368-3373	NeuN−	_
19-20	3374-3375	)	_
19-21	3376-3382	nuclei	_
19-22	3383-3386	was	_
19-23	3387-3395	required	_
19-24	3396-3398	as	_
19-25	3399-3407	starting	_
19-26	3408-3416	material	_
19-27	3417-3418	.	_

Text=For selected gene promoters ChIP-PCR was conducted to validate cell-type specific peak profiles (Figure S18 and ref .).
20-1	3419-3422	For	_
20-2	3423-3431	selected	_
20-3	3432-3436	gene	_
20-4	3437-3446	promoters	_
20-5	3447-3455	ChIP-PCR	_
20-6	3456-3459	was	_
20-7	3460-3469	conducted	_
20-8	3470-3472	to	_
20-9	3473-3481	validate	_
20-10	3482-3491	cell-type	_
20-11	3492-3500	specific	_
20-12	3501-3505	peak	_
20-13	3506-3514	profiles	_
20-14	3515-3516	(	_
20-15	3517-3523	Figure	_
20-16	3524-3527	S18	_
20-17	3528-3531	and	_
20-18	3532-3535	ref	_
20-19	3536-3537	.	_
20-20	3538-3539	)	_
20-21	3540-3541	.	_

Text=Furthermore, quality controls for nuclei post-FACS included visual inspection under the microscope as described.
21-1	3542-3553	Furthermore	_
21-2	3554-3555	,	_
21-3	3556-3563	quality	_
21-4	3564-3572	controls	_
21-5	3573-3576	for	_
21-6	3577-3583	nuclei	_
21-7	3584-3593	post-FACS	_
21-8	3594-3602	included	_
21-9	3603-3609	visual	_
21-10	3610-3620	inspection	_
21-11	3621-3626	under	_
21-12	3627-3630	the	_
21-13	3631-3641	microscope	_
21-14	3642-3644	as	_
21-15	3645-3654	described	_
21-16	3655-3656	.	_

Text=Of note, due to our stringent FACS gating criteria with maximized specificity (not sensitivity) (Figure S19), 100% of sorted nuclei in the neuronal fraction showed green fluorescence confirming NeuN+ status, while 100% of sorted nuclei in the non-neuronal fraction only showed blue DAPI stain, confirming NeuN− status.
22-1	3657-3659	Of	_
22-2	3660-3664	note	_
22-3	3665-3666	,	_
22-4	3667-3670	due	_
22-5	3671-3673	to	_
22-6	3674-3677	our	_
22-7	3678-3687	stringent	_
22-8	3688-3692	FACS	_
22-9	3693-3699	gating	_
22-10	3700-3708	criteria	_
22-11	3709-3713	with	_
22-12	3714-3723	maximized	_
22-13	3724-3735	specificity	_
22-14	3736-3737	(	_
22-15	3738-3741	not	_
22-16	3742-3753	sensitivity	_
22-17	3754-3755	)	_
22-18	3756-3757	(	_
22-19	3758-3764	Figure	_
22-20	3765-3768	S19	_
22-21	3769-3770	)	_
22-22	3771-3772	,	_
22-23	3773-3776	100	_
22-24	3777-3778	%	_
22-25	3779-3781	of	_
22-26	3782-3788	sorted	_
22-27	3789-3795	nuclei	_
22-28	3796-3798	in	_
22-29	3799-3802	the	_
22-30	3803-3811	neuronal	_
22-31	3812-3820	fraction	_
22-32	3821-3827	showed	_
22-33	3828-3833	green	_
22-34	3834-3846	fluorescence	_
22-35	3847-3857	confirming	_
22-36	3858-3863	NeuN+	_
22-37	3864-3870	status	_
22-38	3871-3872	,	_
22-39	3873-3878	while	_
22-40	3879-3882	100	_
22-41	3883-3884	%	_
22-42	3885-3887	of	_
22-43	3888-3894	sorted	_
22-44	3895-3901	nuclei	_
22-45	3902-3904	in	_
22-46	3905-3908	the	_
22-47	3909-3921	non-neuronal	_
22-48	3922-3930	fraction	_
22-49	3931-3935	only	_
22-50	3936-3942	showed	_
22-51	3943-3947	blue	_
22-52	3948-3952	DAPI	_
22-53	3953-3958	stain	_
22-54	3959-3960	,	_
22-55	3961-3971	confirming	_
22-56	3972-3977	NeuN−	_
22-57	3978-3984	status	_
22-58	3985-3986	.	_

Text=For the prefrontal cortex samples, we collected (mean±SD) NeuN+ (PFC) 667,675±196,847 and NeuN- (PFC) 611,025±203,172 nuclei.
23-1	3987-3990	For	_
23-2	3991-3994	the	_
23-3	3995-4005	prefrontal	_
23-4	4006-4012	cortex	_
23-5	4013-4020	samples	_
23-6	4021-4022	,	_
23-7	4023-4025	we	_
23-8	4026-4035	collected	_
23-9	4036-4037	(	_
23-10	4038-4045	mean±SD	_
23-11	4046-4047	)	_
23-12	4048-4053	NeuN+	_
23-13	4054-4055	(	_
23-14	4056-4059	PFC	_
23-15	4060-4061	)	_
23-16	4062-4077	667,675±196,847	_
23-17	4078-4081	and	_
23-18	4082-4087	NeuN-	_
23-19	4088-4089	(	_
23-20	4090-4093	PFC	_
23-21	4094-4095	)	_
23-22	4096-4111	611,025±203,172	_
23-23	4112-4118	nuclei	_
23-24	4119-4120	.	_

Text=For the anterior cingulate cortex samples, we collected NeuN+ (ACC) 490,585±184,358 and NeuN- (ACC) 653,743±389,284 nuclei.
24-1	4121-4124	For	_
24-2	4125-4128	the	_
24-3	4129-4137	anterior	_
24-4	4138-4147	cingulate	_
24-5	4148-4154	cortex	_
24-6	4155-4162	samples	_
24-7	4163-4164	,	_
24-8	4165-4167	we	_
24-9	4168-4177	collected	_
24-10	4178-4183	NeuN+	_
24-11	4184-4185	(	_
24-12	4186-4189	ACC	_
24-13	4190-4191	)	_
24-14	4192-4207	490,585±184,358	_
24-15	4208-4211	and	_
24-16	4212-4217	NeuN-	_
24-17	4218-4219	(	_
24-18	4220-4223	ACC	_
24-19	4224-4225	)	_
24-20	4226-4241	653,743±389,284	_
24-21	4242-4248	nuclei	_
24-22	4249-4250	.	_

Text=Additional ChIP-seq studies were conducted with homogenized dorsolateral prefrontal cortex as input.
25-1	4251-4261	Additional	_
25-2	4262-4270	ChIP-seq	_
25-3	4271-4278	studies	_
25-4	4279-4283	were	_
25-5	4284-4293	conducted	_
25-6	4294-4298	with	_
25-7	4299-4310	homogenized	_
25-8	4311-4323	dorsolateral	_
25-9	4324-4334	prefrontal	_
25-10	4335-4341	cortex	_
25-11	4342-4344	as	_
25-12	4345-4350	input	_
25-13	4351-4352	.	_

Text=To this end, frozen human postmortem brain tissue (approximately 20–200mg) was homogenized in lysis buffer and the total nuclei were purified.
26-1	4353-4355	To	_
26-2	4356-4360	this	_
26-3	4361-4364	end	_
26-4	4365-4366	,	_
26-5	4367-4373	frozen	_
26-6	4374-4379	human	_
26-7	4380-4390	postmortem	_
26-8	4391-4396	brain	_
26-9	4397-4403	tissue	_
26-10	4404-4405	(	_
26-11	4406-4419	approximately	_
26-12	4420-4428	20–200mg	_
26-13	4429-4430	)	_
26-14	4431-4434	was	_
26-15	4435-4446	homogenized	_
26-16	4447-4449	in	_
26-17	4450-4455	lysis	_
26-18	4456-4462	buffer	_
26-19	4463-4466	and	_
26-20	4467-4470	the	_
26-21	4471-4476	total	_
26-22	4477-4483	nuclei	_
26-23	4484-4488	were	_
26-24	4489-4497	purified	_
26-25	4498-4499	.	_

Text=The nuclei solution was resuspended in 300ul of douncing buffer, treated with 2uL of micrococcal nuclease (0.2U/uL) for 5 minutes at 28 degrees Celsius, followed by 30uL of 500mM of EDTA to stop the reaction.
27-1	4500-4503	The	_
27-2	4504-4510	nuclei	_
27-3	4511-4519	solution	_
27-4	4520-4523	was	_
27-5	4524-4535	resuspended	_
27-6	4536-4538	in	_
27-7	4539-4544	300ul	_
27-8	4545-4547	of	_
27-9	4548-4556	douncing	_
27-10	4557-4563	buffer	_
27-11	4564-4565	,	_
27-12	4566-4573	treated	_
27-13	4574-4578	with	_
27-14	4579-4582	2uL	_
27-15	4583-4585	of	_
27-16	4586-4597	micrococcal	_
27-17	4598-4606	nuclease	_
27-18	4607-4608	(	_
27-19	4609-4616	0.2U/uL	_
27-20	4617-4618	)	_
27-21	4619-4622	for	_
27-22	4623-4624	5	_
27-23	4625-4632	minutes	_
27-24	4633-4635	at	_
27-25	4636-4638	28	_
27-26	4639-4646	degrees	_
27-27	4647-4654	Celsius	_
27-28	4655-4656	,	_
27-29	4657-4665	followed	_
27-30	4666-4668	by	_
27-31	4669-4673	30uL	_
27-32	4674-4676	of	_
27-33	4677-4682	500mM	_
27-34	4683-4685	of	_
27-35	4686-4690	EDTA	_
27-36	4691-4693	to	_
27-37	4694-4698	stop	_
27-38	4699-4702	the	_
27-39	4703-4711	reaction	_
27-40	4712-4713	.	_

Text=After this initial procedure for nuclei preparation and digestion, the sample was processed in the same manner as described for the FACS sorted nuclei samples.
28-1	4714-4719	After	_
28-2	4720-4724	this	_
28-3	4725-4732	initial	_
28-4	4733-4742	procedure	_
28-5	4743-4746	for	_
28-6	4747-4753	nuclei	_
28-7	4754-4765	preparation	_
28-8	4766-4769	and	_
28-9	4770-4779	digestion	_
28-10	4780-4781	,	_
28-11	4782-4785	the	_
28-12	4786-4792	sample	_
28-13	4793-4796	was	_
28-14	4797-4806	processed	_
28-15	4807-4809	in	_
28-16	4810-4813	the	_
28-17	4814-4818	same	_
28-18	4819-4825	manner	_
28-19	4826-4828	as	_
28-20	4829-4838	described	_
28-21	4839-4842	for	_
28-22	4843-4846	the	_
28-23	4847-4851	FACS	_
28-24	4852-4858	sorted	_
28-25	4859-4865	nuclei	_
28-26	4866-4873	samples	_
28-27	4874-4875	.	_

Text=Randomization and blinding To avoid batch effects and other confounds, samples underwent repeated rounds of randomization, including (i) chromatin immunoprecipitation procedures and (ii) library preparation.
29-1	4876-4889	Randomization	_
29-2	4890-4893	and	_
29-3	4894-4902	blinding	_
29-4	4903-4905	To	_
29-5	4906-4911	avoid	_
29-6	4912-4917	batch	_
29-7	4918-4925	effects	_
29-8	4926-4929	and	_
29-9	4930-4935	other	_
29-10	4936-4945	confounds	_
29-11	4946-4947	,	_
29-12	4948-4955	samples	_
29-13	4956-4965	underwent	_
29-14	4966-4974	repeated	_
29-15	4975-4981	rounds	_
29-16	4982-4984	of	_
29-17	4985-4998	randomization	_
29-18	4999-5000	,	_
29-19	5001-5010	including	_
29-20	5011-5012	(	_
29-21	5013-5014	i	_
29-22	5015-5016	)	_
29-23	5017-5026	chromatin	_
29-24	5027-5046	immunoprecipitation	_
29-25	5047-5057	procedures	_
29-26	5058-5061	and	_
29-27	5062-5063	(	_
29-28	5064-5066	ii	_
29-29	5067-5068	)	_
29-30	5069-5076	library	_
29-31	5077-5088	preparation	_
29-32	5089-5090	.	_

Text=Blinding was not relevant to this study, analysts were aware of data generation, processing and donor metadata.
30-1	5091-5099	Blinding	_
30-2	5100-5103	was	_
30-3	5104-5107	not	_
30-4	5108-5116	relevant	_
30-5	5117-5119	to	_
30-6	5120-5124	this	_
30-7	5125-5130	study	_
30-8	5131-5132	,	_
30-9	5133-5141	analysts	_
30-10	5142-5146	were	_
30-11	5147-5152	aware	_
30-12	5153-5155	of	_
30-13	5156-5160	data	_
30-14	5161-5171	generation	_
30-15	5172-5173	,	_
30-16	5174-5184	processing	_
30-17	5185-5188	and	_
30-18	5189-5194	donor	_
30-19	5195-5203	metadata	_
30-20	5204-5205	.	_

Text=ChIP-Seq Alignment Sequenced cell-specific and homogenate ChIP-Seq FASTQ files were aligned to Hg19 (Feb 2009, GRCh37) human genome using the Burrows-Wheeler Aligner (BWA-0.7.8-r455) method with default settings ..
31-1	5206-5214	ChIP-Seq	_
31-2	5215-5224	Alignment	_
31-3	5225-5234	Sequenced	_
31-4	5235-5248	cell-specific	_
31-5	5249-5252	and	_
31-6	5253-5263	homogenate	_
31-7	5264-5272	ChIP-Seq	_
31-8	5273-5278	FASTQ	_
31-9	5279-5284	files	_
31-10	5285-5289	were	_
31-11	5290-5297	aligned	_
31-12	5298-5300	to	_
31-13	5301-5305	Hg19	_
31-14	5306-5307	(	_
31-15	5308-5311	Feb	_
31-16	5312-5316	2009	_
31-17	5317-5318	,	_
31-18	5319-5325	GRCh37	_
31-19	5326-5327	)	_
31-20	5328-5333	human	_
31-21	5334-5340	genome	_
31-22	5341-5346	using	_
31-23	5347-5350	the	_
31-24	5351-5366	Burrows-Wheeler	_
31-25	5367-5374	Aligner	_
31-26	5375-5376	(	_
31-27	5377-5391	BWA-0.7.8-r455	_
31-28	5392-5393	)	_
31-29	5394-5400	method	_
31-30	5401-5405	with	_
31-31	5406-5413	default	_
31-32	5414-5422	settings	_
31-33	5423-5425	..	_

Text=The output files were exported as BAM files.
32-1	5426-5429	The	_
32-2	5430-5436	output	_
32-3	5437-5442	files	_
32-4	5443-5447	were	_
32-5	5448-5456	exported	_
32-6	5457-5459	as	_
32-7	5460-5463	BAM	_
32-8	5464-5469	files	_
32-9	5470-5471	.	_

Text=Filtering and quality control PCR duplicates in aligned BAM files were removed using picard 2.2.4 tool.
33-1	5472-5481	Filtering	_
33-2	5482-5485	and	_
33-3	5486-5493	quality	_
33-4	5494-5501	control	_
33-5	5502-5505	PCR	_
33-6	5506-5516	duplicates	_
33-7	5517-5519	in	_
33-8	5520-5527	aligned	_
33-9	5528-5531	BAM	_
33-10	5532-5537	files	_
33-11	5538-5542	were	_
33-12	5543-5550	removed	_
33-13	5551-5556	using	_
33-14	5557-5563	picard	_
33-15	5564-5569	2.2.4	_
33-16	5570-5574	tool	_
33-17	5575-5576	.	_

Text=After filtering out duplicates, all BAM files were preprocessed to remove unmapped reads and any inter-chromosomal read pairs of length> 10 kb.
34-1	5577-5582	After	_
34-2	5583-5592	filtering	_
34-3	5593-5596	out	_
34-4	5597-5607	duplicates	_
34-5	5608-5609	,	_
34-6	5610-5613	all	_
34-7	5614-5617	BAM	_
34-8	5618-5623	files	_
34-9	5624-5628	were	_
34-10	5629-5641	preprocessed	_
34-11	5642-5644	to	_
34-12	5645-5651	remove	_
34-13	5652-5660	unmapped	_
34-14	5661-5666	reads	_
34-15	5667-5670	and	_
34-16	5671-5674	any	_
34-17	5675-5692	inter-chromosomal	_
34-18	5693-5697	read	_
34-19	5698-5703	pairs	_
34-20	5704-5706	of	_
34-21	5707-5713	length	_
34-22	5714-5715	>	_
34-23	5716-5718	10	_
34-24	5719-5721	kb	_
34-25	5722-5723	.	_

Text=The mapped reads were subsampled to the median number of paired-end reads of each dataset; H3K4me3=13M and H3K27ac=23M (Figure S1).
35-1	5724-5727	The	_
35-2	5728-5734	mapped	_
35-3	5735-5740	reads	_
35-4	5741-5745	were	_
35-5	5746-5756	subsampled	_
35-6	5757-5759	to	_
35-7	5760-5763	the	_
35-8	5764-5770	median	_
35-9	5771-5777	number	_
35-10	5778-5780	of	_
35-11	5781-5791	paired-end	_
35-12	5792-5797	reads	_
35-13	5798-5800	of	_
35-14	5801-5805	each	_
35-15	5806-5813	dataset	_
35-16	5814-5815	;	_
35-17	5816-5827	H3K4me3=13M	_
35-18	5828-5831	and	_
35-19	5832-5843	H3K27ac=23M	_
35-20	5844-5845	(	_
35-21	5846-5852	Figure	_
35-22	5853-5855	S1	_
35-23	5856-5857	)	_
35-24	5858-5859	.	_

Text=Any samples after removing duplicates with sequencing depth <10M (from ENCODE) were flagged in this study.
36-1	5860-5863	Any	_
36-2	5864-5871	samples	_
36-3	5872-5877	after	_
36-4	5878-5886	removing	_
36-5	5887-5897	duplicates	_
36-6	5898-5902	with	_
36-7	5903-5913	sequencing	_
36-8	5914-5919	depth	_
36-9	5920-5921	<	_
36-10	5922-5925	10M	_
36-11	5926-5927	(	_
36-12	5928-5932	from	_
36-13	5933-5939	ENCODE	_
36-14	5940-5941	)	_
36-15	5942-5946	were	_
36-16	5947-5954	flagged	_
36-17	5955-5957	in	_
36-18	5958-5962	this	_
36-19	5963-5968	study	_
36-20	5969-5970	.	_

Text=These uniformly subsampled files were used for further downstream analysis.
37-1	5971-5976	These	_
37-2	5977-5986	uniformly	_
37-3	5987-5997	subsampled	_
37-4	5998-6003	files	_
37-5	6004-6008	were	_
37-6	6009-6013	used	_
37-7	6014-6017	for	_
37-8	6018-6025	further	_
37-9	6026-6036	downstream	_
37-10	6037-6045	analysis	_
37-11	6046-6047	.	_

Text=Experimental design and statistical analyses For a general overview of the bioinformatical analyses see Figure S2.
38-1	6048-6060	Experimental	_
38-2	6061-6067	design	_
38-3	6068-6071	and	_
38-4	6072-6083	statistical	_
38-5	6084-6092	analyses	_
38-6	6093-6096	For	_
38-7	6097-6098	a	_
38-8	6099-6106	general	_
38-9	6107-6115	overview	_
38-10	6116-6118	of	_
38-11	6119-6122	the	_
38-12	6123-6138	bioinformatical	_
38-13	6139-6147	analyses	_
38-14	6148-6151	see	_
38-15	6152-6158	Figure	_
38-16	6159-6161	S2	_
38-17	6162-6163	.	_

Text=To determine the best Peak calling method, we used p-value from irreproducible discovery rate (IDR) analysis where the input was peaks called using MACS2, PeakSeq and SPP methods.
39-1	6164-6166	To	_
39-2	6167-6176	determine	_
39-3	6177-6180	the	_
39-4	6181-6185	best	_
39-5	6186-6190	Peak	_
39-6	6191-6198	calling	_
39-7	6199-6205	method	_
39-8	6206-6207	,	_
39-9	6208-6210	we	_
39-10	6211-6215	used	_
39-11	6216-6223	p-value	_
39-12	6224-6228	from	_
39-13	6229-6243	irreproducible	_
39-14	6244-6253	discovery	_
39-15	6254-6258	rate	_
39-16	6259-6260	(	_
39-17	6261-6264	IDR	_
39-18	6265-6266	)	_
39-19	6267-6275	analysis	_
39-20	6276-6281	where	_
39-21	6282-6285	the	_
39-22	6286-6291	input	_
39-23	6292-6295	was	_
39-24	6296-6301	peaks	_
39-25	6302-6308	called	_
39-26	6309-6314	using	_
39-27	6315-6320	MACS2	_
39-28	6321-6322	,	_
39-29	6323-6330	PeakSeq	_
39-30	6331-6334	and	_
39-31	6335-6338	SPP	_
39-32	6339-6346	methods	_
39-33	6347-6348	.	_

Text=To identify differentially modified histone peaks across cell types and brain regions, we applied quasi-likelihood negative binomial generalized log-linear model on normalized CPM matrix.
40-1	6349-6351	To	_
40-2	6352-6360	identify	_
40-3	6361-6375	differentially	_
40-4	6376-6384	modified	_
40-5	6385-6392	histone	_
40-6	6393-6398	peaks	_
40-7	6399-6405	across	_
40-8	6406-6410	cell	_
40-9	6411-6416	types	_
40-10	6417-6420	and	_
40-11	6421-6426	brain	_
40-12	6427-6434	regions	_
40-13	6435-6436	,	_
40-14	6437-6439	we	_
40-15	6440-6447	applied	_
40-16	6448-6464	quasi-likelihood	_
40-17	6465-6473	negative	_
40-18	6474-6482	binomial	_
40-19	6483-6494	generalized	_
40-20	6495-6505	log-linear	_
40-21	6506-6511	model	_
40-22	6512-6514	on	_
40-23	6515-6525	normalized	_
40-24	6526-6529	CPM	_
40-25	6530-6536	matrix	_
40-26	6537-6538	.	_

Text=For multiple testing correction of identified differential peaks, we used Benjamini-Hochberg method on the p-values to control false discovery rate.
41-1	6539-6542	For	_
41-2	6543-6551	multiple	_
41-3	6552-6559	testing	_
41-4	6560-6570	correction	_
41-5	6571-6573	of	_
41-6	6574-6584	identified	_
41-7	6585-6597	differential	_
41-8	6598-6603	peaks	_
41-9	6604-6605	,	_
41-10	6606-6608	we	_
41-11	6609-6613	used	_
41-12	6614-6632	Benjamini-Hochberg	_
41-13	6633-6639	method	_
41-14	6640-6642	on	_
41-15	6643-6646	the	_
41-16	6647-6655	p-values	_
41-17	6656-6658	to	_
41-18	6659-6666	control	_
41-19	6667-6672	false	_
41-20	6673-6682	discovery	_
41-21	6683-6687	rate	_
41-22	6688-6689	.	_

Text=For pathway enrichment analysis of differentially modified peaks, we used p-values from hypergeometric test computed by GREAT and did multiple testing correction using Bonferroni correction method.
42-1	6690-6693	For	_
42-2	6694-6701	pathway	_
42-3	6702-6712	enrichment	_
42-4	6713-6721	analysis	_
42-5	6722-6724	of	_
42-6	6725-6739	differentially	_
42-7	6740-6748	modified	_
42-8	6749-6754	peaks	_
42-9	6755-6756	,	_
42-10	6757-6759	we	_
42-11	6760-6764	used	_
42-12	6765-6773	p-values	_
42-13	6774-6778	from	_
42-14	6779-6793	hypergeometric	_
42-15	6794-6798	test	_
42-16	6799-6807	computed	_
42-17	6808-6810	by	_
42-18	6811-6816	GREAT	_
42-19	6817-6820	and	_
42-20	6821-6824	did	_
42-21	6825-6833	multiple	_
42-22	6834-6841	testing	_
42-23	6842-6852	correction	_
42-24	6853-6858	using	_
42-25	6859-6869	Bonferroni	_
42-26	6870-6880	correction	_
42-27	6881-6887	method	_
42-28	6888-6889	.	_

Text=To test overlap of identified peaks with disease and trait-associated genetic variants, we used LDSR method which take p-values of peak regions as an input.
43-1	6890-6892	To	_
43-2	6893-6897	test	_
43-3	6898-6905	overlap	_
43-4	6906-6908	of	_
43-5	6909-6919	identified	_
43-6	6920-6925	peaks	_
43-7	6926-6930	with	_
43-8	6931-6938	disease	_
43-9	6939-6942	and	_
43-10	6943-6959	trait-associated	_
43-11	6960-6967	genetic	_
43-12	6968-6976	variants	_
43-13	6977-6978	,	_
43-14	6979-6981	we	_
43-15	6982-6986	used	_
43-16	6987-6991	LDSR	_
43-17	6992-6998	method	_
43-18	6999-7004	which	_
43-19	7005-7009	take	_
43-20	7010-7018	p-values	_
43-21	7019-7021	of	_
43-22	7022-7026	peak	_
43-23	7027-7034	regions	_
43-24	7035-7037	as	_
43-25	7038-7040	an	_
43-26	7041-7046	input	_
43-27	7047-7048	.	_

Text=See methods paragraphs below for additional details on statistical methods.
44-1	7049-7052	See	_
44-2	7053-7060	methods	_
44-3	7061-7071	paragraphs	_
44-4	7072-7077	below	_
44-5	7078-7081	for	_
44-6	7082-7092	additional	_
44-7	7093-7100	details	_
44-8	7101-7103	on	_
44-9	7104-7115	statistical	_
44-10	7116-7123	methods	_
44-11	7124-7125	.	_

Text=Variant Calling Variants were called from BAM files using GATK 3.5–0 to produce gVCF files.
45-1	7126-7133	Variant	_
45-2	7134-7141	Calling	_
45-3	7142-7150	Variants	_
45-4	7151-7155	were	_
45-5	7156-7162	called	_
45-6	7163-7167	from	_
45-7	7168-7171	BAM	_
45-8	7172-7177	files	_
45-9	7178-7183	using	_
45-10	7184-7188	GATK	_
45-11	7189-7194	3.5–0	_
45-12	7195-7197	to	_
45-13	7198-7205	produce	_
45-14	7206-7210	gVCF	_
45-15	7211-7216	files	_
45-16	7217-7218	.	_

Text=Variant concordance analysis was performed to identify any mislabeling issues.
46-1	7219-7226	Variant	_
46-2	7227-7238	concordance	_
46-3	7239-7247	analysis	_
46-4	7248-7251	was	_
46-5	7252-7261	performed	_
46-6	7262-7264	to	_
46-7	7265-7273	identify	_
46-8	7274-7277	any	_
46-9	7278-7289	mislabeling	_
46-10	7290-7296	issues	_
46-11	7297-7298	.	_

Text=Variants on chr22 were merged using GATK ’ s CombineVCFs functionality.
47-1	7299-7307	Variants	_
47-2	7308-7310	on	_
47-3	7311-7316	chr22	_
47-4	7317-7321	were	_
47-5	7322-7328	merged	_
47-6	7329-7334	using	_
47-7	7335-7339	GATK	_
47-8	7340-7341	’	_
47-9	7342-7343	s	_
47-10	7344-7355	CombineVCFs	_
47-11	7356-7369	functionality	_
47-12	7370-7371	.	_

Text=Variant concordance between all pairs of samples was evaluated with bcftools v1.3.
48-1	7372-7379	Variant	_
48-2	7380-7391	concordance	_
48-3	7392-7399	between	_
48-4	7400-7403	all	_
48-5	7404-7409	pairs	_
48-6	7410-7412	of	_
48-7	7413-7420	samples	_
48-8	7421-7424	was	_
48-9	7425-7434	evaluated	_
48-10	7435-7439	with	_
48-11	7440-7448	bcftools	_
48-12	7449-7453	v1.3	_
48-13	7454-7455	.	_

Text=Two mislabeled samples were identified and were relabeled appropriately for all downstream analysis.
49-1	7456-7459	Two	_
49-2	7460-7470	mislabeled	_
49-3	7471-7478	samples	_
49-4	7479-7483	were	_
49-5	7484-7494	identified	_
49-6	7495-7498	and	_
49-7	7499-7503	were	_
49-8	7504-7513	relabeled	_
49-9	7514-7527	appropriately	_
49-10	7528-7531	for	_
49-11	7532-7535	all	_
49-12	7536-7546	downstream	_
49-13	7547-7555	analysis	_
49-14	7556-7557	.	_

Text=Comparison of peak calling methods For each histone mark, we consolidated BAMs across all individuals for PFC neuronal set and subsampled 3 files.
50-1	7558-7568	Comparison	_
50-2	7569-7571	of	_
50-3	7572-7576	peak	_
50-4	7577-7584	calling	_
50-5	7585-7592	methods	_
50-6	7593-7596	For	_
50-7	7597-7601	each	_
50-8	7602-7609	histone	_
50-9	7610-7614	mark	_
50-10	7615-7616	,	_
50-11	7617-7619	we	_
50-12	7620-7632	consolidated	_
50-13	7633-7637	BAMs	_
50-14	7638-7644	across	_
50-15	7645-7648	all	_
50-16	7649-7660	individuals	_
50-17	7661-7664	for	_
50-18	7665-7668	PFC	_
50-19	7669-7677	neuronal	_
50-20	7678-7681	set	_
50-21	7682-7685	and	_
50-22	7686-7696	subsampled	_
50-23	7697-7698	3	_
50-24	7699-7704	files	_
50-25	7705-7706	.	_

Text=Our approach to determine best peak calling method was to derive irreproducible discovery rate (IDR) after calling peaks using MACS (v.2.1.0), SPP (v.1.13) and PeakSeq methods.
51-1	7707-7710	Our	_
51-2	7711-7719	approach	_
51-3	7720-7722	to	_
51-4	7723-7732	determine	_
51-5	7733-7737	best	_
51-6	7738-7742	peak	_
51-7	7743-7750	calling	_
51-8	7751-7757	method	_
51-9	7758-7761	was	_
51-10	7762-7764	to	_
51-11	7765-7771	derive	_
51-12	7772-7786	irreproducible	_
51-13	7787-7796	discovery	_
51-14	7797-7801	rate	_
51-15	7802-7803	(	_
51-16	7804-7807	IDR	_
51-17	7808-7809	)	_
51-18	7810-7815	after	_
51-19	7816-7823	calling	_
51-20	7824-7829	peaks	_
51-21	7830-7835	using	_
51-22	7836-7840	MACS	_
51-23	7841-7842	(	_
51-24	7843-7850	v.2.1.0	_
51-25	7851-7852	)	_
51-26	7853-7854	,	_
51-27	7855-7858	SPP	_
51-28	7859-7860	(	_
51-29	7861-7867	v.1.13	_
51-30	7868-7869	)	_
51-31	7870-7873	and	_
51-32	7874-7881	PeakSeq	_
51-33	7882-7889	methods	_
51-34	7890-7891	.	_

Text=Afterwards, the method which gave maximum number of overlapping regions between subsamples at 5% IDR was used for peak calling on full dataset.
52-1	7892-7902	Afterwards	_
52-2	7903-7904	,	_
52-3	7905-7908	the	_
52-4	7909-7915	method	_
52-5	7916-7921	which	_
52-6	7922-7926	gave	_
52-7	7927-7934	maximum	_
52-8	7935-7941	number	_
52-9	7942-7944	of	_
52-10	7945-7956	overlapping	_
52-11	7957-7964	regions	_
52-12	7965-7972	between	_
52-13	7973-7983	subsamples	_
52-14	7984-7986	at	_
52-15	7987-7988	5	_
52-16	7989-7990	%	_
52-17	7991-7994	IDR	_
52-18	7995-7998	was	_
52-19	7999-8003	used	_
52-20	8004-8007	for	_
52-21	8008-8012	peak	_
52-22	8013-8020	calling	_
52-23	8021-8023	on	_
52-24	8024-8028	full	_
52-25	8029-8036	dataset	_
52-26	8037-8038	.	_

Text=We find that MACS2 is the best peak caller method with maximum number of peak regions at 5% IDR for both marks (Figure S1D).
53-1	8039-8041	We	_
53-2	8042-8046	find	_
53-3	8047-8051	that	_
53-4	8052-8057	MACS2	_
53-5	8058-8060	is	_
53-6	8061-8064	the	_
53-7	8065-8069	best	_
53-8	8070-8074	peak	_
53-9	8075-8081	caller	_
53-10	8082-8088	method	_
53-11	8089-8093	with	_
53-12	8094-8101	maximum	_
53-13	8102-8108	number	_
53-14	8109-8111	of	_
53-15	8112-8116	peak	_
53-16	8117-8124	regions	_
53-17	8125-8127	at	_
53-18	8128-8129	5	_
53-19	8130-8131	%	_
53-20	8132-8135	IDR	_
53-21	8136-8139	for	_
53-22	8140-8144	both	_
53-23	8145-8150	marks	_
53-24	8151-8152	(	_
53-25	8153-8159	Figure	_
53-26	8160-8163	S1D	_
53-27	8164-8165	)	_
53-28	8166-8167	.	_

Text=ENCODE uses IDR on technical replicates of samples to determine the reproducibility of peaks while we have used it globally on our dataset.
54-1	8168-8174	ENCODE	_
54-2	8175-8179	uses	_
54-3	8180-8183	IDR	_
54-4	8184-8186	on	_
54-5	8187-8196	technical	_
54-6	8197-8207	replicates	_
54-7	8208-8210	of	_
54-8	8211-8218	samples	_
54-9	8219-8221	to	_
54-10	8222-8231	determine	_
54-11	8232-8235	the	_
54-12	8236-8251	reproducibility	_
54-13	8252-8254	of	_
54-14	8255-8260	peaks	_
54-15	8261-8266	while	_
54-16	8267-8269	we	_
54-17	8270-8274	have	_
54-18	8275-8279	used	_
54-19	8280-8282	it	_
54-20	8283-8291	globally	_
54-21	8292-8294	on	_
54-22	8295-8298	our	_
54-23	8299-8306	dataset	_
54-24	8307-8308	.	_

Text=We applied following parameters in MACS2: SE, SE no model, PE, PE no model and p-values = 0.01, 0.1, 0.5, SPP: FDR 0.01, 0.05, 0.99, background model=simulated, minimum interpeak distance=150 and PeakSeq: target FDR=0.01, 0.05, 0.99.
55-1	8309-8311	We	_
55-2	8312-8319	applied	_
55-3	8320-8329	following	_
55-4	8330-8340	parameters	_
55-5	8341-8343	in	_
55-6	8344-8349	MACS2	_
55-7	8350-8351	:	_
55-8	8352-8354	SE	_
55-9	8355-8356	,	_
55-10	8357-8359	SE	_
55-11	8360-8362	no	_
55-12	8363-8368	model	_
55-13	8369-8370	,	_
55-14	8371-8373	PE	_
55-15	8374-8375	,	_
55-16	8376-8378	PE	_
55-17	8379-8381	no	_
55-18	8382-8387	model	_
55-19	8388-8391	and	_
55-20	8392-8400	p-values	_
55-21	8401-8402	=	_
55-22	8403-8407	0.01	_
55-23	8408-8409	,	_
55-24	8410-8413	0.1	_
55-25	8414-8415	,	_
55-26	8416-8419	0.5	_
55-27	8420-8421	,	_
55-28	8422-8425	SPP	_
55-29	8426-8427	:	_
55-30	8428-8431	FDR	_
55-31	8432-8436	0.01	_
55-32	8437-8438	,	_
55-33	8439-8443	0.05	_
55-34	8444-8445	,	_
55-35	8446-8450	0.99	_
55-36	8451-8452	,	_
55-37	8453-8463	background	_
55-38	8464-8479	model=simulated	_
55-39	8480-8481	,	_
55-40	8482-8489	minimum	_
55-41	8490-8499	interpeak	_
55-42	8500-8512	distance=150	_
55-43	8513-8516	and	_
55-44	8517-8524	PeakSeq	_
55-45	8525-8526	:	_
55-46	8527-8533	target	_
55-47	8534-8542	FDR=0.01	_
55-48	8543-8544	,	_
55-49	8545-8549	0.05	_
55-50	8550-8551	,	_
55-51	8552-8556	0.99	_
55-52	8557-8558	.	_

Text=Consolidating Datasets For cell-specific data set, we consolidated uniformly processed BAMs by cell type for each brain region.
56-1	8559-8572	Consolidating	_
56-2	8573-8581	Datasets	_
56-3	8582-8585	For	_
56-4	8586-8599	cell-specific	_
56-5	8600-8604	data	_
56-6	8605-8608	set	_
56-7	8609-8610	,	_
56-8	8611-8613	we	_
56-9	8614-8626	consolidated	_
56-10	8627-8636	uniformly	_
56-11	8637-8646	processed	_
56-12	8647-8651	BAMs	_
56-13	8652-8654	by	_
56-14	8655-8659	cell	_
56-15	8660-8664	type	_
56-16	8665-8668	for	_
56-17	8669-8673	each	_
56-18	8674-8679	brain	_
56-19	8680-8686	region	_
56-20	8687-8688	.	_

Text=For example H3K4me3 modified Chip-seq BAMs from neuronal cells from PFC brain region for all individuals (n=17) were consolidated as H3K4me3-PFC neuronal data set.
57-1	8689-8692	For	_
57-2	8693-8700	example	_
57-3	8701-8708	H3K4me3	_
57-4	8709-8717	modified	_
57-5	8718-8726	Chip-seq	_
57-6	8727-8731	BAMs	_
57-7	8732-8736	from	_
57-8	8737-8745	neuronal	_
57-9	8746-8751	cells	_
57-10	8752-8756	from	_
57-11	8757-8760	PFC	_
57-12	8761-8766	brain	_
57-13	8767-8773	region	_
57-14	8774-8777	for	_
57-15	8778-8781	all	_
57-16	8782-8793	individuals	_
57-17	8794-8795	(	_
57-18	8796-8800	n=17	_
57-19	8801-8802	)	_
57-20	8803-8807	were	_
57-21	8808-8820	consolidated	_
57-22	8821-8823	as	_
57-23	8824-8835	H3K4me3-PFC	_
57-24	8836-8844	neuronal	_
57-25	8845-8849	data	_
57-26	8850-8853	set	_
57-27	8854-8855	.	_

Text=Consolidating the BAMs by cell type for each brain region produces 8 large BAM files for both marks: 1) H3K4me3-PFC neuronal 2) H3K4me3-PFC neuron-depleted 3) H3K4me3-ACC neuronal 4) H3K4me3-ACC neuron-depleted and 5) H3K27ac-PFC neuronal 6) H3K27ac-PFC neuron-depleted 7) H3K27ac-ACC neuronal 8) H3K27ac-ACC neuron-depleted.
58-1	8856-8869	Consolidating	_
58-2	8870-8873	the	_
58-3	8874-8878	BAMs	_
58-4	8879-8881	by	_
58-5	8882-8886	cell	_
58-6	8887-8891	type	_
58-7	8892-8895	for	_
58-8	8896-8900	each	_
58-9	8901-8906	brain	_
58-10	8907-8913	region	_
58-11	8914-8922	produces	_
58-12	8923-8924	8	_
58-13	8925-8930	large	_
58-14	8931-8934	BAM	_
58-15	8935-8940	files	_
58-16	8941-8944	for	_
58-17	8945-8949	both	_
58-18	8950-8955	marks	_
58-19	8956-8957	:	_
58-20	8958-8959	1	_
58-21	8960-8961	)	_
58-22	8962-8973	H3K4me3-PFC	_
58-23	8974-8982	neuronal	_
58-24	8983-8984	2	_
58-25	8985-8986	)	_
58-26	8987-8998	H3K4me3-PFC	_
58-27	8999-9014	neuron-depleted	_
58-28	9015-9016	3	_
58-29	9017-9018	)	_
58-30	9019-9030	H3K4me3-ACC	_
58-31	9031-9039	neuronal	_
58-32	9040-9041	4	_
58-33	9042-9043	)	_
58-34	9044-9055	H3K4me3-ACC	_
58-35	9056-9071	neuron-depleted	_
58-36	9072-9075	and	_
58-37	9076-9077	5	_
58-38	9078-9079	)	_
58-39	9080-9091	H3K27ac-PFC	_
58-40	9092-9100	neuronal	_
58-41	9101-9102	6	_
58-42	9103-9104	)	_
58-43	9105-9116	H3K27ac-PFC	_
58-44	9117-9132	neuron-depleted	_
58-45	9133-9134	7	_
58-46	9135-9136	)	_
58-47	9137-9148	H3K27ac-ACC	_
58-48	9149-9157	neuronal	_
58-49	9158-9159	8	_
58-50	9160-9161	)	_
58-51	9162-9173	H3K27ac-ACC	_
58-52	9174-9189	neuron-depleted	_
58-53	9190-9191	.	_

Text=Chip-seq BAMs for homogenate were generated from one brain region, therefore, all individuals BAMs were consolidated into 2 large BAM files for both marks as 1) H3K4me3-PFC HBCC homogenate 2) H3K27ac-PFC HBCC homogenate.
59-1	9192-9200	Chip-seq	_
59-2	9201-9205	BAMs	_
59-3	9206-9209	for	_
59-4	9210-9220	homogenate	_
59-5	9221-9225	were	_
59-6	9226-9235	generated	_
59-7	9236-9240	from	_
59-8	9241-9244	one	_
59-9	9245-9250	brain	_
59-10	9251-9257	region	_
59-11	9258-9259	,	_
59-12	9260-9269	therefore	_
59-13	9270-9271	,	_
59-14	9272-9275	all	_
59-15	9276-9287	individuals	_
59-16	9288-9292	BAMs	_
59-17	9293-9297	were	_
59-18	9298-9310	consolidated	_
59-19	9311-9315	into	_
59-20	9316-9317	2	_
59-21	9318-9323	large	_
59-22	9324-9327	BAM	_
59-23	9328-9333	files	_
59-24	9334-9337	for	_
59-25	9338-9342	both	_
59-26	9343-9348	marks	_
59-27	9349-9351	as	_
59-28	9352-9353	1	_
59-29	9354-9355	)	_
59-30	9356-9367	H3K4me3-PFC	_
59-31	9368-9372	HBCC	_
59-32	9373-9383	homogenate	_
59-33	9384-9385	2	_
59-34	9386-9387	)	_
59-35	9388-9399	H3K27ac-PFC	_
59-36	9400-9404	HBCC	_
59-37	9405-9415	homogenate	_
59-38	9416-9417	.	_

Text=Similarly input samples were consolidated separately for cell-specific and homogenate datasets.
60-1	9418-9427	Similarly	_
60-2	9428-9433	input	_
60-3	9434-9441	samples	_
60-4	9442-9446	were	_
60-5	9447-9459	consolidated	_
60-6	9460-9470	separately	_
60-7	9471-9474	for	_
60-8	9475-9488	cell-specific	_
60-9	9489-9492	and	_
60-10	9493-9503	homogenate	_
60-11	9504-9512	datasets	_
60-12	9513-9514	.	_

Text=For details of set of individual files contributing to consolidated dataset (Table S3).
61-1	9515-9518	For	_
61-2	9519-9526	details	_
61-3	9527-9529	of	_
61-4	9530-9533	set	_
61-5	9534-9536	of	_
61-6	9537-9547	individual	_
61-7	9548-9553	files	_
61-8	9554-9566	contributing	_
61-9	9567-9569	to	_
61-10	9570-9582	consolidated	_
61-11	9583-9590	dataset	_
61-12	9591-9592	(	_
61-13	9593-9598	Table	_
61-14	9599-9601	S3	_
61-15	9602-9603	)	_
61-16	9604-9605	.	_

Text=We use these cell-specific (n=8) and homogenate (n=2) consolidated BAMs for further downstream analysis.
62-1	9606-9608	We	_
62-2	9609-9612	use	_
62-3	9613-9618	these	_
62-4	9619-9632	cell-specific	_
62-5	9633-9634	(	_
62-6	9635-9638	n=8	_
62-7	9639-9640	)	_
62-8	9641-9644	and	_
62-9	9645-9655	homogenate	_
62-10	9656-9657	(	_
62-11	9658-9661	n=2	_
62-12	9662-9663	)	_
62-13	9664-9676	consolidated	_
62-14	9677-9681	BAMs	_
62-15	9682-9685	for	_
62-16	9686-9693	further	_
62-17	9694-9704	downstream	_
62-18	9705-9713	analysis	_
62-19	9714-9715	.	_

Text=Peak Calling Narrow peak regions were called for H3K4me3 histone mark datasets on each of the consolidated cell-specific and homogenate BAMs: 1) H3K4me3-PFC neuronal 2) H3K4me3-PFC neuron-depleted 3) H3K4me3-ACC neuronal 4) H3K4me3-ACC neuron-depleted 5) H3K4me3-PFC HBCC homogenate with Poisson p-value = 0.01 with--keep-dup all--nomodel--extsize = fragment length.
63-1	9716-9720	Peak	_
63-2	9721-9728	Calling	_
63-3	9729-9735	Narrow	_
63-4	9736-9740	peak	_
63-5	9741-9748	regions	_
63-6	9749-9753	were	_
63-7	9754-9760	called	_
63-8	9761-9764	for	_
63-9	9765-9772	H3K4me3	_
63-10	9773-9780	histone	_
63-11	9781-9785	mark	_
63-12	9786-9794	datasets	_
63-13	9795-9797	on	_
63-14	9798-9802	each	_
63-15	9803-9805	of	_
63-16	9806-9809	the	_
63-17	9810-9822	consolidated	_
63-18	9823-9836	cell-specific	_
63-19	9837-9840	and	_
63-20	9841-9851	homogenate	_
63-21	9852-9856	BAMs	_
63-22	9857-9858	:	_
63-23	9859-9860	1	_
63-24	9861-9862	)	_
63-25	9863-9874	H3K4me3-PFC	_
63-26	9875-9883	neuronal	_
63-27	9884-9885	2	_
63-28	9886-9887	)	_
63-29	9888-9899	H3K4me3-PFC	_
63-30	9900-9915	neuron-depleted	_
63-31	9916-9917	3	_
63-32	9918-9919	)	_
63-33	9920-9931	H3K4me3-ACC	_
63-34	9932-9940	neuronal	_
63-35	9941-9942	4	_
63-36	9943-9944	)	_
63-37	9945-9956	H3K4me3-ACC	_
63-38	9957-9972	neuron-depleted	_
63-39	9973-9974	5	_
63-40	9975-9976	)	_
63-41	9977-9988	H3K4me3-PFC	_
63-42	9989-9993	HBCC	_
63-43	9994-10004	homogenate	_
63-44	10005-10009	with	_
63-45	10010-10017	Poisson	_
63-46	10018-10025	p-value	_
63-47	10026-10027	=	_
63-48	10028-10032	0.01	_
63-49	10033-10037	with	_
63-50	10038-10040	--	_
63-51	10041-10049	keep-dup	_
63-52	10050-10053	all	_
63-53	10054-10056	--	_
63-54	10057-10064	nomodel	_
63-55	10065-10067	--	_
63-56	10068-10075	extsize	_
63-57	10076-10077	=	_
63-58	10078-10086	fragment	_
63-59	10087-10093	length	_
63-60	10094-10095	.	_

Text=Broad peak regions were called for H3K27ac histone mark datasets on each of the consolidated BAMs 6) H3K27ac-PFC neuronal 7) H3K27ac-PFC neuron-depleted 8) H3K27ac-ACC neuronal 9) H3K27ac-ACC neuron-depleted and 10) H3K27ac-PFC HBCC homogenate using latter parameters.
64-1	10096-10101	Broad	_
64-2	10102-10106	peak	_
64-3	10107-10114	regions	_
64-4	10115-10119	were	_
64-5	10120-10126	called	_
64-6	10127-10130	for	_
64-7	10131-10138	H3K27ac	_
64-8	10139-10146	histone	_
64-9	10147-10151	mark	_
64-10	10152-10160	datasets	_
64-11	10161-10163	on	_
64-12	10164-10168	each	_
64-13	10169-10171	of	_
64-14	10172-10175	the	_
64-15	10176-10188	consolidated	_
64-16	10189-10193	BAMs	_
64-17	10194-10195	6	_
64-18	10196-10197	)	_
64-19	10198-10209	H3K27ac-PFC	_
64-20	10210-10218	neuronal	_
64-21	10219-10220	7	_
64-22	10221-10222	)	_
64-23	10223-10234	H3K27ac-PFC	_
64-24	10235-10250	neuron-depleted	_
64-25	10251-10252	8	_
64-26	10253-10254	)	_
64-27	10255-10266	H3K27ac-ACC	_
64-28	10267-10275	neuronal	_
64-29	10276-10277	9	_
64-30	10278-10279	)	_
64-31	10280-10291	H3K27ac-ACC	_
64-32	10292-10307	neuron-depleted	_
64-33	10308-10311	and	_
64-34	10312-10314	10	_
64-35	10315-10316	)	_
64-36	10317-10328	H3K27ac-PFC	_
64-37	10329-10333	HBCC	_
64-38	10334-10344	homogenate	_
64-39	10345-10350	using	_
64-40	10351-10357	latter	_
64-41	10358-10368	parameters	_
64-42	10369-10370	.	_

Text=The consolidated cell-type and homogenate input control samples were used as control inputs for peak calling on cell-specific and homogenate datasets respectively.
65-1	10371-10374	The	_
65-2	10375-10387	consolidated	_
65-3	10388-10397	cell-type	_
65-4	10398-10401	and	_
65-5	10402-10412	homogenate	_
65-6	10413-10418	input	_
65-7	10419-10426	control	_
65-8	10427-10434	samples	_
65-9	10435-10439	were	_
65-10	10440-10444	used	_
65-11	10445-10447	as	_
65-12	10448-10455	control	_
65-13	10456-10462	inputs	_
65-14	10463-10466	for	_
65-15	10467-10471	peak	_
65-16	10472-10479	calling	_
65-17	10480-10482	on	_
65-18	10483-10496	cell-specific	_
65-19	10497-10500	and	_
65-20	10501-10511	homogenate	_
65-21	10512-10520	datasets	_
65-22	10521-10533	respectively	_
65-23	10534-10535	.	_

Text=All called peaks were filtered from blacklisted region peaks and p-values> 3.05 (p-value obtained from IDR analysis) for downstream analysis.
66-1	10536-10539	All	_
66-2	10540-10546	called	_
66-3	10547-10552	peaks	_
66-4	10553-10557	were	_
66-5	10558-10566	filtered	_
66-6	10567-10571	from	_
66-7	10572-10583	blacklisted	_
66-8	10584-10590	region	_
66-9	10591-10596	peaks	_
66-10	10597-10600	and	_
66-11	10601-10609	p-values	_
66-12	10610-10611	>	_
66-13	10612-10616	3.05	_
66-14	10617-10618	(	_
66-15	10619-10626	p-value	_
66-16	10627-10635	obtained	_
66-17	10636-10640	from	_
66-18	10641-10644	IDR	_
66-19	10645-10653	analysis	_
66-20	10654-10655	)	_
66-21	10656-10659	for	_
66-22	10660-10670	downstream	_
66-23	10671-10679	analysis	_
66-24	10680-10681	.	_

Text=For each mark, the coordinates for peaks for each set PFC neuronal, PFC neuron-depleted, ACC neuronal, ACC neuron-depleted used in this study are given for cell specifc-H3K4me3=syn11306591, homogenate-H3K4me3=syn11306589, cell specific-H3K27ac= syn9998643 and homogenate-H3K27ac= syn11485660.
67-1	10682-10685	For	_
67-2	10686-10690	each	_
67-3	10691-10695	mark	_
67-4	10696-10697	,	_
67-5	10698-10701	the	_
67-6	10702-10713	coordinates	_
67-7	10714-10717	for	_
67-8	10718-10723	peaks	_
67-9	10724-10727	for	_
67-10	10728-10732	each	_
67-11	10733-10736	set	_
67-12	10737-10740	PFC	_
67-13	10741-10749	neuronal	_
67-14	10750-10751	,	_
67-15	10752-10755	PFC	_
67-16	10756-10771	neuron-depleted	_
67-17	10772-10773	,	_
67-18	10774-10777	ACC	_
67-19	10778-10786	neuronal	_
67-20	10787-10788	,	_
67-21	10789-10792	ACC	_
67-22	10793-10808	neuron-depleted	_
67-23	10809-10813	used	_
67-24	10814-10816	in	_
67-25	10817-10821	this	_
67-26	10822-10827	study	_
67-27	10828-10831	are	_
67-28	10832-10837	given	_
67-29	10838-10841	for	_
67-30	10842-10846	cell	_
67-31	10847-10874	specifc-H3K4me3=syn11306591	_
67-32	10875-10876	,	_
67-33	10877-10907	homogenate-H3K4me3=syn11306589	_
67-34	10908-10909	,	_
67-35	10910-10914	cell	_
67-36	10915-10932	specific-H3K27ac=	_
67-37	10933-10943	syn9998643	_
67-38	10944-10947	and	_
67-39	10948-10967	homogenate-H3K27ac=	_
67-40	10968-10979	syn11485660	_
67-41	10980-10981	.	_

Text=Before calling peaks using MACS2, we first ran SPP to find the fragment length using maximum strand cross correlation (Figure S1B, S2).
68-1	10982-10988	Before	_
68-2	10989-10996	calling	_
68-3	10997-11002	peaks	_
68-4	11003-11008	using	_
68-5	11009-11014	MACS2	_
68-6	11015-11016	,	_
68-7	11017-11019	we	_
68-8	11020-11025	first	_
68-9	11026-11029	ran	_
68-10	11030-11033	SPP	_
68-11	11034-11036	to	_
68-12	11037-11041	find	_
68-13	11042-11045	the	_
68-14	11046-11054	fragment	_
68-15	11055-11061	length	_
68-16	11062-11067	using	_
68-17	11068-11075	maximum	_
68-18	11076-11082	strand	_
68-19	11083-11088	cross	_
68-20	11089-11100	correlation	_
68-21	11101-11102	(	_
68-22	11103-11109	Figure	_
68-23	11110-11113	S1B	_
68-24	11114-11115	,	_
68-25	11116-11118	S2	_
68-26	11119-11120	)	_
68-27	11121-11122	.	_

Text=For QC parameters (NSC, RSC, PBC and number of mapped reads) of uniformly reprocessed and consolidated ChIP-Seq sets we used phantompeakqualtools.
69-1	11123-11126	For	_
69-2	11127-11129	QC	_
69-3	11130-11140	parameters	_
69-4	11141-11142	(	_
69-5	11143-11146	NSC	_
69-6	11147-11148	,	_
69-7	11149-11152	RSC	_
69-8	11153-11154	,	_
69-9	11155-11158	PBC	_
69-10	11159-11162	and	_
69-11	11163-11169	number	_
69-12	11170-11172	of	_
69-13	11173-11179	mapped	_
69-14	11180-11185	reads	_
69-15	11186-11187	)	_
69-16	11188-11190	of	_
69-17	11191-11200	uniformly	_
69-18	11201-11212	reprocessed	_
69-19	11213-11216	and	_
69-20	11217-11229	consolidated	_
69-21	11230-11238	ChIP-Seq	_
69-22	11239-11243	sets	_
69-23	11244-11246	we	_
69-24	11247-11251	used	_
69-25	11252-11272	phantompeakqualtools	_
69-26	11273-11274	.	_

Text=The NSC of all samples used in this study were above threshold of 1.1 (Figure S1C).
70-1	11275-11278	The	_
70-2	11279-11282	NSC	_
70-3	11283-11285	of	_
70-4	11286-11289	all	_
70-5	11290-11297	samples	_
70-6	11298-11302	used	_
70-7	11303-11305	in	_
70-8	11306-11310	this	_
70-9	11311-11316	study	_
70-10	11317-11321	were	_
70-11	11322-11327	above	_
70-12	11328-11337	threshold	_
70-13	11338-11340	of	_
70-14	11341-11344	1.1	_
70-15	11345-11346	(	_
70-16	11347-11353	Figure	_
70-17	11354-11357	S1C	_
70-18	11358-11359	)	_
70-19	11360-11361	.	_

Text=We provide summarized QC parameters of individual files (Table S2) and consolidated (Table S5) data sets respectively.
71-1	11362-11364	We	_
71-2	11365-11372	provide	_
71-3	11373-11383	summarized	_
71-4	11384-11386	QC	_
71-5	11387-11397	parameters	_
71-6	11398-11400	of	_
71-7	11401-11411	individual	_
71-8	11412-11417	files	_
71-9	11418-11419	(	_
71-10	11420-11425	Table	_
71-11	11426-11428	S2	_
71-12	11429-11430	)	_
71-13	11431-11434	and	_
71-14	11435-11447	consolidated	_
71-15	11448-11449	(	_
71-16	11450-11455	Table	_
71-17	11456-11458	S5	_
71-18	11459-11460	)	_
71-19	11461-11465	data	_
71-20	11466-11470	sets	_
71-21	11471-11483	respectively	_
71-22	11484-11485	.	_

Text=Functional enrichment of non-overlapping cell- and tissue-specific histone peaks In order to interpret the specificity of cell-type and homogenate data, we identified their respective unique or non-overlapping peak regions.
72-1	11486-11496	Functional	_
72-2	11497-11507	enrichment	_
72-3	11508-11510	of	_
72-4	11511-11526	non-overlapping	_
72-5	11527-11532	cell-	_
72-6	11533-11536	and	_
72-7	11537-11552	tissue-specific	_
72-8	11553-11560	histone	_
72-9	11561-11566	peaks	_
72-10	11567-11569	In	_
72-11	11570-11575	order	_
72-12	11576-11578	to	_
72-13	11579-11588	interpret	_
72-14	11589-11592	the	_
72-15	11593-11604	specificity	_
72-16	11605-11607	of	_
72-17	11608-11617	cell-type	_
72-18	11618-11621	and	_
72-19	11622-11632	homogenate	_
72-20	11633-11637	data	_
72-21	11638-11639	,	_
72-22	11640-11642	we	_
72-23	11643-11653	identified	_
72-24	11654-11659	their	_
72-25	11660-11670	respective	_
72-26	11671-11677	unique	_
72-27	11678-11680	or	_
72-28	11681-11696	non-overlapping	_
72-29	11697-11701	peak	_
72-30	11702-11709	regions	_
72-31	11710-11711	.	_

Text=Non-overlapping regions in a dataset are defined as all genomic regions except the ones that have at least 50% overlap with the dataset they are compared with.
73-1	11712-11727	Non-overlapping	_
73-2	11728-11735	regions	_
73-3	11736-11738	in	_
73-4	11739-11740	a	_
73-5	11741-11748	dataset	_
73-6	11749-11752	are	_
73-7	11753-11760	defined	_
73-8	11761-11763	as	_
73-9	11764-11767	all	_
73-10	11768-11775	genomic	_
73-11	11776-11783	regions	_
73-12	11784-11790	except	_
73-13	11791-11794	the	_
73-14	11795-11799	ones	_
73-15	11800-11804	that	_
73-16	11805-11809	have	_
73-17	11810-11812	at	_
73-18	11813-11818	least	_
73-19	11819-11821	50	_
73-20	11822-11823	%	_
73-21	11824-11831	overlap	_
73-22	11832-11836	with	_
73-23	11837-11840	the	_
73-24	11841-11848	dataset	_
73-25	11849-11853	they	_
73-26	11854-11857	are	_
73-27	11858-11866	compared	_
73-28	11867-11871	with	_
73-29	11872-11873	.	_

Text=We have examined the biological function of nearby genes of these non-overlapping peak regions using Genomic Regions Enrichment of Annotations Tool (GREAT).
74-1	11874-11876	We	_
74-2	11877-11881	have	_
74-3	11882-11890	examined	_
74-4	11891-11894	the	_
74-5	11895-11905	biological	_
74-6	11906-11914	function	_
74-7	11915-11917	of	_
74-8	11918-11924	nearby	_
74-9	11925-11930	genes	_
74-10	11931-11933	of	_
74-11	11934-11939	these	_
74-12	11940-11955	non-overlapping	_
74-13	11956-11960	peak	_
74-14	11961-11968	regions	_
74-15	11969-11974	using	_
74-16	11975-11982	Genomic	_
74-17	11983-11990	Regions	_
74-18	11991-12001	Enrichment	_
74-19	12002-12004	of	_
74-20	12005-12016	Annotations	_
74-21	12017-12021	Tool	_
74-22	12022-12023	(	_
74-23	12024-12029	GREAT	_
74-24	12030-12031	)	_
74-25	12032-12033	.	_

Text=The settings for genomic regions used are (proximal: 5.0 kb upstream, 5.0kb upstream and distal to 100 kb.)
75-1	12034-12037	The	_
75-2	12038-12046	settings	_
75-3	12047-12050	for	_
75-4	12051-12058	genomic	_
75-5	12059-12066	regions	_
75-6	12067-12071	used	_
75-7	12072-12075	are	_
75-8	12076-12077	(	_
75-9	12078-12086	proximal	_
75-10	12087-12088	:	_
75-11	12089-12092	5.0	_
75-12	12093-12095	kb	_
75-13	12096-12104	upstream	_
75-14	12105-12106	,	_
75-15	12107-12112	5.0kb	_
75-16	12113-12121	upstream	_
75-17	12122-12125	and	_
75-18	12126-12132	distal	_
75-19	12133-12135	to	_
75-20	12136-12139	100	_
75-21	12140-12142	kb	_
75-22	12143-12144	.	_
75-23	12145-12146	)	_

Text=Gene set enrichment analysis based on single cell RNA-seq We next examined the difference between the Chip-seq signal in cell specific and homogenate datasets by measuring the enrichment of gene sets identified in neuronal and neuron-depleted chromatin subtypes by massive parallel profiling of single brain nuclei.
76-1	12147-12151	Gene	_
76-2	12152-12155	set	_
76-3	12156-12166	enrichment	_
76-4	12167-12175	analysis	_
76-5	12176-12181	based	_
76-6	12182-12184	on	_
76-7	12185-12191	single	_
76-8	12192-12196	cell	_
76-9	12197-12204	RNA-seq	_
76-10	12205-12207	We	_
76-11	12208-12212	next	_
76-12	12213-12221	examined	_
76-13	12222-12225	the	_
76-14	12226-12236	difference	_
76-15	12237-12244	between	_
76-16	12245-12248	the	_
76-17	12249-12257	Chip-seq	_
76-18	12258-12264	signal	_
76-19	12265-12267	in	_
76-20	12268-12272	cell	_
76-21	12273-12281	specific	_
76-22	12282-12285	and	_
76-23	12286-12296	homogenate	_
76-24	12297-12305	datasets	_
76-25	12306-12308	by	_
76-26	12309-12318	measuring	_
76-27	12319-12322	the	_
76-28	12323-12333	enrichment	_
76-29	12334-12336	of	_
76-30	12337-12341	gene	_
76-31	12342-12346	sets	_
76-32	12347-12357	identified	_
76-33	12358-12360	in	_
76-34	12361-12369	neuronal	_
76-35	12370-12373	and	_
76-36	12374-12389	neuron-depleted	_
76-37	12390-12399	chromatin	_
76-38	12400-12408	subtypes	_
76-39	12409-12411	by	_
76-40	12412-12419	massive	_
76-41	12420-12428	parallel	_
76-42	12429-12438	profiling	_
76-43	12439-12441	of	_
76-44	12442-12448	single	_
76-45	12449-12454	brain	_
76-46	12455-12461	nuclei	_
76-47	12462-12463	.	_

Text=For neuronal subtypes we used identified gene sets for excitatory neurons (n=24), pyramidal neurons CA1 (n=132), pyramidal neurons CA2 (n=111), pyramidal neurons CA3 (n=50), GABAergic interneurons (n=145) and granule cells DG (n=163) and for non-neuronal subtypes we used identified genes sets for radial glia (n=10), myelin (n=16), oligodendrocytes (n=120), astrocytes (n=155) and oligoprogenitor cells (n=42).
77-1	12464-12467	For	_
77-2	12468-12476	neuronal	_
77-3	12477-12485	subtypes	_
77-4	12486-12488	we	_
77-5	12489-12493	used	_
77-6	12494-12504	identified	_
77-7	12505-12509	gene	_
77-8	12510-12514	sets	_
77-9	12515-12518	for	_
77-10	12519-12529	excitatory	_
77-11	12530-12537	neurons	_
77-12	12538-12539	(	_
77-13	12540-12544	n=24	_
77-14	12545-12546	)	_
77-15	12547-12548	,	_
77-16	12549-12558	pyramidal	_
77-17	12559-12566	neurons	_
77-18	12567-12570	CA1	_
77-19	12571-12572	(	_
77-20	12573-12578	n=132	_
77-21	12579-12580	)	_
77-22	12581-12582	,	_
77-23	12583-12592	pyramidal	_
77-24	12593-12600	neurons	_
77-25	12601-12604	CA2	_
77-26	12605-12606	(	_
77-27	12607-12612	n=111	_
77-28	12613-12614	)	_
77-29	12615-12616	,	_
77-30	12617-12626	pyramidal	_
77-31	12627-12634	neurons	_
77-32	12635-12638	CA3	_
77-33	12639-12640	(	_
77-34	12641-12645	n=50	_
77-35	12646-12647	)	_
77-36	12648-12649	,	_
77-37	12650-12659	GABAergic	_
77-38	12660-12672	interneurons	_
77-39	12673-12674	(	_
77-40	12675-12680	n=145	_
77-41	12681-12682	)	_
77-42	12683-12686	and	_
77-43	12687-12694	granule	_
77-44	12695-12700	cells	_
77-45	12701-12703	DG	_
77-46	12704-12705	(	_
77-47	12706-12711	n=163	_
77-48	12712-12713	)	_
77-49	12714-12717	and	_
77-50	12718-12721	for	_
77-51	12722-12734	non-neuronal	_
77-52	12735-12743	subtypes	_
77-53	12744-12746	we	_
77-54	12747-12751	used	_
77-55	12752-12762	identified	_
77-56	12763-12768	genes	_
77-57	12769-12773	sets	_
77-58	12774-12777	for	_
77-59	12778-12784	radial	_
77-60	12785-12789	glia	_
77-61	12790-12791	(	_
77-62	12792-12796	n=10	_
77-63	12797-12798	)	_
77-64	12799-12800	,	_
77-65	12801-12807	myelin	_
77-66	12808-12809	(	_
77-67	12810-12814	n=16	_
77-68	12815-12816	)	_
77-69	12817-12818	,	_
77-70	12819-12835	oligodendrocytes	_
77-71	12836-12837	(	_
77-72	12838-12843	n=120	_
77-73	12844-12845	)	_
77-74	12846-12847	,	_
77-75	12848-12858	astrocytes	_
77-76	12859-12860	(	_
77-77	12861-12866	n=155	_
77-78	12867-12868	)	_
77-79	12869-12872	and	_
77-80	12873-12888	oligoprogenitor	_
77-81	12889-12894	cells	_
77-82	12895-12896	(	_
77-83	12897-12901	n=42	_
77-84	12902-12903	)	_
77-85	12904-12905	.	_

Text=nsgplot v2.61 was used to quantify ChIP-Seq reads enrichment of 7 datasets for both marks: 1) PFC neuronal 2) PFC neuron-depleted, 3) ACC neuronal 4) ACC neuron-depleted, 5) PFC HBCC homogenate, 6) PFC REP Homogenate 7) ACC REP homogenate for abovementioned neuronal and non-neuronal gene sets as a function of 15kb distance upstream, downstream around TSS for both marks.
78-1	12906-12913	nsgplot	_
78-2	12914-12919	v2.61	_
78-3	12920-12923	was	_
78-4	12924-12928	used	_
78-5	12929-12931	to	_
78-6	12932-12940	quantify	_
78-7	12941-12949	ChIP-Seq	_
78-8	12950-12955	reads	_
78-9	12956-12966	enrichment	_
78-10	12967-12969	of	_
78-11	12970-12971	7	_
78-12	12972-12980	datasets	_
78-13	12981-12984	for	_
78-14	12985-12989	both	_
78-15	12990-12995	marks	_
78-16	12996-12997	:	_
78-17	12998-12999	1	_
78-18	13000-13001	)	_
78-19	13002-13005	PFC	_
78-20	13006-13014	neuronal	_
78-21	13015-13016	2	_
78-22	13017-13018	)	_
78-23	13019-13022	PFC	_
78-24	13023-13038	neuron-depleted	_
78-25	13039-13040	,	_
78-26	13041-13042	3	_
78-27	13043-13044	)	_
78-28	13045-13048	ACC	_
78-29	13049-13057	neuronal	_
78-30	13058-13059	4	_
78-31	13060-13061	)	_
78-32	13062-13065	ACC	_
78-33	13066-13081	neuron-depleted	_
78-34	13082-13083	,	_
78-35	13084-13085	5	_
78-36	13086-13087	)	_
78-37	13088-13091	PFC	_
78-38	13092-13096	HBCC	_
78-39	13097-13107	homogenate	_
78-40	13108-13109	,	_
78-41	13110-13111	6	_
78-42	13112-13113	)	_
78-43	13114-13117	PFC	_
78-44	13118-13121	REP	_
78-45	13122-13132	Homogenate	_
78-46	13133-13134	7	_
78-47	13135-13136	)	_
78-48	13137-13140	ACC	_
78-49	13141-13144	REP	_
78-50	13145-13155	homogenate	_
78-51	13156-13159	for	_
78-52	13160-13174	abovementioned	_
78-53	13175-13183	neuronal	_
78-54	13184-13187	and	_
78-55	13188-13200	non-neuronal	_
78-56	13201-13205	gene	_
78-57	13206-13210	sets	_
78-58	13211-13213	as	_
78-59	13214-13215	a	_
78-60	13216-13224	function	_
78-61	13225-13227	of	_
78-62	13228-13232	15kb	_
78-63	13233-13241	distance	_
78-64	13242-13250	upstream	_
78-65	13251-13252	,	_
78-66	13253-13263	downstream	_
78-67	13264-13270	around	_
78-68	13271-13274	TSS	_
78-69	13275-13278	for	_
78-70	13279-13283	both	_
78-71	13284-13289	marks	_
78-72	13290-13291	.	_

Text=We calculated the magnitude of area under these ChIP-Seq reads enrichment curve to examine the difference between the enrichment of cell-specific and homogenate datasets for neuronal and non-neuronal subtypes.
79-1	13292-13294	We	_
79-2	13295-13305	calculated	_
79-3	13306-13309	the	_
79-4	13310-13319	magnitude	_
79-5	13320-13322	of	_
79-6	13323-13327	area	_
79-7	13328-13333	under	_
79-8	13334-13339	these	_
79-9	13340-13348	ChIP-Seq	_
79-10	13349-13354	reads	_
79-11	13355-13365	enrichment	_
79-12	13366-13371	curve	_
79-13	13372-13374	to	_
79-14	13375-13382	examine	_
79-15	13383-13386	the	_
79-16	13387-13397	difference	_
79-17	13398-13405	between	_
79-18	13406-13409	the	_
79-19	13410-13420	enrichment	_
79-20	13421-13423	of	_
79-21	13424-13437	cell-specific	_
79-22	13438-13441	and	_
79-23	13442-13452	homogenate	_
79-24	13453-13461	datasets	_
79-25	13462-13465	for	_
79-26	13466-13474	neuronal	_
79-27	13475-13478	and	_
79-28	13479-13491	non-neuronal	_
79-29	13492-13500	subtypes	_
79-30	13501-13502	.	_

Text=In addition to these genesets we measured the enrichment of ChIP-Seq reads for neuropsychiatric disease signatures as well.
80-1	13503-13505	In	_
80-2	13506-13514	addition	_
80-3	13515-13517	to	_
80-4	13518-13523	these	_
80-5	13524-13532	genesets	_
80-6	13533-13535	we	_
80-7	13536-13544	measured	_
80-8	13545-13548	the	_
80-9	13549-13559	enrichment	_
80-10	13560-13562	of	_
80-11	13563-13571	ChIP-Seq	_
80-12	13572-13577	reads	_
80-13	13578-13581	for	_
80-14	13582-13598	neuropsychiatric	_
80-15	13599-13606	disease	_
80-16	13607-13617	signatures	_
80-17	13618-13620	as	_
80-18	13621-13625	well	_
80-19	13626-13627	.	_

Text=We curated these genesets for 1) CMC schizophrenia (n=693) based on RNA-seq differential gene expression between cases and controls from PFC region from 690 individuals (p-value <= 0.05) and 2) schizophrenia (n=884), 3) bipolar disorder (n=179), 4) major depressive disorder (n=25) 5) autism spectrum disorder (n=933) based on differential gene expression cerebral cortex region from microarray studied done on 715 individuals (p-value <= 0.05 and log2FC> = 2.)
81-1	13628-13630	We	_
81-2	13631-13638	curated	_
81-3	13639-13644	these	_
81-4	13645-13653	genesets	_
81-5	13654-13657	for	_
81-6	13658-13659	1	_
81-7	13660-13661	)	_
81-8	13662-13665	CMC	_
81-9	13666-13679	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
81-10	13680-13681	(	_
81-11	13682-13687	n=693	_
81-12	13688-13689	)	_
81-13	13690-13695	based	_
81-14	13696-13698	on	_
81-15	13699-13706	RNA-seq	_
81-16	13707-13719	differential	_
81-17	13720-13724	gene	_
81-18	13725-13735	expression	_
81-19	13736-13743	between	_
81-20	13744-13749	cases	_
81-21	13750-13753	and	_
81-22	13754-13762	controls	_
81-23	13763-13767	from	_
81-24	13768-13771	PFC	_
81-25	13772-13778	region	_
81-26	13779-13783	from	_
81-27	13784-13787	690	_
81-28	13788-13799	individuals	_
81-29	13800-13801	(	_
81-30	13802-13809	p-value	_
81-31	13810-13811	<	_
81-32	13812-13813	=	_
81-33	13814-13818	0.05	_
81-34	13819-13820	)	_
81-35	13821-13824	and	_
81-36	13825-13826	2	_
81-37	13827-13828	)	_
81-38	13829-13842	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
81-39	13843-13844	(	_
81-40	13845-13850	n=884	_
81-41	13851-13852	)	_
81-42	13853-13854	,	_
81-43	13855-13856	3	_
81-44	13857-13858	)	_
81-45	13859-13866	bipolar	_
81-46	13867-13875	disorder	_
81-47	13876-13877	(	_
81-48	13878-13883	n=179	_
81-49	13884-13885	)	_
81-50	13886-13887	,	_
81-51	13888-13889	4	_
81-52	13890-13891	)	_
81-53	13892-13897	major	_
81-54	13898-13908	depressive	_
81-55	13909-13917	disorder	_
81-56	13918-13919	(	_
81-57	13920-13924	n=25	_
81-58	13925-13926	)	_
81-59	13927-13928	5	_
81-60	13929-13930	)	_
81-61	13931-13937	autism	_
81-62	13938-13946	spectrum	_
81-63	13947-13955	disorder	_
81-64	13956-13957	(	_
81-65	13958-13963	n=933	_
81-66	13964-13965	)	_
81-67	13966-13971	based	_
81-68	13972-13974	on	_
81-69	13975-13987	differential	_
81-70	13988-13992	gene	_
81-71	13993-14003	expression	_
81-72	14004-14012	cerebral	_
81-73	14013-14019	cortex	_
81-74	14020-14026	region	_
81-75	14027-14031	from	_
81-76	14032-14042	microarray	_
81-77	14043-14050	studied	_
81-78	14051-14055	done	_
81-79	14056-14058	on	_
81-80	14059-14062	715	_
81-81	14063-14074	individuals	_
81-82	14075-14076	(	_
81-83	14077-14084	p-value	_
81-84	14085-14086	<	_
81-85	14087-14088	=	_
81-86	14089-14093	0.05	_
81-87	14094-14097	and	_
81-88	14098-14104	log2FC	_
81-89	14105-14106	>	_
81-90	14107-14108	=	_
81-91	14109-14110	2	_
81-92	14111-14112	.	_
81-93	14113-14114	)	_

Text=Quantification of ChIP-seq signal in each peak To determine the reads coverage across the whole genoßme for a BAM file, we used featureCounts from subread 1.5.2.
82-1	14115-14129	Quantification	_
82-2	14130-14132	of	_
82-3	14133-14141	ChIP-seq	_
82-4	14142-14148	signal	_
82-5	14149-14151	in	_
82-6	14152-14156	each	_
82-7	14157-14161	peak	_
82-8	14162-14164	To	_
82-9	14165-14174	determine	_
82-10	14175-14178	the	_
82-11	14179-14184	reads	_
82-12	14185-14193	coverage	_
82-13	14194-14200	across	_
82-14	14201-14204	the	_
82-15	14205-14210	whole	_
82-16	14211-14218	genoßme	_
82-17	14219-14222	for	_
82-18	14223-14224	a	_
82-19	14225-14228	BAM	_
82-20	14229-14233	file	_
82-21	14234-14235	,	_
82-22	14236-14238	we	_
82-23	14239-14243	used	_
82-24	14244-14257	featureCounts	_
82-25	14258-14262	from	_
82-26	14263-14270	subread	_
82-27	14271-14276	1.5.2	_
82-28	14277-14278	.	_

Text=The data input to featureCounts consists of a) uniformly processed BAM files and b) a consensus peak file in Simplified Automation Format (SAF).
83-1	14279-14282	The	_
83-2	14283-14287	data	_
83-3	14288-14293	input	_
83-4	14294-14296	to	_
83-5	14297-14310	featureCounts	_
83-6	14311-14319	consists	_
83-7	14320-14322	of	_
83-8	14323-14324	a	_
83-9	14325-14326	)	_
83-10	14327-14336	uniformly	_
83-11	14337-14346	processed	_
83-12	14347-14350	BAM	_
83-13	14351-14356	files	_
83-14	14357-14360	and	_
83-15	14361-14362	b	_
83-16	14363-14364	)	_
83-17	14365-14366	a	_
83-18	14367-14376	consensus	_
83-19	14377-14381	peak	_
83-20	14382-14386	file	_
83-21	14387-14389	in	_
83-22	14390-14400	Simplified	_
83-23	14401-14411	Automation	_
83-24	14412-14418	Format	_
83-25	14419-14420	(	_
83-26	14421-14424	SAF	_
83-27	14425-14426	)	_
83-28	14427-14428	.	_

Text=The consensus peak signals for H3K4me3 and H3K27ac were generated by taking the union of MACS2 narrowPeak files of cell-specific and homogenate consolidated datasets which are 1) H3K4me3-PFC neuronal, 2) H3K4me3-PFC non-neuronal, 3) H3K4me3-ACC neuronal, 4) H3K4me3-ACC neuron-depleted and 5) H3K4me3-PFC HBCC homogenate and union of MACS2 broadPeaks files of 5) H3K27ac-PFC neuronal, 6) H3K27ac-PFC neuron-depleted, 7) H3K27ac-ACC neuronal, 8) H3K27ac-ACC neuron-depleted respectively.
84-1	14429-14432	The	_
84-2	14433-14442	consensus	_
84-3	14443-14447	peak	_
84-4	14448-14455	signals	_
84-5	14456-14459	for	_
84-6	14460-14467	H3K4me3	_
84-7	14468-14471	and	_
84-8	14472-14479	H3K27ac	_
84-9	14480-14484	were	_
84-10	14485-14494	generated	_
84-11	14495-14497	by	_
84-12	14498-14504	taking	_
84-13	14505-14508	the	_
84-14	14509-14514	union	_
84-15	14515-14517	of	_
84-16	14518-14523	MACS2	_
84-17	14524-14534	narrowPeak	_
84-18	14535-14540	files	_
84-19	14541-14543	of	_
84-20	14544-14557	cell-specific	_
84-21	14558-14561	and	_
84-22	14562-14572	homogenate	_
84-23	14573-14585	consolidated	_
84-24	14586-14594	datasets	_
84-25	14595-14600	which	_
84-26	14601-14604	are	_
84-27	14605-14606	1	_
84-28	14607-14608	)	_
84-29	14609-14620	H3K4me3-PFC	_
84-30	14621-14629	neuronal	_
84-31	14630-14631	,	_
84-32	14632-14633	2	_
84-33	14634-14635	)	_
84-34	14636-14647	H3K4me3-PFC	_
84-35	14648-14660	non-neuronal	_
84-36	14661-14662	,	_
84-37	14663-14664	3	_
84-38	14665-14666	)	_
84-39	14667-14678	H3K4me3-ACC	_
84-40	14679-14687	neuronal	_
84-41	14688-14689	,	_
84-42	14690-14691	4	_
84-43	14692-14693	)	_
84-44	14694-14705	H3K4me3-ACC	_
84-45	14706-14721	neuron-depleted	_
84-46	14722-14725	and	_
84-47	14726-14727	5	_
84-48	14728-14729	)	_
84-49	14730-14741	H3K4me3-PFC	_
84-50	14742-14746	HBCC	_
84-51	14747-14757	homogenate	_
84-52	14758-14761	and	_
84-53	14762-14767	union	_
84-54	14768-14770	of	_
84-55	14771-14776	MACS2	_
84-56	14777-14787	broadPeaks	_
84-57	14788-14793	files	_
84-58	14794-14796	of	_
84-59	14797-14798	5	_
84-60	14799-14800	)	_
84-61	14801-14812	H3K27ac-PFC	_
84-62	14813-14821	neuronal	_
84-63	14822-14823	,	_
84-64	14824-14825	6	_
84-65	14826-14827	)	_
84-66	14828-14839	H3K27ac-PFC	_
84-67	14840-14855	neuron-depleted	_
84-68	14856-14857	,	_
84-69	14858-14859	7	_
84-70	14860-14861	)	_
84-71	14862-14873	H3K27ac-ACC	_
84-72	14874-14882	neuronal	_
84-73	14883-14884	,	_
84-74	14885-14886	8	_
84-75	14887-14888	)	_
84-76	14889-14900	H3K27ac-ACC	_
84-77	14901-14916	neuron-depleted	_
84-78	14917-14929	respectively	_
84-79	14930-14931	.	_

Text=featureCounts quantifies number of reads for each sample in every peak region of consensus signal.
85-1	14932-14945	featureCounts	_
85-2	14946-14956	quantifies	_
85-3	14957-14963	number	_
85-4	14964-14966	of	_
85-5	14967-14972	reads	_
85-6	14973-14976	for	_
85-7	14977-14981	each	_
85-8	14982-14988	sample	_
85-9	14989-14991	in	_
85-10	14992-14997	every	_
85-11	14998-15002	peak	_
85-12	15003-15009	region	_
85-13	15010-15012	of	_
85-14	15013-15022	consensus	_
85-15	15023-15029	signal	_
85-16	15030-15031	.	_

Text=The counts were put together in a matrix separately for H3K4me3 and H3K27ac marks with 74 (cell-specifc=63, homogenate=11) samples from 28 individuals (cell-specific=17, homogenate=11) as rows for H3K4me3 and 83 (cell-specific=66, homogenate=17) from 34 individuals (cell-specific=17, homogenate=17) as rows for H3K27ac and 107,480 (152,590) peak regions as columns for H3K4me3 (H3K27ac).
86-1	15032-15035	The	_
86-2	15036-15042	counts	_
86-3	15043-15047	were	_
86-4	15048-15051	put	_
86-5	15052-15060	together	_
86-6	15061-15063	in	_
86-7	15064-15065	a	_
86-8	15066-15072	matrix	_
86-9	15073-15083	separately	_
86-10	15084-15087	for	_
86-11	15088-15095	H3K4me3	_
86-12	15096-15099	and	_
86-13	15100-15107	H3K27ac	_
86-14	15108-15113	marks	_
86-15	15114-15118	with	_
86-16	15119-15121	74	_
86-17	15122-15123	(	_
86-18	15124-15139	cell-specifc=63	_
86-19	15140-15141	,	_
86-20	15142-15155	homogenate=11	_
86-21	15156-15157	)	_
86-22	15158-15165	samples	_
86-23	15166-15170	from	_
86-24	15171-15173	28	_
86-25	15174-15185	individuals	_
86-26	15186-15187	(	_
86-27	15188-15204	cell-specific=17	_
86-28	15205-15206	,	_
86-29	15207-15220	homogenate=11	_
86-30	15221-15222	)	_
86-31	15223-15225	as	_
86-32	15226-15230	rows	_
86-33	15231-15234	for	_
86-34	15235-15242	H3K4me3	_
86-35	15243-15246	and	_
86-36	15247-15249	83	_
86-37	15250-15251	(	_
86-38	15252-15268	cell-specific=66	_
86-39	15269-15270	,	_
86-40	15271-15284	homogenate=17	_
86-41	15285-15286	)	_
86-42	15287-15291	from	_
86-43	15292-15294	34	_
86-44	15295-15306	individuals	_
86-45	15307-15308	(	_
86-46	15309-15325	cell-specific=17	_
86-47	15326-15327	,	_
86-48	15328-15341	homogenate=17	_
86-49	15342-15343	)	_
86-50	15344-15346	as	_
86-51	15347-15351	rows	_
86-52	15352-15355	for	_
86-53	15356-15363	H3K27ac	_
86-54	15364-15367	and	_
86-55	15368-15375	107,480	_
86-56	15376-15377	(	_
86-57	15378-15385	152,590	_
86-58	15386-15387	)	_
86-59	15388-15392	peak	_
86-60	15393-15400	regions	_
86-61	15401-15403	as	_
86-62	15404-15411	columns	_
86-63	15412-15415	for	_
86-64	15416-15423	H3K4me3	_
86-65	15424-15425	(	_
86-66	15426-15433	H3K27ac	_
86-67	15434-15435	)	_
86-68	15436-15437	.	_

Text=This matrix was converted into log2 counts per million (CPM) using TMM normalization to correct for the total number of reads.
87-1	15438-15442	This	_
87-2	15443-15449	matrix	_
87-3	15450-15453	was	_
87-4	15454-15463	converted	_
87-5	15464-15468	into	_
87-6	15469-15473	log2	_
87-7	15474-15480	counts	_
87-8	15481-15484	per	_
87-9	15485-15492	million	_
87-10	15493-15494	(	_
87-11	15495-15498	CPM	_
87-12	15499-15500	)	_
87-13	15501-15506	using	_
87-14	15507-15510	TMM	_
87-15	15511-15524	normalization	_
87-16	15525-15527	to	_
87-17	15528-15535	correct	_
87-18	15536-15539	for	_
87-19	15540-15543	the	_
87-20	15544-15549	total	_
87-21	15550-15556	number	_
87-22	15557-15559	of	_
87-23	15560-15565	reads	_
87-24	15566-15567	.	_

Text=The log2 CPM matrix was used for downstream analysis.
88-1	15568-15571	The	_
88-2	15572-15576	log2	_
88-3	15577-15580	CPM	_
88-4	15581-15587	matrix	_
88-5	15588-15591	was	_
88-6	15592-15596	used	_
88-7	15597-15600	for	_
88-8	15601-15611	downstream	_
88-9	15612-15620	analysis	_
88-10	15621-15622	.	_

Text=Decomposing variation into multiple components with variancePartition For cell-specific dataset for each histone mark, the epigenetic variance of each peak was decomposed into variation attributable to cell type, subject, brain region, sex, plus the residual variation: These 4 variables are categorical and so were modeled as random effects.
89-1	15623-15634	Decomposing	_
89-2	15635-15644	variation	_
89-3	15645-15649	into	_
89-4	15650-15658	multiple	_
89-5	15659-15669	components	_
89-6	15670-15674	with	_
89-7	15675-15692	variancePartition	_
89-8	15693-15696	For	_
89-9	15697-15710	cell-specific	_
89-10	15711-15718	dataset	_
89-11	15719-15722	for	_
89-12	15723-15727	each	_
89-13	15728-15735	histone	_
89-14	15736-15740	mark	_
89-15	15741-15742	,	_
89-16	15743-15746	the	_
89-17	15747-15757	epigenetic	_
89-18	15758-15766	variance	_
89-19	15767-15769	of	_
89-20	15770-15774	each	_
89-21	15775-15779	peak	_
89-22	15780-15783	was	_
89-23	15784-15794	decomposed	_
89-24	15795-15799	into	_
89-25	15800-15809	variation	_
89-26	15810-15822	attributable	_
89-27	15823-15825	to	_
89-28	15826-15830	cell	_
89-29	15831-15835	type	_
89-30	15836-15837	,	_
89-31	15838-15845	subject	_
89-32	15846-15847	,	_
89-33	15848-15853	brain	_
89-34	15854-15860	region	_
89-35	15861-15862	,	_
89-36	15863-15866	sex	_
89-37	15867-15868	,	_
89-38	15869-15873	plus	_
89-39	15874-15877	the	_
89-40	15878-15886	residual	_
89-41	15887-15896	variation	_
89-42	15897-15898	:	_
89-43	15899-15904	These	_
89-44	15905-15906	4	_
89-45	15907-15916	variables	_
89-46	15917-15920	are	_
89-47	15921-15932	categorical	_
89-48	15933-15936	and	_
89-49	15937-15939	so	_
89-50	15940-15944	were	_
89-51	15945-15952	modeled	_
89-52	15953-15955	as	_
89-53	15956-15962	random	_
89-54	15963-15970	effects	_
89-55	15971-15972	.	_

Text=The analysis was performed by modeling the log2 CPM with a linear mixed model implemented in variancePartition v1.4.1 and treating each variable as a random effect.
90-1	15973-15976	The	_
90-2	15977-15985	analysis	_
90-3	15986-15989	was	_
90-4	15990-15999	performed	_
90-5	16000-16002	by	_
90-6	16003-16011	modeling	_
90-7	16012-16015	the	_
90-8	16016-16020	log2	_
90-9	16021-16024	CPM	_
90-10	16025-16029	with	_
90-11	16030-16031	a	_
90-12	16032-16038	linear	_
90-13	16039-16044	mixed	_
90-14	16045-16050	model	_
90-15	16051-16062	implemented	_
90-16	16063-16065	in	_
90-17	16066-16083	variancePartition	_
90-18	16084-16090	v1.4.1	_
90-19	16091-16094	and	_
90-20	16095-16103	treating	_
90-21	16104-16108	each	_
90-22	16109-16117	variable	_
90-23	16118-16120	as	_
90-24	16121-16122	a	_
90-25	16123-16129	random	_
90-26	16130-16136	effect	_
90-27	16137-16138	.	_

Text=Each peak was considered separately and the results for all peaks were aggregated afterwards.
91-1	16139-16143	Each	_
91-2	16144-16148	peak	_
91-3	16149-16152	was	_
91-4	16153-16163	considered	_
91-5	16164-16174	separately	_
91-6	16175-16178	and	_
91-7	16179-16182	the	_
91-8	16183-16190	results	_
91-9	16191-16194	for	_
91-10	16195-16198	all	_
91-11	16199-16204	peaks	_
91-12	16205-16209	were	_
91-13	16210-16220	aggregated	_
91-14	16221-16231	afterwards	_
91-15	16232-16233	.	_

Text=Results were summarized in terms of the fraction of total variation explained by each variable for each peak.
92-1	16234-16241	Results	_
92-2	16242-16246	were	_
92-3	16247-16257	summarized	_
92-4	16258-16260	in	_
92-5	16261-16266	terms	_
92-6	16267-16269	of	_
92-7	16270-16273	the	_
92-8	16274-16282	fraction	_
92-9	16283-16285	of	_
92-10	16286-16291	total	_
92-11	16292-16301	variation	_
92-12	16302-16311	explained	_
92-13	16312-16314	by	_
92-14	16315-16319	each	_
92-15	16320-16328	variable	_
92-16	16329-16332	for	_
92-17	16333-16337	each	_
92-18	16338-16342	peak	_
92-19	16343-16344	.	_

Text=A variancePartition analysis was also performed on additional metadata variables such as QC statistics (i.e.
93-1	16345-16346	A	_
93-2	16347-16364	variancePartition	_
93-3	16365-16373	analysis	_
93-4	16374-16377	was	_
93-5	16378-16382	also	_
93-6	16383-16392	performed	_
93-7	16393-16395	on	_
93-8	16396-16406	additional	_
93-9	16407-16415	metadata	_
93-10	16416-16425	variables	_
93-11	16426-16430	such	_
93-12	16431-16433	as	_
93-13	16434-16436	QC	_
93-14	16437-16447	statistics	_
93-15	16448-16449	(	_
93-16	16450-16453	i.e	_
93-17	16454-16455	.	_

Text=NSC, RSC, PCR PBC and NRF), and sample processing batches (library preparation date of chip, chip DNA volume, chip DNA amount (ng), total chip DNA in a library, library preparation operator, library AMpure beads lot, library PCR cycles number, library volume, library sequencing batch, library sequencing submission date, library preparation library batch.)
94-1	16456-16459	NSC	_
94-2	16460-16461	,	_
94-3	16462-16465	RSC	_
94-4	16466-16467	,	_
94-5	16468-16471	PCR	_
94-6	16472-16475	PBC	_
94-7	16476-16479	and	_
94-8	16480-16483	NRF	_
94-9	16484-16485	)	_
94-10	16486-16487	,	_
94-11	16488-16491	and	_
94-12	16492-16498	sample	_
94-13	16499-16509	processing	_
94-14	16510-16517	batches	_
94-15	16518-16519	(	_
94-16	16520-16527	library	_
94-17	16528-16539	preparation	_
94-18	16540-16544	date	_
94-19	16545-16547	of	_
94-20	16548-16552	chip	_
94-21	16553-16554	,	_
94-22	16555-16559	chip	_
94-23	16560-16563	DNA	_
94-24	16564-16570	volume	_
94-25	16571-16572	,	_
94-26	16573-16577	chip	_
94-27	16578-16581	DNA	_
94-28	16582-16588	amount	_
94-29	16589-16590	(	_
94-30	16591-16593	ng	_
94-31	16594-16595	)	_
94-32	16596-16597	,	_
94-33	16598-16603	total	_
94-34	16604-16608	chip	_
94-35	16609-16612	DNA	_
94-36	16613-16615	in	_
94-37	16616-16617	a	_
94-38	16618-16625	library	_
94-39	16626-16627	,	_
94-40	16628-16635	library	_
94-41	16636-16647	preparation	_
94-42	16648-16656	operator	_
94-43	16657-16658	,	_
94-44	16659-16666	library	_
94-45	16667-16673	AMpure	_
94-46	16674-16679	beads	_
94-47	16680-16683	lot	_
94-48	16684-16685	,	_
94-49	16686-16693	library	_
94-50	16694-16697	PCR	_
94-51	16698-16704	cycles	_
94-52	16705-16711	number	_
94-53	16712-16713	,	_
94-54	16714-16721	library	_
94-55	16722-16728	volume	_
94-56	16729-16730	,	_
94-57	16731-16738	library	_
94-58	16739-16749	sequencing	_
94-59	16750-16755	batch	_
94-60	16756-16757	,	_
94-61	16758-16765	library	_
94-62	16766-16776	sequencing	_
94-63	16777-16787	submission	_
94-64	16788-16792	date	_
94-65	16793-16794	,	_
94-66	16795-16802	library	_
94-67	16803-16814	preparation	_
94-68	16815-16822	library	_
94-69	16823-16828	batch	_
94-70	16829-16830	.	_
94-71	16831-16832	)	_

Text=Continuous variables were modeled as fixed effects and categorical variables were modeled as random effects.
95-1	16833-16843	Continuous	_
95-2	16844-16853	variables	_
95-3	16854-16858	were	_
95-4	16859-16866	modeled	_
95-5	16867-16869	as	_
95-6	16870-16875	fixed	_
95-7	16876-16883	effects	_
95-8	16884-16887	and	_
95-9	16888-16899	categorical	_
95-10	16900-16909	variables	_
95-11	16910-16914	were	_
95-12	16915-16922	modeled	_
95-13	16923-16925	as	_
95-14	16926-16932	random	_
95-15	16933-16940	effects	_
95-16	16941-16942	.	_

Text=The percentage variation explained by technical variables such as experimental batches or QC statistics was either relatively small or better explained by the 4 major variables described above.
96-1	16943-16946	The	_
96-2	16947-16957	percentage	_
96-3	16958-16967	variation	_
96-4	16968-16977	explained	_
96-5	16978-16980	by	_
96-6	16981-16990	technical	_
96-7	16991-17000	variables	_
96-8	17001-17005	such	_
96-9	17006-17008	as	_
96-10	17009-17021	experimental	_
96-11	17022-17029	batches	_
96-12	17030-17032	or	_
96-13	17033-17035	QC	_
96-14	17036-17046	statistics	_
96-15	17047-17050	was	_
96-16	17051-17057	either	_
96-17	17058-17068	relatively	_
96-18	17069-17074	small	_
96-19	17075-17077	or	_
96-20	17078-17084	better	_
96-21	17085-17094	explained	_
96-22	17095-17097	by	_
96-23	17098-17101	the	_
96-24	17102-17103	4	_
96-25	17104-17109	major	_
96-26	17110-17119	variables	_
96-27	17120-17129	described	_
96-28	17130-17135	above	_
96-29	17136-17137	.	_

Text=Principal components analysis As a QC step, performed PCA on the log2 CPM matrix in order to identify outliers.
97-1	17138-17147	Principal	_
97-2	17148-17158	components	_
97-3	17159-17167	analysis	_
97-4	17168-17170	As	_
97-5	17171-17172	a	_
97-6	17173-17175	QC	_
97-7	17176-17180	step	_
97-8	17181-17182	,	_
97-9	17183-17192	performed	_
97-10	17193-17196	PCA	_
97-11	17197-17199	on	_
97-12	17200-17203	the	_
97-13	17204-17208	log2	_
97-14	17209-17212	CPM	_
97-15	17213-17219	matrix	_
97-16	17220-17222	in	_
97-17	17223-17228	order	_
97-18	17229-17231	to	_
97-19	17232-17240	identify	_
97-20	17241-17249	outliers	_
97-21	17250-17251	.	_

Text=8 samples were identified as outliers (Table S2) and these corresponded to samples that barely passed our previous QC cutoffs.
98-1	17252-17253	8	_
98-2	17254-17261	samples	_
98-3	17262-17266	were	_
98-4	17267-17277	identified	_
98-5	17278-17280	as	_
98-6	17281-17289	outliers	_
98-7	17290-17291	(	_
98-8	17292-17297	Table	_
98-9	17298-17300	S2	_
98-10	17301-17302	)	_
98-11	17303-17306	and	_
98-12	17307-17312	these	_
98-13	17313-17325	corresponded	_
98-14	17326-17328	to	_
98-15	17329-17336	samples	_
98-16	17337-17341	that	_
98-17	17342-17348	barely	_
98-18	17349-17355	passed	_
98-19	17356-17359	our	_
98-20	17360-17368	previous	_
98-21	17369-17371	QC	_
98-22	17372-17379	cutoffs	_
98-23	17380-17381	.	_

Text=These samples were excluded from further analysis.
99-1	17382-17387	These	_
99-2	17388-17395	samples	_
99-3	17396-17400	were	_
99-4	17401-17409	excluded	_
99-5	17410-17414	from	_
99-6	17415-17422	further	_
99-7	17423-17431	analysis	_
99-8	17432-17433	.	_

Text=Differential histone modification For cell-specific dataset for each mark, we performed differential analysis to identify peak regions with significant differences 1) across the cell types (neuronal and non-neuronal) 2) across brain regions (ACC neuronal and PFC neuronal) and (ACC neuron-depleted and PFC neuron-depleted) using edgeR v.3.14.0.
100-1	17434-17446	Differential	_
100-2	17447-17454	histone	_
100-3	17455-17467	modification	_
100-4	17468-17471	For	_
100-5	17472-17485	cell-specific	_
100-6	17486-17493	dataset	_
100-7	17494-17497	for	_
100-8	17498-17502	each	_
100-9	17503-17507	mark	_
100-10	17508-17509	,	_
100-11	17510-17512	we	_
100-12	17513-17522	performed	_
100-13	17523-17535	differential	_
100-14	17536-17544	analysis	_
100-15	17545-17547	to	_
100-16	17548-17556	identify	_
100-17	17557-17561	peak	_
100-18	17562-17569	regions	_
100-19	17570-17574	with	_
100-20	17575-17586	significant	_
100-21	17587-17598	differences	_
100-22	17599-17600	1	_
100-23	17601-17602	)	_
100-24	17603-17609	across	_
100-25	17610-17613	the	_
100-26	17614-17618	cell	_
100-27	17619-17624	types	_
100-28	17625-17626	(	_
100-29	17627-17635	neuronal	_
100-30	17636-17639	and	_
100-31	17640-17652	non-neuronal	_
100-32	17653-17654	)	_
100-33	17655-17656	2	_
100-34	17657-17658	)	_
100-35	17659-17665	across	_
100-36	17666-17671	brain	_
100-37	17672-17679	regions	_
100-38	17680-17681	(	_
100-39	17682-17685	ACC	_
100-40	17686-17694	neuronal	_
100-41	17695-17698	and	_
100-42	17699-17702	PFC	_
100-43	17703-17711	neuronal	_
100-44	17712-17713	)	_
100-45	17714-17717	and	_
100-46	17718-17719	(	_
100-47	17720-17723	ACC	_
100-48	17724-17739	neuron-depleted	_
100-49	17740-17743	and	_
100-50	17744-17747	PFC	_
100-51	17748-17763	neuron-depleted	_
100-52	17764-17765	)	_
100-53	17766-17771	using	_
100-54	17772-17777	edgeR	_
100-55	17778-17786	v.3.14.0	_
100-56	17787-17788	.	_

Text=The CPM matrix was prefiltered to regions with CPM> 1 in at least 5 samples for both histone marks and normalized using calcNormFactors function which uses trimmed mean of M-values (TMM).
101-1	17789-17792	The	_
101-2	17793-17796	CPM	_
101-3	17797-17803	matrix	_
101-4	17804-17807	was	_
101-5	17808-17819	prefiltered	_
101-6	17820-17822	to	_
101-7	17823-17830	regions	_
101-8	17831-17835	with	_
101-9	17836-17839	CPM	_
101-10	17840-17841	>	_
101-11	17842-17843	1	_
101-12	17844-17846	in	_
101-13	17847-17849	at	_
101-14	17850-17855	least	_
101-15	17856-17857	5	_
101-16	17858-17865	samples	_
101-17	17866-17869	for	_
101-18	17870-17874	both	_
101-19	17875-17882	histone	_
101-20	17883-17888	marks	_
101-21	17889-17892	and	_
101-22	17893-17903	normalized	_
101-23	17904-17909	using	_
101-24	17910-17925	calcNormFactors	_
101-25	17926-17934	function	_
101-26	17935-17940	which	_
101-27	17941-17945	uses	_
101-28	17946-17953	trimmed	_
101-29	17954-17958	mean	_
101-30	17959-17961	of	_
101-31	17962-17970	M-values	_
101-32	17971-17972	(	_
101-33	17973-17976	TMM	_
101-34	17977-17978	)	_
101-35	17979-17980	.	_

Text=The edgeR software modeled the reads counts matrix as negative binomial distribution using cell types and brain regions as covariates.
102-1	17981-17984	The	_
102-2	17985-17990	edgeR	_
102-3	17991-17999	software	_
102-4	18000-18007	modeled	_
102-5	18008-18011	the	_
102-6	18012-18017	reads	_
102-7	18018-18024	counts	_
102-8	18025-18031	matrix	_
102-9	18032-18034	as	_
102-10	18035-18043	negative	_
102-11	18044-18052	binomial	_
102-12	18053-18065	distribution	_
102-13	18066-18071	using	_
102-14	18072-18076	cell	_
102-15	18077-18082	types	_
102-16	18083-18086	and	_
102-17	18087-18092	brain	_
102-18	18093-18100	regions	_
102-19	18101-18103	as	_
102-20	18104-18114	covariates	_
102-21	18115-18116	.	_

Text=We fit the normalized CPM matrix to quasi-likelihood negative binomial generalized log-linear model using glmQLFit function with robust = TRUE option.
103-1	18117-18119	We	_
103-2	18120-18123	fit	_
103-3	18124-18127	the	_
103-4	18128-18138	normalized	_
103-5	18139-18142	CPM	_
103-6	18143-18149	matrix	_
103-7	18150-18152	to	_
103-8	18153-18169	quasi-likelihood	_
103-9	18170-18178	negative	_
103-10	18179-18187	binomial	_
103-11	18188-18199	generalized	_
103-12	18200-18210	log-linear	_
103-13	18211-18216	model	_
103-14	18217-18222	using	_
103-15	18223-18231	glmQLFit	_
103-16	18232-18240	function	_
103-17	18241-18245	with	_
103-18	18246-18252	robust	_
103-19	18253-18254	=	_
103-20	18255-18259	TRUE	_
103-21	18260-18266	option	_
103-22	18267-18268	.	_

Text=The Quasi-Likelihood F-test was then applied to test to identify peak regions that are significantly different across cell types and brain region (for both neuronal and non-neuronal cell types) using glmQLFTest (glmQLFit object, contrast=cell type or brain region).
104-1	18269-18272	The	_
104-2	18273-18289	Quasi-Likelihood	_
104-3	18290-18296	F-test	_
104-4	18297-18300	was	_
104-5	18301-18305	then	_
104-6	18306-18313	applied	_
104-7	18314-18316	to	_
104-8	18317-18321	test	_
104-9	18322-18324	to	_
104-10	18325-18333	identify	_
104-11	18334-18338	peak	_
104-12	18339-18346	regions	_
104-13	18347-18351	that	_
104-14	18352-18355	are	_
104-15	18356-18369	significantly	_
104-16	18370-18379	different	_
104-17	18380-18386	across	_
104-18	18387-18391	cell	_
104-19	18392-18397	types	_
104-20	18398-18401	and	_
104-21	18402-18407	brain	_
104-22	18408-18414	region	_
104-23	18415-18416	(	_
104-24	18417-18420	for	_
104-25	18421-18425	both	_
104-26	18426-18434	neuronal	_
104-27	18435-18438	and	_
104-28	18439-18451	non-neuronal	_
104-29	18452-18456	cell	_
104-30	18457-18462	types	_
104-31	18463-18464	)	_
104-32	18465-18470	using	_
104-33	18471-18481	glmQLFTest	_
104-34	18482-18483	(	_
104-35	18484-18492	glmQLFit	_
104-36	18493-18499	object	_
104-37	18500-18501	,	_
104-38	18502-18515	contrast=cell	_
104-39	18516-18520	type	_
104-40	18521-18523	or	_
104-41	18524-18529	brain	_
104-42	18530-18536	region	_
104-43	18537-18538	)	_
104-44	18539-18540	.	_

Text=Multiple testing was done by applying the Benjamini-Hochberg method on the p-values to control false discovery rate.
105-1	18541-18549	Multiple	_
105-2	18550-18557	testing	_
105-3	18558-18561	was	_
105-4	18562-18566	done	_
105-5	18567-18569	by	_
105-6	18570-18578	applying	_
105-7	18579-18582	the	_
105-8	18583-18601	Benjamini-Hochberg	_
105-9	18602-18608	method	_
105-10	18609-18611	on	_
105-11	18612-18615	the	_
105-12	18616-18624	p-values	_
105-13	18625-18627	to	_
105-14	18628-18635	control	_
105-15	18636-18641	false	_
105-16	18642-18651	discovery	_
105-17	18652-18656	rate	_
105-18	18657-18658	.	_

Text=The total number of differential peaks was determined at a FDR of 5%.
106-1	18659-18662	The	_
106-2	18663-18668	total	_
106-3	18669-18675	number	_
106-4	18676-18678	of	_
106-5	18679-18691	differential	_
106-6	18692-18697	peaks	_
106-7	18698-18701	was	_
106-8	18702-18712	determined	_
106-9	18713-18715	at	_
106-10	18716-18717	a	_
106-11	18718-18721	FDR	_
106-12	18722-18724	of	_
106-13	18725-18726	5	_
106-14	18727-18728	%	_
106-15	18729-18730	.	_

Text=The coordinates of neuronal, non-neuronal, ACC neuronal, PFC neuronal, PFC neuronal, PFC non-neuronal genomic regions are given in Table S8, S9.
107-1	18731-18734	The	_
107-2	18735-18746	coordinates	_
107-3	18747-18749	of	_
107-4	18750-18758	neuronal	_
107-5	18759-18760	,	_
107-6	18761-18773	non-neuronal	_
107-7	18774-18775	,	_
107-8	18776-18779	ACC	_
107-9	18780-18788	neuronal	_
107-10	18789-18790	,	_
107-11	18791-18794	PFC	_
107-12	18795-18803	neuronal	_
107-13	18804-18805	,	_
107-14	18806-18809	PFC	_
107-15	18810-18818	neuronal	_
107-16	18819-18820	,	_
107-17	18821-18824	PFC	_
107-18	18825-18837	non-neuronal	_
107-19	18838-18845	genomic	_
107-20	18846-18853	regions	_
107-21	18854-18857	are	_
107-22	18858-18863	given	_
107-23	18864-18866	in	_
107-24	18867-18872	Table	_
107-25	18873-18875	S8	_
107-26	18876-18877	,	_
107-27	18878-18880	S9	_
107-28	18881-18882	.	_

Text=Comparison with Roadmap Epigenomics Project For each mark, we measured the similarity of genomic regions of cell specific (4) and homogenate (1) consolidated data sets: ACC neuronal, PFC neuronal, PFC neuronal, PFC neuron-depleted/non-neuronal and PFC HBCC homogenate with REP data from 111 tissues.
108-1	18883-18893	Comparison	_
108-2	18894-18898	with	_
108-3	18899-18906	Roadmap	_
108-4	18907-18918	Epigenomics	_
108-5	18919-18926	Project	_
108-6	18927-18930	For	_
108-7	18931-18935	each	_
108-8	18936-18940	mark	_
108-9	18941-18942	,	_
108-10	18943-18945	we	_
108-11	18946-18954	measured	_
108-12	18955-18958	the	_
108-13	18959-18969	similarity	_
108-14	18970-18972	of	_
108-15	18973-18980	genomic	_
108-16	18981-18988	regions	_
108-17	18989-18991	of	_
108-18	18992-18996	cell	_
108-19	18997-19005	specific	_
108-20	19006-19007	(	_
108-21	19008-19009	4	_
108-22	19010-19011	)	_
108-23	19012-19015	and	_
108-24	19016-19026	homogenate	_
108-25	19027-19028	(	_
108-26	19029-19030	1	_
108-27	19031-19032	)	_
108-28	19033-19045	consolidated	_
108-29	19046-19050	data	_
108-30	19051-19055	sets	_
108-31	19056-19057	:	_
108-32	19058-19061	ACC	_
108-33	19062-19070	neuronal	_
108-34	19071-19072	,	_
108-35	19073-19076	PFC	_
108-36	19077-19085	neuronal	_
108-37	19086-19087	,	_
108-38	19088-19091	PFC	_
108-39	19092-19100	neuronal	_
108-40	19101-19102	,	_
108-41	19103-19106	PFC	_
108-42	19107-19135	neuron-depleted/non-neuronal	_
108-43	19136-19139	and	_
108-44	19140-19143	PFC	_
108-45	19144-19148	HBCC	_
108-46	19149-19159	homogenate	_
108-47	19160-19164	with	_
108-48	19165-19168	REP	_
108-49	19169-19173	data	_
108-50	19174-19178	from	_
108-51	19179-19182	111	_
108-52	19183-19190	tissues	_
108-53	19191-19192	.	_

Text=We used bedtools jaccard –a sample bed file –b REP bed file.
109-1	19193-19195	We	_
109-2	19196-19200	used	_
109-3	19201-19209	bedtools	_
109-4	19210-19217	jaccard	_
109-5	19218-19220	–a	_
109-6	19221-19227	sample	_
109-7	19228-19231	bed	_
109-8	19232-19236	file	_
109-9	19237-19239	–b	_
109-10	19240-19243	REP	_
109-11	19244-19247	bed	_
109-12	19248-19252	file	_
109-13	19253-19254	.	_

Text=This command outputs Jaccard index parameter (see Table S4) which is evaluated as Cell composition analysis Cell type proportions were quantified using R library CellMix.
110-1	19255-19259	This	_
110-2	19260-19267	command	_
110-3	19268-19275	outputs	_
110-4	19276-19283	Jaccard	_
110-5	19284-19289	index	_
110-6	19290-19299	parameter	_
110-7	19300-19301	(	_
110-8	19302-19305	see	_
110-9	19306-19311	Table	_
110-10	19312-19314	S4	_
110-11	19315-19316	)	_
110-12	19317-19322	which	_
110-13	19323-19325	is	_
110-14	19326-19335	evaluated	_
110-15	19336-19338	as	_
110-16	19339-19343	Cell	_
110-17	19344-19355	composition	_
110-18	19356-19364	analysis	_
110-19	19365-19369	Cell	_
110-20	19370-19374	type	_
110-21	19375-19386	proportions	_
110-22	19387-19391	were	_
110-23	19392-19402	quantified	_
110-24	19403-19408	using	_
110-25	19409-19410	R	_
110-26	19411-19418	library	_
110-27	19419-19426	CellMix	_
110-28	19427-19428	.	_

Text=Using our neuronal and non-neuronal ChIP-seq datasets, we generated cell type signatures to run deconvolution on homogenate samples to quantify the proportion of each cell type for every sample.
111-1	19429-19434	Using	_
111-2	19435-19438	our	_
111-3	19439-19447	neuronal	_
111-4	19448-19451	and	_
111-5	19452-19464	non-neuronal	_
111-6	19465-19473	ChIP-seq	_
111-7	19474-19482	datasets	_
111-8	19483-19484	,	_
111-9	19485-19487	we	_
111-10	19488-19497	generated	_
111-11	19498-19502	cell	_
111-12	19503-19507	type	_
111-13	19508-19518	signatures	_
111-14	19519-19521	to	_
111-15	19522-19525	run	_
111-16	19526-19539	deconvolution	_
111-17	19540-19542	on	_
111-18	19543-19553	homogenate	_
111-19	19554-19561	samples	_
111-20	19562-19564	to	_
111-21	19565-19573	quantify	_
111-22	19574-19577	the	_
111-23	19578-19588	proportion	_
111-24	19589-19591	of	_
111-25	19592-19596	each	_
111-26	19597-19601	cell	_
111-27	19602-19606	type	_
111-28	19607-19610	for	_
111-29	19611-19616	every	_
111-30	19617-19623	sample	_
111-31	19624-19625	.	_

Text=We first created the basis set for neuronal and non-neuronal cell types by taking the mean of RPKM values for each peak across neuronal samples and neuron-depleted samples respectively for both marks.
112-1	19626-19628	We	_
112-2	19629-19634	first	_
112-3	19635-19642	created	_
112-4	19643-19646	the	_
112-5	19647-19652	basis	_
112-6	19653-19656	set	_
112-7	19657-19660	for	_
112-8	19661-19669	neuronal	_
112-9	19670-19673	and	_
112-10	19674-19686	non-neuronal	_
112-11	19687-19691	cell	_
112-12	19692-19697	types	_
112-13	19698-19700	by	_
112-14	19701-19707	taking	_
112-15	19708-19711	the	_
112-16	19712-19716	mean	_
112-17	19717-19719	of	_
112-18	19720-19724	RPKM	_
112-19	19725-19731	values	_
112-20	19732-19735	for	_
112-21	19736-19740	each	_
112-22	19741-19745	peak	_
112-23	19746-19752	across	_
112-24	19753-19761	neuronal	_
112-25	19762-19769	samples	_
112-26	19770-19773	and	_
112-27	19774-19789	neuron-depleted	_
112-28	19790-19797	samples	_
112-29	19798-19810	respectively	_
112-30	19811-19814	for	_
112-31	19815-19819	both	_
112-32	19820-19825	marks	_
112-33	19826-19827	.	_

Text=We defined as our input matrix the HBCC homogenate samples ’ RPKM matrix.
113-1	19828-19830	We	_
113-2	19831-19838	defined	_
113-3	19839-19841	as	_
113-4	19842-19845	our	_
113-5	19846-19851	input	_
113-6	19852-19858	matrix	_
113-7	19859-19862	the	_
113-8	19863-19867	HBCC	_
113-9	19868-19878	homogenate	_
113-10	19879-19886	samples	_
113-11	19887-19888	’	_
113-12	19889-19893	RPKM	_
113-13	19894-19900	matrix	_
113-14	19901-19902	.	_

Text=We then used the “ lsfit ” method from CellMix library for decomposition of RPKM matrix to calculate the coefficients of neuronal and non-neuronal cell types.
114-1	19903-19905	We	_
114-2	19906-19910	then	_
114-3	19911-19915	used	_
114-4	19916-19919	the	_
114-5	19920-19921	“	_
114-6	19922-19927	lsfit	_
114-7	19928-19929	”	_
114-8	19930-19936	method	_
114-9	19937-19941	from	_
114-10	19942-19949	CellMix	_
114-11	19950-19957	library	_
114-12	19958-19961	for	_
114-13	19962-19975	decomposition	_
114-14	19976-19978	of	_
114-15	19979-19983	RPKM	_
114-16	19984-19990	matrix	_
114-17	19991-19993	to	_
114-18	19994-20003	calculate	_
114-19	20004-20007	the	_
114-20	20008-20020	coefficients	_
114-21	20021-20023	of	_
114-22	20024-20032	neuronal	_
114-23	20033-20036	and	_
114-24	20037-20049	non-neuronal	_
114-25	20050-20054	cell	_
114-26	20055-20060	types	_
114-27	20061-20062	.	_

Text=Genic annotation We used CHIPSeeker v.1.8.9 to annotate peaks to seven distinct categories: promoter, 5′UTR, exons, introns, 3′UTR, downstream (<=3 kb) and distal intergenic regions within 5Kb of downstream and upstream of the transcription start site.
115-1	20063-20068	Genic	_
115-2	20069-20079	annotation	_
115-3	20080-20082	We	_
115-4	20083-20087	used	_
115-5	20088-20098	CHIPSeeker	_
115-6	20099-20106	v.1.8.9	_
115-7	20107-20109	to	_
115-8	20110-20118	annotate	_
115-9	20119-20124	peaks	_
115-10	20125-20127	to	_
115-11	20128-20133	seven	_
115-12	20134-20142	distinct	_
115-13	20143-20153	categories	_
115-14	20154-20155	:	_
115-15	20156-20164	promoter	_
115-16	20165-20166	,	_
115-17	20167-20172	5′UTR	_
115-18	20173-20174	,	_
115-19	20175-20180	exons	_
115-20	20181-20182	,	_
115-21	20183-20190	introns	_
115-22	20191-20192	,	_
115-23	20193-20198	3′UTR	_
115-24	20199-20200	,	_
115-25	20201-20211	downstream	_
115-26	20212-20213	(	_
115-27	20214-20215	<	_
115-28	20216-20218	=3	_
115-29	20219-20221	kb	_
115-30	20222-20223	)	_
115-31	20224-20227	and	_
115-32	20228-20234	distal	_
115-33	20235-20245	intergenic	_
115-34	20246-20253	regions	_
115-35	20254-20260	within	_
115-36	20261-20264	5Kb	_
115-37	20265-20267	of	_
115-38	20268-20278	downstream	_
115-39	20279-20282	and	_
115-40	20283-20291	upstream	_
115-41	20292-20294	of	_
115-42	20295-20298	the	_
115-43	20299-20312	transcription	_
115-44	20313-20318	start	_
115-45	20319-20323	site	_
115-46	20324-20325	.	_

Text=The transcript database used for the annotation is ENSEMBL v75 for GRCh37.70.
116-1	20326-20329	The	_
116-2	20330-20340	transcript	_
116-3	20341-20349	database	_
116-4	20350-20354	used	_
116-5	20355-20358	for	_
116-6	20359-20362	the	_
116-7	20363-20373	annotation	_
116-8	20374-20376	is	_
116-9	20377-20384	ENSEMBL	_
116-10	20385-20388	v75	_
116-11	20389-20392	for	_
116-12	20393-20402	GRCh37.70	_
116-13	20403-20404	.	_

Text=Correlation of ChIP-Seq reads counts with RNA-Seq expression We next examined the enrichment of ChIP-Seq reads counts around transcription start site (TSS) region of protein coding genes with RNA-Seq expressions from 537 individuals for 20,330 genes from PFC brain regions.
117-1	20405-20416	Correlation	_
117-2	20417-20419	of	_
117-3	20420-20428	ChIP-Seq	_
117-4	20429-20434	reads	_
117-5	20435-20441	counts	_
117-6	20442-20446	with	_
117-7	20447-20454	RNA-Seq	_
117-8	20455-20465	expression	_
117-9	20466-20468	We	_
117-10	20469-20473	next	_
117-11	20474-20482	examined	_
117-12	20483-20486	the	_
117-13	20487-20497	enrichment	_
117-14	20498-20500	of	_
117-15	20501-20509	ChIP-Seq	_
117-16	20510-20515	reads	_
117-17	20516-20522	counts	_
117-18	20523-20529	around	_
117-19	20530-20543	transcription	_
117-20	20544-20549	start	_
117-21	20550-20554	site	_
117-22	20555-20556	(	_
117-23	20557-20560	TSS	_
117-24	20561-20562	)	_
117-25	20563-20569	region	_
117-26	20570-20572	of	_
117-27	20573-20580	protein	_
117-28	20581-20587	coding	_
117-29	20588-20593	genes	_
117-30	20594-20598	with	_
117-31	20599-20606	RNA-Seq	_
117-32	20607-20618	expressions	_
117-33	20619-20623	from	_
117-34	20624-20627	537	_
117-35	20628-20639	individuals	_
117-36	20640-20643	for	_
117-37	20644-20650	20,330	_
117-38	20651-20656	genes	_
117-39	20657-20661	from	_
117-40	20662-20665	PFC	_
117-41	20666-20671	brain	_
117-42	20672-20679	regions	_
117-43	20680-20681	.	_

Text=We use nsgplot v2.61 to plot ChIP-Seq read enrichment of combined PFC neuronal data sets as a function of 15kb distance upstream, downstream around TSS for both marks.
118-1	20682-20684	We	_
118-2	20685-20688	use	_
118-3	20689-20696	nsgplot	_
118-4	20697-20702	v2.61	_
118-5	20703-20705	to	_
118-6	20706-20710	plot	_
118-7	20711-20719	ChIP-Seq	_
118-8	20720-20724	read	_
118-9	20725-20735	enrichment	_
118-10	20736-20738	of	_
118-11	20739-20747	combined	_
118-12	20748-20751	PFC	_
118-13	20752-20760	neuronal	_
118-14	20761-20765	data	_
118-15	20766-20770	sets	_
118-16	20771-20773	as	_
118-17	20774-20775	a	_
118-18	20776-20784	function	_
118-19	20785-20787	of	_
118-20	20788-20792	15kb	_
118-21	20793-20801	distance	_
118-22	20802-20810	upstream	_
118-23	20811-20812	,	_
118-24	20813-20823	downstream	_
118-25	20824-20830	around	_
118-26	20831-20834	TSS	_
118-27	20835-20838	for	_
118-28	20839-20843	both	_
118-29	20844-20849	marks	_
118-30	20850-20851	.	_

Text=Enrichments plots were made for all protein coding genes grouped into 5 categories sorted by the RPKM mean values across 537 subjects from the CommonMind RNA-Seq dataset.
119-1	20852-20863	Enrichments	_
119-2	20864-20869	plots	_
119-3	20870-20874	were	_
119-4	20875-20879	made	_
119-5	20880-20883	for	_
119-6	20884-20887	all	_
119-7	20888-20895	protein	_
119-8	20896-20902	coding	_
119-9	20903-20908	genes	_
119-10	20909-20916	grouped	_
119-11	20917-20921	into	_
119-12	20922-20923	5	_
119-13	20924-20934	categories	_
119-14	20935-20941	sorted	_
119-15	20942-20944	by	_
119-16	20945-20948	the	_
119-17	20949-20953	RPKM	_
119-18	20954-20958	mean	_
119-19	20959-20965	values	_
119-20	20966-20972	across	_
119-21	20973-20976	537	_
119-22	20977-20985	subjects	_
119-23	20986-20990	from	_
119-24	20991-20994	the	_
119-25	20995-21005	CommonMind	_
119-26	21006-21013	RNA-Seq	_
119-27	21014-21021	dataset	_
119-28	21022-21023	.	_

Text=Histone QTL enrichment analysis The overlap between peak regions with a) histone QTLs detected in lymphoblastoid cell lines (LCL) and peak regions exceeding a variance percentage cutoff for a particular variable for both marks is computed.
120-1	21024-21031	Histone	_
120-2	21032-21035	QTL	_
120-3	21036-21046	enrichment	_
120-4	21047-21055	analysis	_
120-5	21056-21059	The	_
120-6	21060-21067	overlap	_
120-7	21068-21075	between	_
120-8	21076-21080	peak	_
120-9	21081-21088	regions	_
120-10	21089-21093	with	_
120-11	21094-21095	a	_
120-12	21096-21097	)	_
120-13	21098-21105	histone	_
120-14	21106-21110	QTLs	_
120-15	21111-21119	detected	_
120-16	21120-21122	in	_
120-17	21123-21137	lymphoblastoid	_
120-18	21138-21142	cell	_
120-19	21143-21148	lines	_
120-20	21149-21150	(	_
120-21	21151-21154	LCL	_
120-22	21155-21156	)	_
120-23	21157-21160	and	_
120-24	21161-21165	peak	_
120-25	21166-21173	regions	_
120-26	21174-21183	exceeding	_
120-27	21184-21185	a	_
120-28	21186-21194	variance	_
120-29	21195-21205	percentage	_
120-30	21206-21212	cutoff	_
120-31	21213-21216	for	_
120-32	21217-21218	a	_
120-33	21219-21229	particular	_
120-34	21230-21238	variable	_
120-35	21239-21242	for	_
120-36	21243-21247	both	_
120-37	21248-21253	marks	_
120-38	21254-21256	is	_
120-39	21257-21265	computed	_
120-40	21266-21267	.	_

Text=This overlap is then compared to the overlap computed from randomly permutated variance percentages.
121-1	21268-21272	This	_
121-2	21273-21280	overlap	_
121-3	21281-21283	is	_
121-4	21284-21288	then	_
121-5	21289-21297	compared	_
121-6	21298-21300	to	_
121-7	21301-21304	the	_
121-8	21305-21312	overlap	_
121-9	21313-21321	computed	_
121-10	21322-21326	from	_
121-11	21327-21335	randomly	_
121-12	21336-21346	permutated	_
121-13	21347-21355	variance	_
121-14	21356-21367	percentages	_
121-15	21368-21369	.	_

Text=Each peak region is assigned a value based on the percentage of variance explained by a particular variable in the variancePartition analysis.
122-1	21370-21374	Each	_
122-2	21375-21379	peak	_
122-3	21380-21386	region	_
122-4	21387-21389	is	_
122-5	21390-21398	assigned	_
122-6	21399-21400	a	_
122-7	21401-21406	value	_
122-8	21407-21412	based	_
122-9	21413-21415	on	_
122-10	21416-21419	the	_
122-11	21420-21430	percentage	_
122-12	21431-21433	of	_
122-13	21434-21442	variance	_
122-14	21443-21452	explained	_
122-15	21453-21455	by	_
122-16	21456-21457	a	_
122-17	21458-21468	particular	_
122-18	21469-21477	variable	_
122-19	21478-21480	in	_
122-20	21481-21484	the	_
122-21	21485-21502	variancePartition	_
122-22	21503-21511	analysis	_
122-23	21512-21513	.	_

Text=At each of 40 cutoff values, the overlap between peak regions with values exceeding this cutoff and the peak regions with a histone QTL for the same histone mark in LCLs/PFC is evaluated using the Jaccard index.
123-1	21514-21516	At	_
123-2	21517-21521	each	_
123-3	21522-21524	of	_
123-4	21525-21527	40	_
123-5	21528-21534	cutoff	_
123-6	21535-21541	values	_
123-7	21542-21543	,	_
123-8	21544-21547	the	_
123-9	21548-21555	overlap	_
123-10	21556-21563	between	_
123-11	21564-21568	peak	_
123-12	21569-21576	regions	_
123-13	21577-21581	with	_
123-14	21582-21588	values	_
123-15	21589-21598	exceeding	_
123-16	21599-21603	this	_
123-17	21604-21610	cutoff	_
123-18	21611-21614	and	_
123-19	21615-21618	the	_
123-20	21619-21623	peak	_
123-21	21624-21631	regions	_
123-22	21632-21636	with	_
123-23	21637-21638	a	_
123-24	21639-21646	histone	_
123-25	21647-21650	QTL	_
123-26	21651-21654	for	_
123-27	21655-21658	the	_
123-28	21659-21663	same	_
123-29	21664-21671	histone	_
123-30	21672-21676	mark	_
123-31	21677-21679	in	_
123-32	21680-21688	LCLs/PFC	_
123-33	21689-21691	is	_
123-34	21692-21701	evaluated	_
123-35	21702-21707	using	_
123-36	21708-21711	the	_
123-37	21712-21719	Jaccard	_
123-38	21720-21725	index	_
123-39	21726-21727	.	_

Text=The overlap was computed for the observed data and 10,000 datasets with the variance percentages randomly permutated.
124-1	21728-21731	The	_
124-2	21732-21739	overlap	_
124-3	21740-21743	was	_
124-4	21744-21752	computed	_
124-5	21753-21756	for	_
124-6	21757-21760	the	_
124-7	21761-21769	observed	_
124-8	21770-21774	data	_
124-9	21775-21778	and	_
124-10	21779-21785	10,000	_
124-11	21786-21794	datasets	_
124-12	21795-21799	with	_
124-13	21800-21803	the	_
124-14	21804-21812	variance	_
124-15	21813-21824	percentages	_
124-16	21825-21833	randomly	_
124-17	21834-21844	permutated	_
124-18	21845-21846	.	_

Text=At each cutoff, the enrichment is computed as The mean enrichment value and the 90% confidence interval are shown in the plot.
125-1	21847-21849	At	_
125-2	21850-21854	each	_
125-3	21855-21861	cutoff	_
125-4	21862-21863	,	_
125-5	21864-21867	the	_
125-6	21868-21878	enrichment	_
125-7	21879-21881	is	_
125-8	21882-21890	computed	_
125-9	21891-21893	as	_
125-10	21894-21897	The	_
125-11	21898-21902	mean	_
125-12	21903-21913	enrichment	_
125-13	21914-21919	value	_
125-14	21920-21923	and	_
125-15	21924-21927	the	_
125-16	21928-21930	90	_
125-17	21931-21932	%	_
125-18	21933-21943	confidence	_
125-19	21944-21952	interval	_
125-20	21953-21956	are	_
125-21	21957-21962	shown	_
125-22	21963-21965	in	_
125-23	21966-21969	the	_
125-24	21970-21974	plot	_
125-25	21975-21976	.	_

Text=Only regions on autosomes are considered leaving 9,575 H3K4me3 hQTLs in LCLs and 1,912 H3K27ac hQTLs in post mortem PCF.
126-1	21977-21981	Only	_
126-2	21982-21989	regions	_
126-3	21990-21992	on	_
126-4	21993-22002	autosomes	_
126-5	22003-22006	are	_
126-6	22007-22017	considered	_
126-7	22018-22025	leaving	_
126-8	22026-22031	9,575	_
126-9	22032-22039	H3K4me3	_
126-10	22040-22045	hQTLs	_
126-11	22046-22048	in	_
126-12	22049-22053	LCLs	_
126-13	22054-22057	and	_
126-14	22058-22063	1,912	_
126-15	22064-22071	H3K27ac	_
126-16	22072-22077	hQTLs	_
126-17	22078-22080	in	_
126-18	22081-22085	post	_
126-19	22086-22092	mortem	_
126-20	22093-22096	PCF	_
126-21	22097-22098	.	_

Text=Permutation and overlap calculations were performed using regioneR.
127-1	22099-22110	Permutation	_
127-2	22111-22114	and	_
127-3	22115-22122	overlap	_
127-4	22123-22135	calculations	_
127-5	22136-22140	were	_
127-6	22141-22150	performed	_
127-7	22151-22156	using	_
127-8	22157-22165	regioneR	_
127-9	22166-22167	.	_

Text=We ran similar analysis to test the overlap between the peak regions with a) hQTLs in H3K27ac modified peak regions from PFC homogenate from Sun et.al.
128-1	22168-22170	We	_
128-2	22171-22174	ran	_
128-3	22175-22182	similar	_
128-4	22183-22191	analysis	_
128-5	22192-22194	to	_
128-6	22195-22199	test	_
128-7	22200-22203	the	_
128-8	22204-22211	overlap	_
128-9	22212-22219	between	_
128-10	22220-22223	the	_
128-11	22224-22228	peak	_
128-12	22229-22236	regions	_
128-13	22237-22241	with	_
128-14	22242-22243	a	_
128-15	22244-22245	)	_
128-16	22246-22251	hQTLs	_
128-17	22252-22254	in	_
128-18	22255-22262	H3K27ac	_
128-19	22263-22271	modified	_
128-20	22272-22276	peak	_
128-21	22277-22284	regions	_
128-22	22285-22289	from	_
128-23	22290-22293	PFC	_
128-24	22294-22304	homogenate	_
128-25	22305-22309	from	_
128-26	22310-22313	Sun	_
128-27	22314-22319	et.al	_
128-28	22320-22321	.	_

Text=b) hQTLs in H3K9ac modified peak regions from PFC homogenate from Ng et.al.
129-1	22322-22323	b	_
129-2	22324-22325	)	_
129-3	22326-22331	hQTLs	_
129-4	22332-22334	in	_
129-5	22335-22341	H3K9ac	_
129-6	22342-22350	modified	_
129-7	22351-22355	peak	_
129-8	22356-22363	regions	_
129-9	22364-22368	from	_
129-10	22369-22372	PFC	_
129-11	22373-22383	homogenate	_
129-12	22384-22388	from	_
129-13	22389-22391	Ng	_
129-14	22392-22397	et.al	_
129-15	22398-22399	.	_

Text=with peak regions from 1) H3K27ac-PFC neuronal 2) H3K27ac-PFC non-neuronal, 3) H3K27ac-ACC neuronal 4) H3K27ac-ACC non-neuronal datasets and 5) differentially modified neuronal and 6) non-neuronal H3K27ac modified peak regions.
130-1	22400-22404	with	_
130-2	22405-22409	peak	_
130-3	22410-22417	regions	_
130-4	22418-22422	from	_
130-5	22423-22424	1	_
130-6	22425-22426	)	_
130-7	22427-22438	H3K27ac-PFC	_
130-8	22439-22447	neuronal	_
130-9	22448-22449	2	_
130-10	22450-22451	)	_
130-11	22452-22463	H3K27ac-PFC	_
130-12	22464-22476	non-neuronal	_
130-13	22477-22478	,	_
130-14	22479-22480	3	_
130-15	22481-22482	)	_
130-16	22483-22494	H3K27ac-ACC	_
130-17	22495-22503	neuronal	_
130-18	22504-22505	4	_
130-19	22506-22507	)	_
130-20	22508-22519	H3K27ac-ACC	_
130-21	22520-22532	non-neuronal	_
130-22	22533-22541	datasets	_
130-23	22542-22545	and	_
130-24	22546-22547	5	_
130-25	22548-22549	)	_
130-26	22550-22564	differentially	_
130-27	22565-22573	modified	_
130-28	22574-22582	neuronal	_
130-29	22583-22586	and	_
130-30	22587-22588	6	_
130-31	22589-22590	)	_
130-32	22591-22603	non-neuronal	_
130-33	22604-22611	H3K27ac	_
130-34	22612-22620	modified	_
130-35	22621-22625	peak	_
130-36	22626-22633	regions	_
130-37	22634-22635	.	_

Text=The overlapobserved is the jaccard index between a, b hQTL regions and 1–6 datasets.
131-1	22636-22639	The	_
131-2	22640-22655	overlapobserved	_
131-3	22656-22658	is	_
131-4	22659-22662	the	_
131-5	22663-22670	jaccard	_
131-6	22671-22676	index	_
131-7	22677-22684	between	_
131-8	22685-22686	a	_
131-9	22687-22688	,	_
131-10	22689-22690	b	_
131-11	22691-22695	hQTL	_
131-12	22696-22703	regions	_
131-13	22704-22707	and	_
131-14	22708-22711	1–6	_
131-15	22712-22720	datasets	_
131-16	22721-22722	.	_

Text=The overlappermuted is the jaccard index between abovementioned 1–6 datsets and 1000 datsets obtained by randomly permuting x no.
132-1	22723-22726	The	_
132-2	22727-22742	overlappermuted	_
132-3	22743-22745	is	_
132-4	22746-22749	the	_
132-5	22750-22757	jaccard	_
132-6	22758-22763	index	_
132-7	22764-22771	between	_
132-8	22772-22786	abovementioned	_
132-9	22787-22790	1–6	_
132-10	22791-22798	datsets	_
132-11	22799-22802	and	_
132-12	22803-22807	1000	_
132-13	22808-22815	datsets	_
132-14	22816-22824	obtained	_
132-15	22825-22827	by	_
132-16	22828-22836	randomly	_
132-17	22837-22846	permuting	_
132-18	22847-22848	x	_
132-19	22849-22851	no	_
132-20	22852-22853	.	_

Text=of peak regions from a) PFC homogenate from Sun et.al b) PFC homogenate from Ng et.al.
133-1	22854-22856	of	_
133-2	22857-22861	peak	_
133-3	22862-22869	regions	_
133-4	22870-22874	from	_
133-5	22875-22876	a	_
133-6	22877-22878	)	_
133-7	22879-22882	PFC	_
133-8	22883-22893	homogenate	_
133-9	22894-22898	from	_
133-10	22899-22902	Sun	_
133-11	22903-22908	et.al	_
133-12	22909-22910	b	_
133-13	22911-22912	)	_
133-14	22913-22916	PFC	_
133-15	22917-22927	homogenate	_
133-16	22928-22932	from	_
133-17	22933-22935	Ng	_
133-18	22936-22941	et.al	_
133-19	22942-22943	.	_

Text=(x = length of hQTLs) Pathway Enrichment analysis Genomic Regions Enrichment of Annotations Tool (GREAT) was used to interpret differentially modified peaks in terms of the biological function of nearby genes.
134-1	22944-22945	(	_
134-2	22946-22947	x	_
134-3	22948-22949	=	_
134-4	22950-22956	length	_
134-5	22957-22959	of	_
134-6	22960-22965	hQTLs	_
134-7	22966-22967	)	_
134-8	22968-22975	Pathway	_
134-9	22976-22986	Enrichment	_
134-10	22987-22995	analysis	_
134-11	22996-23003	Genomic	_
134-12	23004-23011	Regions	_
134-13	23012-23022	Enrichment	_
134-14	23023-23025	of	_
134-15	23026-23037	Annotations	_
134-16	23038-23042	Tool	_
134-17	23043-23044	(	_
134-18	23045-23050	GREAT	_
134-19	23051-23052	)	_
134-20	23053-23056	was	_
134-21	23057-23061	used	_
134-22	23062-23064	to	_
134-23	23065-23074	interpret	_
134-24	23075-23089	differentially	_
134-25	23090-23098	modified	_
134-26	23099-23104	peaks	_
134-27	23105-23107	in	_
134-28	23108-23113	terms	_
134-29	23114-23116	of	_
134-30	23117-23120	the	_
134-31	23121-23131	biological	_
134-32	23132-23140	function	_
134-33	23141-23143	of	_
134-34	23144-23150	nearby	_
134-35	23151-23156	genes	_
134-36	23157-23158	.	_

Text=We took the sets of peaks that showed significant (<5% FDR) differences across cell types (neurons and non-neurons) from edgeR analysis and tested for functional enrichment using the consensus peaks for each mark as a background (see Table S7, S9).
135-1	23159-23161	We	_
135-2	23162-23166	took	_
135-3	23167-23170	the	_
135-4	23171-23175	sets	_
135-5	23176-23178	of	_
135-6	23179-23184	peaks	_
135-7	23185-23189	that	_
135-8	23190-23196	showed	_
135-9	23197-23208	significant	_
135-10	23209-23210	(	_
135-11	23211-23212	<	_
135-12	23213-23214	5	_
135-13	23215-23216	%	_
135-14	23217-23220	FDR	_
135-15	23221-23222	)	_
135-16	23223-23234	differences	_
135-17	23235-23241	across	_
135-18	23242-23246	cell	_
135-19	23247-23252	types	_
135-20	23253-23254	(	_
135-21	23255-23262	neurons	_
135-22	23263-23266	and	_
135-23	23267-23278	non-neurons	_
135-24	23279-23280	)	_
135-25	23281-23285	from	_
135-26	23286-23291	edgeR	_
135-27	23292-23300	analysis	_
135-28	23301-23304	and	_
135-29	23305-23311	tested	_
135-30	23312-23315	for	_
135-31	23316-23326	functional	_
135-32	23327-23337	enrichment	_
135-33	23338-23343	using	_
135-34	23344-23347	the	_
135-35	23348-23357	consensus	_
135-36	23358-23363	peaks	_
135-37	23364-23367	for	_
135-38	23368-23372	each	_
135-39	23373-23377	mark	_
135-40	23378-23380	as	_
135-41	23381-23382	a	_
135-42	23383-23393	background	_
135-43	23394-23395	(	_
135-44	23396-23399	see	_
135-45	23400-23405	Table	_
135-46	23406-23408	S7	_
135-47	23409-23410	,	_
135-48	23411-23413	S9	_
135-49	23414-23415	)	_
135-50	23416-23417	.	_

Text=The settings for genomic regions used are (proximal: 5.0 kb upstream, 5.0kb upstream and distal to 100 kb.)
136-1	23418-23421	The	_
136-2	23422-23430	settings	_
136-3	23431-23434	for	_
136-4	23435-23442	genomic	_
136-5	23443-23450	regions	_
136-6	23451-23455	used	_
136-7	23456-23459	are	_
136-8	23460-23461	(	_
136-9	23462-23470	proximal	_
136-10	23471-23472	:	_
136-11	23473-23476	5.0	_
136-12	23477-23479	kb	_
136-13	23480-23488	upstream	_
136-14	23489-23490	,	_
136-15	23491-23496	5.0kb	_
136-16	23497-23505	upstream	_
136-17	23506-23509	and	_
136-18	23510-23516	distal	_
136-19	23517-23519	to	_
136-20	23520-23523	100	_
136-21	23524-23526	kb	_
136-22	23527-23528	.	_
136-23	23529-23530	)	_

Text=Since many of the gene set from different databases are redundant, we only considered REACTOME, KEGG and PID for a total of gene sets.
137-1	23531-23536	Since	_
137-2	23537-23541	many	_
137-3	23542-23544	of	_
137-4	23545-23548	the	_
137-5	23549-23553	gene	_
137-6	23554-23557	set	_
137-7	23558-23562	from	_
137-8	23563-23572	different	_
137-9	23573-23582	databases	_
137-10	23583-23586	are	_
137-11	23587-23596	redundant	_
137-12	23597-23598	,	_
137-13	23599-23601	we	_
137-14	23602-23606	only	_
137-15	23607-23617	considered	_
137-16	23618-23626	REACTOME	_
137-17	23627-23628	,	_
137-18	23629-23633	KEGG	_
137-19	23634-23637	and	_
137-20	23638-23641	PID	_
137-21	23642-23645	for	_
137-22	23646-23647	a	_
137-23	23648-23653	total	_
137-24	23654-23656	of	_
137-25	23657-23661	gene	_
137-26	23662-23666	sets	_
137-27	23667-23668	.	_

Text=Significance testing for the enrichment analysis was based on the binomial test compute by GREAT and using a Bonferroni cutoff 4.7 X 10−5 based on these tests.
138-1	23669-23681	Significance	_
138-2	23682-23689	testing	_
138-3	23690-23693	for	_
138-4	23694-23697	the	_
138-5	23698-23708	enrichment	_
138-6	23709-23717	analysis	_
138-7	23718-23721	was	_
138-8	23722-23727	based	_
138-9	23728-23730	on	_
138-10	23731-23734	the	_
138-11	23735-23743	binomial	_
138-12	23744-23748	test	_
138-13	23749-23756	compute	_
138-14	23757-23759	by	_
138-15	23760-23765	GREAT	_
138-16	23766-23769	and	_
138-17	23770-23775	using	_
138-18	23776-23777	a	_
138-19	23778-23788	Bonferroni	_
138-20	23789-23795	cutoff	_
138-21	23796-23799	4.7	_
138-22	23800-23801	X	_
138-23	23802-23806	10−5	_
138-24	23807-23812	based	_
138-25	23813-23815	on	_
138-26	23816-23821	these	_
138-27	23822-23827	tests	_
138-28	23828-23829	.	_

Text=Overlap of identified peaks with disease and trait-associated genetic variants To assess if the genomic regions carrying the two assayed histone marks in the different brain regions and cell types play a role in the various traits and diseases, we examined the overlap with common genetic variants identified by genome-wide association studies (GWAS).
139-1	23830-23837	Overlap	_
139-2	23838-23840	of	_
139-3	23841-23851	identified	_
139-4	23852-23857	peaks	_
139-5	23858-23862	with	_
139-6	23863-23870	disease	_
139-7	23871-23874	and	_
139-8	23875-23891	trait-associated	_
139-9	23892-23899	genetic	_
139-10	23900-23908	variants	_
139-11	23909-23911	To	_
139-12	23912-23918	assess	_
139-13	23919-23921	if	_
139-14	23922-23925	the	_
139-15	23926-23933	genomic	_
139-16	23934-23941	regions	_
139-17	23942-23950	carrying	_
139-18	23951-23954	the	_
139-19	23955-23958	two	_
139-20	23959-23966	assayed	_
139-21	23967-23974	histone	_
139-22	23975-23980	marks	_
139-23	23981-23983	in	_
139-24	23984-23987	the	_
139-25	23988-23997	different	_
139-26	23998-24003	brain	_
139-27	24004-24011	regions	_
139-28	24012-24015	and	_
139-29	24016-24020	cell	_
139-30	24021-24026	types	_
139-31	24027-24031	play	_
139-32	24032-24033	a	_
139-33	24034-24038	role	_
139-34	24039-24041	in	_
139-35	24042-24045	the	_
139-36	24046-24053	various	_
139-37	24054-24060	traits	_
139-38	24061-24064	and	_
139-39	24065-24073	diseases	_
139-40	24074-24075	,	_
139-41	24076-24078	we	_
139-42	24079-24087	examined	_
139-43	24088-24091	the	_
139-44	24092-24099	overlap	_
139-45	24100-24104	with	_
139-46	24105-24111	common	_
139-47	24112-24119	genetic	_
139-48	24120-24128	variants	_
139-49	24129-24139	identified	_
139-50	24140-24142	by	_
139-51	24143-24154	genome-wide	_
139-52	24155-24166	association	_
139-53	24167-24174	studies	_
139-54	24175-24176	(	_
139-55	24177-24181	GWAS	_
139-56	24182-24183	)	_
139-57	24184-24185	.	_

Text=For this, we employed LD-score partitioned heritability, which estimates if common genetic variants in the genomic regions of interest explain more of the heritability of a given trait than genetic variants not overlapping the genomic regions of interest normalized by the number of variants in either category.
140-1	24186-24189	For	_
140-2	24190-24194	this	_
140-3	24195-24196	,	_
140-4	24197-24199	we	_
140-5	24200-24208	employed	_
140-6	24209-24217	LD-score	_
140-7	24218-24229	partitioned	_
140-8	24230-24242	heritability	_
140-9	24243-24244	,	_
140-10	24245-24250	which	_
140-11	24251-24260	estimates	_
140-12	24261-24263	if	_
140-13	24264-24270	common	_
140-14	24271-24278	genetic	_
140-15	24279-24287	variants	_
140-16	24288-24290	in	_
140-17	24291-24294	the	_
140-18	24295-24302	genomic	_
140-19	24303-24310	regions	_
140-20	24311-24313	of	_
140-21	24314-24322	interest	_
140-22	24323-24330	explain	_
140-23	24331-24335	more	_
140-24	24336-24338	of	_
140-25	24339-24342	the	_
140-26	24343-24355	heritability	_
140-27	24356-24358	of	_
140-28	24359-24360	a	_
140-29	24361-24366	given	_
140-30	24367-24372	trait	_
140-31	24373-24377	than	_
140-32	24378-24385	genetic	_
140-33	24386-24394	variants	_
140-34	24395-24398	not	_
140-35	24399-24410	overlapping	_
140-36	24411-24414	the	_
140-37	24415-24422	genomic	_
140-38	24423-24430	regions	_
140-39	24431-24433	of	_
140-40	24434-24442	interest	_
140-41	24443-24453	normalized	_
140-42	24454-24456	by	_
140-43	24457-24460	the	_
140-44	24461-24467	number	_
140-45	24468-24470	of	_
140-46	24471-24479	variants	_
140-47	24480-24482	in	_
140-48	24483-24489	either	_
140-49	24490-24498	category	_
140-50	24499-24500	.	_

Text=The algorithm allows for correction of the general genetic context of the annotation using a baseline model of broad genomic annotations (like coding, intronic, and conserved).
141-1	24501-24504	The	_
141-2	24505-24514	algorithm	_
141-3	24515-24521	allows	_
141-4	24522-24525	for	_
141-5	24526-24536	correction	_
141-6	24537-24539	of	_
141-7	24540-24543	the	_
141-8	24544-24551	general	_
141-9	24552-24559	genetic	_
141-10	24560-24567	context	_
141-11	24568-24570	of	_
141-12	24571-24574	the	_
141-13	24575-24585	annotation	_
141-14	24586-24591	using	_
141-15	24592-24593	a	_
141-16	24594-24602	baseline	_
141-17	24603-24608	model	_
141-18	24609-24611	of	_
141-19	24612-24617	broad	_
141-20	24618-24625	genomic	_
141-21	24626-24637	annotations	_
141-22	24638-24639	(	_
141-23	24640-24644	like	_
141-24	24645-24651	coding	_
141-25	24652-24653	,	_
141-26	24654-24662	intronic	_
141-27	24663-24664	,	_
141-28	24665-24668	and	_
141-29	24669-24678	conserved	_
141-30	24679-24680	)	_
141-31	24681-24682	.	_

Text=By using this baseline model, the algorithm focuses on enrichments above those expected from the genetic context of the interrogated regions.
142-1	24683-24685	By	_
142-2	24686-24691	using	_
142-3	24692-24696	this	_
142-4	24697-24705	baseline	_
142-5	24706-24711	model	_
142-6	24712-24713	,	_
142-7	24714-24717	the	_
142-8	24718-24727	algorithm	_
142-9	24728-24735	focuses	_
142-10	24736-24738	on	_
142-11	24739-24750	enrichments	_
142-12	24751-24756	above	_
142-13	24757-24762	those	_
142-14	24763-24771	expected	_
142-15	24772-24776	from	_
142-16	24777-24780	the	_
142-17	24781-24788	genetic	_
142-18	24789-24796	context	_
142-19	24797-24799	of	_
142-20	24800-24803	the	_
142-21	24804-24816	interrogated	_
142-22	24817-24824	regions	_
142-23	24825-24826	.	_

Text=We applied the method to a range of GWAS traits with presumed involvement of the brain and well powered studies of traits not believed to involve the brain.
143-1	24827-24829	We	_
143-2	24830-24837	applied	_
143-3	24838-24841	the	_
143-4	24842-24848	method	_
143-5	24849-24851	to	_
143-6	24852-24853	a	_
143-7	24854-24859	range	_
143-8	24860-24862	of	_
143-9	24863-24867	GWAS	_
143-10	24868-24874	traits	_
143-11	24875-24879	with	_
143-12	24880-24888	presumed	_
143-13	24889-24900	involvement	_
143-14	24901-24903	of	_
143-15	24904-24907	the	_
143-16	24908-24913	brain	_
143-17	24914-24917	and	_
143-18	24918-24922	well	_
143-19	24923-24930	powered	_
143-20	24931-24938	studies	_
143-21	24939-24941	of	_
143-22	24942-24948	traits	_
143-23	24949-24952	not	_
143-24	24953-24961	believed	_
143-25	24962-24964	to	_
143-26	24965-24972	involve	_
143-27	24973-24976	the	_
143-28	24977-24982	brain	_
143-29	24983-24984	.	_

Text=For the Alzheimer ’ s GWAS, see Materials and Methods for the Alzheimer ’ s GWAS.
144-1	24985-24988	For	_
144-2	24989-24992	the	_
144-3	24993-25002	Alzheimer	_
144-4	25003-25004	’	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
144-5	25005-25006	s	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
144-6	25007-25011	GWAS	_
144-7	25012-25013	,	_
144-8	25014-25017	see	_
144-9	25018-25027	Materials	_
144-10	25028-25031	and	_
144-11	25032-25039	Methods	_
144-12	25040-25043	for	_
144-13	25044-25047	the	_
144-14	25048-25057	Alzheimer	_
144-15	25058-25059	’	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
144-16	25060-25061	s	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
144-17	25062-25066	GWAS	_
144-18	25067-25068	.	_

Text=We used the European only versions of the summary statistics when available.
145-1	25069-25071	We	_
145-2	25072-25076	used	_
145-3	25077-25080	the	_
145-4	25081-25089	European	_
145-5	25090-25094	only	_
145-6	25095-25103	versions	_
145-7	25104-25106	of	_
145-8	25107-25110	the	_
145-9	25111-25118	summary	_
145-10	25119-25129	statistics	_
145-11	25130-25134	when	_
145-12	25135-25144	available	_
145-13	25145-25146	.	_

Text=This led to only coronary artery disease having a somewhat mixed ancestry (77% Europeans).
146-1	25147-25151	This	_
146-2	25152-25155	led	_
146-3	25156-25158	to	_
146-4	25159-25163	only	_
146-5	25164-25172	coronary	_
146-6	25173-25179	artery	_
146-7	25180-25187	disease	_
146-8	25188-25194	having	_
146-9	25195-25196	a	_
146-10	25197-25205	somewhat	_
146-11	25206-25211	mixed	_
146-12	25212-25220	ancestry	_
146-13	25221-25222	(	_
146-14	25223-25225	77	_
146-15	25226-25227	%	_
146-16	25228-25237	Europeans	_
146-17	25238-25239	)	_
146-18	25240-25241	.	_

Text=We excluded the broad MHC-region (chr6:25–35MB) and otherwise used default parameters.
147-1	25242-25244	We	_
147-2	25245-25253	excluded	_
147-3	25254-25257	the	_
147-4	25258-25263	broad	_
147-5	25264-25274	MHC-region	_
147-6	25275-25276	(	_
147-7	25277-25289	chr6:25–35MB	_
147-8	25290-25291	)	_
147-9	25292-25295	and	_
147-10	25296-25305	otherwise	_
147-11	25306-25310	used	_
147-12	25311-25318	default	_
147-13	25319-25329	parameters	_
147-14	25330-25331	.	_

Text=Allele specific QTL analysis We used RASQUAL to call cell- and tissue- specific cis-hQTLs (histone QTLs) in our dataset PFC neuronal, ACC neuronal, PFC non-neuronal, ACC non-neuronal and PFC tissue homogenate for each of the two histone marks, H3K27ac and H3K4me3.
148-1	25332-25338	Allele	_
148-2	25339-25347	specific	_
148-3	25348-25351	QTL	_
148-4	25352-25360	analysis	_
148-5	25361-25363	We	_
148-6	25364-25368	used	_
148-7	25369-25376	RASQUAL	_
148-8	25377-25379	to	_
148-9	25380-25384	call	_
148-10	25385-25390	cell-	_
148-11	25391-25394	and	_
148-12	25395-25402	tissue-	_
148-13	25403-25411	specific	_
148-14	25412-25421	cis-hQTLs	_
148-15	25422-25423	(	_
148-16	25424-25431	histone	_
148-17	25432-25436	QTLs	_
148-18	25437-25438	)	_
148-19	25439-25441	in	_
148-20	25442-25445	our	_
148-21	25446-25453	dataset	_
148-22	25454-25457	PFC	_
148-23	25458-25466	neuronal	_
148-24	25467-25468	,	_
148-25	25469-25472	ACC	_
148-26	25473-25481	neuronal	_
148-27	25482-25483	,	_
148-28	25484-25487	PFC	_
148-29	25488-25500	non-neuronal	_
148-30	25501-25502	,	_
148-31	25503-25506	ACC	_
148-32	25507-25519	non-neuronal	_
148-33	25520-25523	and	_
148-34	25524-25527	PFC	_
148-35	25528-25534	tissue	_
148-36	25535-25545	homogenate	_
148-37	25546-25549	for	_
148-38	25550-25554	each	_
148-39	25555-25557	of	_
148-40	25558-25561	the	_
148-41	25562-25565	two	_
148-42	25566-25573	histone	_
148-43	25574-25579	marks	_
148-44	25580-25581	,	_
148-45	25582-25589	H3K27ac	_
148-46	25590-25593	and	_
148-47	25594-25601	H3K4me3	_
148-48	25602-25603	.	_

Text=RASQUAL uses allele specific reads counts at heterozygous sites to increase power to detect cis-hQTLs correlated with quantitative variation in histone modification.
149-1	25604-25611	RASQUAL	_
149-2	25612-25616	uses	_
149-3	25617-25623	allele	_
149-4	25624-25632	specific	_
149-5	25633-25638	reads	_
149-6	25639-25645	counts	_
149-7	25646-25648	at	_
149-8	25649-25661	heterozygous	_
149-9	25662-25667	sites	_
149-10	25668-25670	to	_
149-11	25671-25679	increase	_
149-12	25680-25685	power	_
149-13	25686-25688	to	_
149-14	25689-25695	detect	_
149-15	25696-25705	cis-hQTLs	_
149-16	25706-25716	correlated	_
149-17	25717-25721	with	_
149-18	25722-25734	quantitative	_
149-19	25735-25744	variation	_
149-20	25745-25747	in	_
149-21	25748-25755	histone	_
149-22	25756-25768	modification	_
149-23	25769-25770	.	_

Text=With RASQUAL a feature in our ChIP-seq dataset is defined by a set of start and end coordinates of identified peaks for calling a cis-hQTLs.
150-1	25771-25775	With	_
150-2	25776-25783	RASQUAL	_
150-3	25784-25785	a	_
150-4	25786-25793	feature	_
150-5	25794-25796	in	_
150-6	25797-25800	our	_
150-7	25801-25809	ChIP-seq	_
150-8	25810-25817	dataset	_
150-9	25818-25820	is	_
150-10	25821-25828	defined	_
150-11	25829-25831	by	_
150-12	25832-25833	a	_
150-13	25834-25837	set	_
150-14	25838-25840	of	_
150-15	25841-25846	start	_
150-16	25847-25850	and	_
150-17	25851-25854	end	_
150-18	25855-25866	coordinates	_
150-19	25867-25869	of	_
150-20	25870-25880	identified	_
150-21	25881-25886	peaks	_
150-22	25887-25890	for	_
150-23	25891-25898	calling	_
150-24	25899-25900	a	_
150-25	25901-25910	cis-hQTLs	_
150-26	25911-25912	.	_

Text=RASQUAL requires few data preprocessing steps before calling cis-hQTLs.
151-1	25913-25920	RASQUAL	_
151-2	25921-25929	requires	_
151-3	25930-25933	few	_
151-4	25934-25938	data	_
151-5	25939-25952	preprocessing	_
151-6	25953-25958	steps	_
151-7	25959-25965	before	_
151-8	25966-25973	calling	_
151-9	25974-25983	cis-hQTLs	_
151-10	25984-25985	.	_

Text=1) ChIP-seq read counts and offset matrices as text and bin files for each dataset and mark.
152-1	25986-25987	1	_
152-2	25988-25989	)	_
152-3	25990-25998	ChIP-seq	_
152-4	25999-26003	read	_
152-5	26004-26010	counts	_
152-6	26011-26014	and	_
152-7	26015-26021	offset	_
152-8	26022-26030	matrices	_
152-9	26031-26033	as	_
152-10	26034-26038	text	_
152-11	26039-26042	and	_
152-12	26043-26046	bin	_
152-13	26047-26052	files	_
152-14	26053-26056	for	_
152-15	26057-26061	each	_
152-16	26062-26069	dataset	_
152-17	26070-26073	and	_
152-18	26074-26078	mark	_
152-19	26079-26080	.	_

Text=We used bedtools –nuc option to obtain GC content for each identified peak region and use that as an input for offset calculation from counts matrix in their custom makeOffset.R script file.
153-1	26081-26083	We	_
153-2	26084-26088	used	_
153-3	26089-26097	bedtools	_
153-4	26098-26102	–nuc	_
153-5	26103-26109	option	_
153-6	26110-26112	to	_
153-7	26113-26119	obtain	_
153-8	26120-26122	GC	_
153-9	26123-26130	content	_
153-10	26131-26134	for	_
153-11	26135-26139	each	_
153-12	26140-26150	identified	_
153-13	26151-26155	peak	_
153-14	26156-26162	region	_
153-15	26163-26166	and	_
153-16	26167-26170	use	_
153-17	26171-26175	that	_
153-18	26176-26178	as	_
153-19	26179-26181	an	_
153-20	26182-26187	input	_
153-21	26188-26191	for	_
153-22	26192-26198	offset	_
153-23	26199-26210	calculation	_
153-24	26211-26215	from	_
153-25	26216-26222	counts	_
153-26	26223-26229	matrix	_
153-27	26230-26232	in	_
153-28	26233-26238	their	_
153-29	26239-26245	custom	_
153-30	26246-26258	makeOffset.R	_
153-31	26259-26265	script	_
153-32	26266-26270	file	_
153-33	26271-26272	.	_

Text=All text files were converted to bin file using text2bin.R script file.
154-1	26273-26276	All	_
154-2	26277-26281	text	_
154-3	26282-26287	files	_
154-4	26288-26292	were	_
154-5	26293-26302	converted	_
154-6	26303-26305	to	_
154-7	26306-26309	bin	_
154-8	26310-26314	file	_
154-9	26315-26320	using	_
154-10	26321-26331	text2bin.R	_
154-11	26332-26338	script	_
154-12	26339-26343	file	_
154-13	26344-26345	.	_

Text=2) Covariates text and bin file for each dataset and mark.
155-1	26346-26347	2	_
155-2	26348-26349	)	_
155-3	26350-26360	Covariates	_
155-4	26361-26365	text	_
155-5	26366-26369	and	_
155-6	26370-26373	bin	_
155-7	26374-26378	file	_
155-8	26379-26382	for	_
155-9	26383-26387	each	_
155-10	26388-26395	dataset	_
155-11	26396-26399	and	_
155-12	26400-26404	mark	_
155-13	26405-26406	.	_

Text=The confounding factors in ChIP-seq reads counts are obtained by applying PCA onto log FPKMs with and without permutation and outputs the first N components whose variances are greater than those from permutation results.
156-1	26407-26410	The	_
156-2	26411-26422	confounding	_
156-3	26423-26430	factors	_
156-4	26431-26433	in	_
156-5	26434-26442	ChIP-seq	_
156-6	26443-26448	reads	_
156-7	26449-26455	counts	_
156-8	26456-26459	are	_
156-9	26460-26468	obtained	_
156-10	26469-26471	by	_
156-11	26472-26480	applying	_
156-12	26481-26484	PCA	_
156-13	26485-26489	onto	_
156-14	26490-26493	log	_
156-15	26494-26499	FPKMs	_
156-16	26500-26504	with	_
156-17	26505-26508	and	_
156-18	26509-26516	without	_
156-19	26517-26528	permutation	_
156-20	26529-26532	and	_
156-21	26533-26540	outputs	_
156-22	26541-26544	the	_
156-23	26545-26550	first	_
156-24	26551-26552	N	_
156-25	26553-26563	components	_
156-26	26564-26569	whose	_
156-27	26570-26579	variances	_
156-28	26580-26583	are	_
156-29	26584-26591	greater	_
156-30	26592-26596	than	_
156-31	26597-26602	those	_
156-32	26603-26607	from	_
156-33	26608-26619	permutation	_
156-34	26620-26627	results	_
156-35	26628-26629	.	_

Text=We used the makeCovariates.R script file and found 5 components as covariates for PFC neuronal, ACC neuronal, PFC non-neuronal, ACC non-neuronal dataset for H3K4me3 and H3K27ac marks whereas PFC homogenate samples have 3 (4) components for H3K4me3 (H3K27ac).
157-1	26630-26632	We	_
157-2	26633-26637	used	_
157-3	26638-26641	the	_
157-4	26642-26658	makeCovariates.R	_
157-5	26659-26665	script	_
157-6	26666-26670	file	_
157-7	26671-26674	and	_
157-8	26675-26680	found	_
157-9	26681-26682	5	_
157-10	26683-26693	components	_
157-11	26694-26696	as	_
157-12	26697-26707	covariates	_
157-13	26708-26711	for	_
157-14	26712-26715	PFC	_
157-15	26716-26724	neuronal	_
157-16	26725-26726	,	_
157-17	26727-26730	ACC	_
157-18	26731-26739	neuronal	_
157-19	26740-26741	,	_
157-20	26742-26745	PFC	_
157-21	26746-26758	non-neuronal	_
157-22	26759-26760	,	_
157-23	26761-26764	ACC	_
157-24	26765-26777	non-neuronal	_
157-25	26778-26785	dataset	_
157-26	26786-26789	for	_
157-27	26790-26797	H3K4me3	_
157-28	26798-26801	and	_
157-29	26802-26809	H3K27ac	_
157-30	26810-26815	marks	_
157-31	26816-26823	whereas	_
157-32	26824-26827	PFC	_
157-33	26828-26838	homogenate	_
157-34	26839-26846	samples	_
157-35	26847-26851	have	_
157-36	26852-26853	3	_
157-37	26854-26855	(	_
157-38	26856-26857	4	_
157-39	26858-26859	)	_
157-40	26860-26870	components	_
157-41	26871-26874	for	_
157-42	26875-26882	H3K4me3	_
157-43	26883-26884	(	_
157-44	26885-26892	H3K27ac	_
157-45	26893-26894	)	_
157-46	26895-26896	.	_

Text=3) Allele specific counts VCF file.
158-1	26897-26898	3	_
158-2	26899-26900	)	_
158-3	26901-26907	Allele	_
158-4	26908-26916	specific	_
158-5	26917-26923	counts	_
158-6	26924-26927	VCF	_
158-7	26928-26932	file	_
158-8	26933-26934	.	_

Text=createASVF.sh script file was used to count allele specific reads for every individual for a given SNP within a feature.
159-1	26935-26948	createASVF.sh	_
159-2	26949-26955	script	_
159-3	26956-26960	file	_
159-4	26961-26964	was	_
159-5	26965-26969	used	_
159-6	26970-26972	to	_
159-7	26973-26978	count	_
159-8	26979-26985	allele	_
159-9	26986-26994	specific	_
159-10	26995-27000	reads	_
159-11	27001-27004	for	_
159-12	27005-27010	every	_
159-13	27011-27021	individual	_
159-14	27022-27025	for	_
159-15	27026-27027	a	_
159-16	27028-27033	given	_
159-17	27034-27037	SNP	_
159-18	27038-27044	within	_
159-19	27045-27046	a	_
159-20	27047-27054	feature	_
159-21	27055-27056	.	_

Text=We used whole genome sequenced data of 17 individuals to generate allele specific counts.
160-1	27057-27059	We	_
160-2	27060-27064	used	_
160-3	27065-27070	whole	_
160-4	27071-27077	genome	_
160-5	27078-27087	sequenced	_
160-6	27088-27092	data	_
160-7	27093-27095	of	_
160-8	27096-27098	17	_
160-9	27099-27110	individuals	_
160-10	27111-27113	to	_
160-11	27114-27122	generate	_
160-12	27123-27129	allele	_
160-13	27130-27138	specific	_
160-14	27139-27145	counts	_
160-15	27146-27147	.	_

Text=WGS paired-end 150bp reads were aligned to the GRCh37 human reference using the Burrows-Wheeler Aligner (BWA-MEM v0.78) and processed using the best-practices pipeline that includes marking of duplicate reads by the use of Picard tools (v1.83, http: //picard.sourceforge.net), realignment around indels, and base recalibration via Genome Analysis Toolkit (GATK v3.2.2).
161-1	27148-27151	WGS	_
161-2	27152-27162	paired-end	_
161-3	27163-27168	150bp	_
161-4	27169-27174	reads	_
161-5	27175-27179	were	_
161-6	27180-27187	aligned	_
161-7	27188-27190	to	_
161-8	27191-27194	the	_
161-9	27195-27201	GRCh37	_
161-10	27202-27207	human	_
161-11	27208-27217	reference	_
161-12	27218-27223	using	_
161-13	27224-27227	the	_
161-14	27228-27243	Burrows-Wheeler	_
161-15	27244-27251	Aligner	_
161-16	27252-27253	(	_
161-17	27254-27261	BWA-MEM	_
161-18	27262-27267	v0.78	_
161-19	27268-27269	)	_
161-20	27270-27273	and	_
161-21	27274-27283	processed	_
161-22	27284-27289	using	_
161-23	27290-27293	the	_
161-24	27294-27308	best-practices	_
161-25	27309-27317	pipeline	_
161-26	27318-27322	that	_
161-27	27323-27331	includes	_
161-28	27332-27339	marking	_
161-29	27340-27342	of	_
161-30	27343-27352	duplicate	_
161-31	27353-27358	reads	_
161-32	27359-27361	by	_
161-33	27362-27365	the	_
161-34	27366-27369	use	_
161-35	27370-27372	of	_
161-36	27373-27379	Picard	_
161-37	27380-27385	tools	_
161-38	27386-27387	(	_
161-39	27388-27393	v1.83	_
161-40	27394-27395	,	_
161-41	27396-27400	http	_
161-42	27401-27402	:	_
161-43	27403-27427	//picard.sourceforge.net	_
161-44	27428-27429	)	_
161-45	27430-27431	,	_
161-46	27432-27443	realignment	_
161-47	27444-27450	around	_
161-48	27451-27457	indels	_
161-49	27458-27459	,	_
161-50	27460-27463	and	_
161-51	27464-27468	base	_
161-52	27469-27482	recalibration	_
161-53	27483-27486	via	_
161-54	27487-27493	Genome	_
161-55	27494-27502	Analysis	_
161-56	27503-27510	Toolkit	_
161-57	27511-27512	(	_
161-58	27513-27517	GATK	_
161-59	27518-27524	v3.2.2	_
161-60	27525-27526	)	_
161-61	27527-27528	.	_

Text=All individuals WGS data was merged into a single vcf file and was used as one of the inputs to createASVF.sh.
162-1	27529-27532	All	_
162-2	27533-27544	individuals	_
162-3	27545-27548	WGS	_
162-4	27549-27553	data	_
162-5	27554-27557	was	_
162-6	27558-27564	merged	_
162-7	27565-27569	into	_
162-8	27570-27571	a	_
162-9	27572-27578	single	_
162-10	27579-27582	vcf	_
162-11	27583-27587	file	_
162-12	27588-27591	and	_
162-13	27592-27595	was	_
162-14	27596-27600	used	_
162-15	27601-27603	as	_
162-16	27604-27607	one	_
162-17	27608-27610	of	_
162-18	27611-27614	the	_
162-19	27615-27621	inputs	_
162-20	27622-27624	to	_
162-21	27625-27638	createASVF.sh	_
162-22	27639-27640	.	_

Text=We ran RASQUAL feature on 90767 H3K4me3 peaks of PFC neuronal (n=17), ACC neuronal (n=14), PFC non-neuronal (n=17), ACC non-neuronal (n=15) and PFC homogenate (n=11) and 127773 H3K27ac peaks from PFC neuronal (n=17), ACC neuronal (n=17), PFC non-neuronal (n=17), ACC non-neuronal (n=15) and PFC homogenate (n=17).
163-1	27641-27643	We	_
163-2	27644-27647	ran	_
163-3	27648-27655	RASQUAL	_
163-4	27656-27663	feature	_
163-5	27664-27666	on	_
163-6	27667-27672	90767	_
163-7	27673-27680	H3K4me3	_
163-8	27681-27686	peaks	_
163-9	27687-27689	of	_
163-10	27690-27693	PFC	_
163-11	27694-27702	neuronal	_
163-12	27703-27704	(	_
163-13	27705-27709	n=17	_
163-14	27710-27711	)	_
163-15	27712-27713	,	_
163-16	27714-27717	ACC	_
163-17	27718-27726	neuronal	_
163-18	27727-27728	(	_
163-19	27729-27733	n=14	_
163-20	27734-27735	)	_
163-21	27736-27737	,	_
163-22	27738-27741	PFC	_
163-23	27742-27754	non-neuronal	_
163-24	27755-27756	(	_
163-25	27757-27761	n=17	_
163-26	27762-27763	)	_
163-27	27764-27765	,	_
163-28	27766-27769	ACC	_
163-29	27770-27782	non-neuronal	_
163-30	27783-27784	(	_
163-31	27785-27789	n=15	_
163-32	27790-27791	)	_
163-33	27792-27795	and	_
163-34	27796-27799	PFC	_
163-35	27800-27810	homogenate	_
163-36	27811-27812	(	_
163-37	27813-27817	n=11	_
163-38	27818-27819	)	_
163-39	27820-27823	and	_
163-40	27824-27830	127773	_
163-41	27831-27838	H3K27ac	_
163-42	27839-27844	peaks	_
163-43	27845-27849	from	_
163-44	27850-27853	PFC	_
163-45	27854-27862	neuronal	_
163-46	27863-27864	(	_
163-47	27865-27869	n=17	_
163-48	27870-27871	)	_
163-49	27872-27873	,	_
163-50	27874-27877	ACC	_
163-51	27878-27886	neuronal	_
163-52	27887-27888	(	_
163-53	27889-27893	n=17	_
163-54	27894-27895	)	_
163-55	27896-27897	,	_
163-56	27898-27901	PFC	_
163-57	27902-27914	non-neuronal	_
163-58	27915-27916	(	_
163-59	27917-27921	n=17	_
163-60	27922-27923	)	_
163-61	27924-27925	,	_
163-62	27926-27929	ACC	_
163-63	27930-27942	non-neuronal	_
163-64	27943-27944	(	_
163-65	27945-27949	n=15	_
163-66	27950-27951	)	_
163-67	27952-27955	and	_
163-68	27956-27959	PFC	_
163-69	27960-27970	homogenate	_
163-70	27971-27972	(	_
163-71	27973-27977	n=17	_
163-72	27978-27979	)	_
163-73	27980-27981	.	_

Text=SNPs were tested within 10 kb of cis region from peak start and end points.
164-1	27982-27986	SNPs	_
164-2	27987-27991	were	_
164-3	27992-27998	tested	_
164-4	27999-28005	within	_
164-5	28006-28008	10	_
164-6	28009-28011	kb	_
164-7	28012-28014	of	_
164-8	28015-28018	cis	_
164-9	28019-28025	region	_
164-10	28026-28030	from	_
164-11	28031-28035	peak	_
164-12	28036-28041	start	_
164-13	28042-28045	and	_
164-14	28046-28049	end	_
164-15	28050-28056	points	_
164-16	28057-28058	.	_

Text=We used Benjamini-Hochberg q-value <0.05 as a threshold to determine the significant cis-hQTLs.
165-1	28059-28061	We	_
165-2	28062-28066	used	_
165-3	28067-28085	Benjamini-Hochberg	_
165-4	28086-28093	q-value	_
165-5	28094-28095	<	_
165-6	28096-28100	0.05	_
165-7	28101-28103	as	_
165-8	28104-28105	a	_
165-9	28106-28115	threshold	_
165-10	28116-28118	to	_
165-11	28119-28128	determine	_
165-12	28129-28132	the	_
165-13	28133-28144	significant	_
165-14	28145-28154	cis-hQTLs	_
165-15	28155-28156	.	_

Text=hQTL-GWAS overlap In order to test the overlap of significant hQTLs (RASQUAL qvalue> 0.05) with GWAS identified SCZ loci, we took the list of lead SNPs and SNPs in LD (R^2> 0.8) with the latter.
166-1	28157-28166	hQTL-GWAS	_
166-2	28167-28174	overlap	_
166-3	28175-28177	In	_
166-4	28178-28183	order	_
166-5	28184-28186	to	_
166-6	28187-28191	test	_
166-7	28192-28195	the	_
166-8	28196-28203	overlap	_
166-9	28204-28206	of	_
166-10	28207-28218	significant	_
166-11	28219-28224	hQTLs	_
166-12	28225-28226	(	_
166-13	28227-28234	RASQUAL	_
166-14	28235-28241	qvalue	_
166-15	28242-28243	>	_
166-16	28244-28248	0.05	_
166-17	28249-28250	)	_
166-18	28251-28255	with	_
166-19	28256-28260	GWAS	_
166-20	28261-28271	identified	_
166-21	28272-28275	SCZ	_
166-22	28276-28280	loci	_
166-23	28281-28282	,	_
166-24	28283-28285	we	_
166-25	28286-28290	took	_
166-26	28291-28294	the	_
166-27	28295-28299	list	_
166-28	28300-28302	of	_
166-29	28303-28307	lead	_
166-30	28308-28312	SNPs	_
166-31	28313-28316	and	_
166-32	28317-28321	SNPs	_
166-33	28322-28324	in	_
166-34	28325-28327	LD	_
166-35	28328-28329	(	_
166-36	28330-28333	R^2	_
166-37	28334-28335	>	_
166-38	28336-28339	0.8	_
166-39	28340-28341	)	_
166-40	28342-28346	with	_
166-41	28347-28350	the	_
166-42	28351-28357	latter	_
166-43	28358-28359	.	_

Text=The list was downloaded from https: //www.med.unc.edu/pgc/results-and-downloads/downloads.
167-1	28360-28363	The	_
167-2	28364-28368	list	_
167-3	28369-28372	was	_
167-4	28373-28383	downloaded	_
167-5	28384-28388	from	_
167-6	28389-28394	https	_
167-7	28395-28396	:	_
167-8	28397-28450	//www.med.unc.edu/pgc/results-and-downloads/downloads	_
167-9	28451-28452	.	_

Text=We report the overlapping loci separately with cell specific hQTLs: - PFC NeuN+, PFC NeuN−, ACC NeuN+, ACC NeuN−) and PFC HBCC tissue homogenate.
168-1	28453-28455	We	_
168-2	28456-28462	report	_
168-3	28463-28466	the	_
168-4	28467-28478	overlapping	_
168-5	28479-28483	loci	_
168-6	28484-28494	separately	_
168-7	28495-28499	with	_
168-8	28500-28504	cell	_
168-9	28505-28513	specific	_
168-10	28514-28519	hQTLs	_
168-11	28520-28521	:	_
168-12	28522-28523	-	_
168-13	28524-28527	PFC	_
168-14	28528-28533	NeuN+	_
168-15	28534-28535	,	_
168-16	28536-28539	PFC	_
168-17	28540-28545	NeuN−	_
168-18	28546-28547	,	_
168-19	28548-28551	ACC	_
168-20	28552-28557	NeuN+	_
168-21	28558-28559	,	_
168-22	28560-28563	ACC	_
168-23	28564-28569	NeuN−	_
168-24	28570-28571	)	_
168-25	28572-28575	and	_
168-26	28576-28579	PFC	_
168-27	28580-28584	HBCC	_
168-28	28585-28591	tissue	_
168-29	28592-28602	homogenate	_
168-30	28603-28604	.	_

Text=hQTLs for both marks are listed in Table S10.
169-1	28605-28610	hQTLs	_
169-2	28611-28614	for	_
169-3	28615-28619	both	_
169-4	28620-28625	marks	_
169-5	28626-28629	are	_
169-6	28630-28636	listed	_
169-7	28637-28639	in	_
169-8	28640-28645	Table	_
169-9	28646-28649	S10	_
169-10	28650-28651	.	_

Text=Materials and Methods for the Alzheimer ’ s GWAS Summary statistics for Alzheimer ’ s disease were provided by the International Genomics of Alzheimer ’ s Project (IGAP).
170-1	28652-28661	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-2	28662-28665	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-3	28666-28673	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-4	28674-28677	for	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-5	28678-28681	the	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-6	28682-28691	Alzheimer	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-7	28692-28693	’	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-8	28694-28695	s	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-9	28696-28700	GWAS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
170-10	28701-28708	Summary	_
170-11	28709-28719	statistics	_
170-12	28720-28723	for	_
170-13	28724-28733	Alzheimer	_
170-14	28734-28735	’	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
170-15	28736-28737	s	http://maven.renci.org/NeuroBridge/neurobridge#SF36Questionnaire
170-16	28738-28745	disease	_
170-17	28746-28750	were	_
170-18	28751-28759	provided	_
170-19	28760-28762	by	_
170-20	28763-28766	the	_
170-21	28767-28780	International	_
170-22	28781-28789	Genomics	_
170-23	28790-28792	of	_
170-24	28793-28802	Alzheimer	_
170-25	28803-28804	’	_
170-26	28805-28806	s	_
170-27	28807-28814	Project	_
170-28	28815-28816	(	_
170-29	28817-28821	IGAP	_
170-30	28822-28823	)	_
170-31	28824-28825	.	_

Text=IGAP is a large two-stage study based upon genome-wide association studies (GWAS) on individuals of European ancestry.
171-1	28826-28830	IGAP	_
171-2	28831-28833	is	_
171-3	28834-28835	a	_
171-4	28836-28841	large	_
171-5	28842-28851	two-stage	_
171-6	28852-28857	study	_
171-7	28858-28863	based	_
171-8	28864-28868	upon	_
171-9	28869-28880	genome-wide	_
171-10	28881-28892	association	_
171-11	28893-28900	studies	_
171-12	28901-28902	(	_
171-13	28903-28907	GWAS	_
171-14	28908-28909	)	_
171-15	28910-28912	on	_
171-16	28913-28924	individuals	_
171-17	28925-28927	of	_
171-18	28928-28936	European	_
171-19	28937-28945	ancestry	_
171-20	28946-28947	.	_

Text=In stage 1, IGAP used genotyped and imputed data on 7,055,881 single nucleotide polymorphisms (SNPs) to meta-analyse four previously-published GWAS datasets consisting of 17,008 Alzheimer ’ s disease cases and 37,154 controls (The European Alzheimer ’ s disease Initiative – EADI the Alzheimer Disease Genetics Consortium – ADGC The Cohorts for Heart and Aging Research in Genomic Epidemiology consortium – CHARGE The Genetic and Environmental Risk in AD consortium – GERAD).
172-1	28948-28950	In	_
172-2	28951-28956	stage	_
172-3	28957-28958	1	_
172-4	28959-28960	,	_
172-5	28961-28965	IGAP	_
172-6	28966-28970	used	_
172-7	28971-28980	genotyped	_
172-8	28981-28984	and	_
172-9	28985-28992	imputed	_
172-10	28993-28997	data	_
172-11	28998-29000	on	_
172-12	29001-29010	7,055,881	_
172-13	29011-29017	single	_
172-14	29018-29028	nucleotide	_
172-15	29029-29042	polymorphisms	_
172-16	29043-29044	(	_
172-17	29045-29049	SNPs	_
172-18	29050-29051	)	_
172-19	29052-29054	to	_
172-20	29055-29067	meta-analyse	_
172-21	29068-29072	four	_
172-22	29073-29093	previously-published	_
172-23	29094-29098	GWAS	_
172-24	29099-29107	datasets	_
172-25	29108-29118	consisting	_
172-26	29119-29121	of	_
172-27	29122-29128	17,008	_
172-28	29129-29138	Alzheimer	http://maven.renci.org/NeuroBridge/neurobridge#Alzheimer'sDisease
172-29	29139-29140	’	http://maven.renci.org/NeuroBridge/neurobridge#Alzheimer'sDisease
172-30	29141-29142	s	http://maven.renci.org/NeuroBridge/neurobridge#Alzheimer'sDisease
172-31	29143-29150	disease	http://maven.renci.org/NeuroBridge/neurobridge#Alzheimer'sDisease
172-32	29151-29156	cases	http://maven.renci.org/NeuroBridge/neurobridge#Alzheimer'sDisease
172-33	29157-29160	and	_
172-34	29161-29167	37,154	_
172-35	29168-29176	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
172-36	29177-29178	(	_
172-37	29179-29182	The	_
172-38	29183-29191	European	_
172-39	29192-29201	Alzheimer	_
172-40	29202-29203	’	_
172-41	29204-29205	s	_
172-42	29206-29213	disease	_
172-43	29214-29224	Initiative	_
172-44	29225-29226	–	_
172-45	29227-29231	EADI	_
172-46	29232-29235	the	_
172-47	29236-29245	Alzheimer	_
172-48	29246-29253	Disease	_
172-49	29254-29262	Genetics	_
172-50	29263-29273	Consortium	_
172-51	29274-29275	–	_
172-52	29276-29280	ADGC	_
172-53	29281-29284	The	_
172-54	29285-29292	Cohorts	_
172-55	29293-29296	for	_
172-56	29297-29302	Heart	_
172-57	29303-29306	and	_
172-58	29307-29312	Aging	_
172-59	29313-29321	Research	_
172-60	29322-29324	in	_
172-61	29325-29332	Genomic	_
172-62	29333-29345	Epidemiology	_
172-63	29346-29356	consortium	_
172-64	29357-29358	–	_
172-65	29359-29365	CHARGE	_
172-66	29366-29369	The	_
172-67	29370-29377	Genetic	_
172-68	29378-29381	and	_
172-69	29382-29395	Environmental	_
172-70	29396-29400	Risk	_
172-71	29401-29403	in	_
172-72	29404-29406	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
172-73	29407-29417	consortium	_
172-74	29418-29419	–	_
172-75	29420-29425	GERAD	_
172-76	29426-29427	)	_
172-77	29428-29429	.	_

Text=In stage 2,11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer ’ s disease cases and 11,312 controls.
173-1	29430-29432	In	_
173-2	29433-29438	stage	_
173-3	29439-29447	2,11,632	_
173-4	29448-29452	SNPs	_
173-5	29453-29457	were	_
173-6	29458-29467	genotyped	_
173-7	29468-29471	and	_
173-8	29472-29478	tested	_
173-9	29479-29482	for	_
173-10	29483-29494	association	_
173-11	29495-29497	in	_
173-12	29498-29500	an	_
173-13	29501-29512	independent	_
173-14	29513-29516	set	_
173-15	29517-29519	of	_
173-16	29520-29525	8,572	_
173-17	29526-29535	Alzheimer	http://maven.renci.org/NeuroBridge/neurobridge#Alzheimer'sDisease
173-18	29536-29537	’	_
173-19	29538-29539	s	_
173-20	29540-29547	disease	http://maven.renci.org/NeuroBridge/neurobridge#DiseaseDiagnosis
173-21	29548-29553	cases	_
173-22	29554-29557	and	_
173-23	29558-29564	11,312	_
173-24	29565-29573	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
173-25	29574-29575	.	_

Text=Finally, a meta-analysis was performed combining results from stages 1 & 2.
174-1	29576-29583	Finally	_
174-2	29584-29585	,	_
174-3	29586-29587	a	_
174-4	29588-29601	meta-analysis	_
174-5	29602-29605	was	_
174-6	29606-29615	performed	_
174-7	29616-29625	combining	_
174-8	29626-29633	results	_
174-9	29634-29638	from	_
174-10	29639-29645	stages	_
174-11	29646-29647	1	_
174-12	29648-29649	&	_
174-13	29650-29651	2	_
174-14	29652-29653	.	_

Text=Data Availability Statement for the current study The data analyzed for this article is available through the psychENCODE Knowledge Portal (psychencode.org).
175-1	29654-29658	Data	_
175-2	29659-29671	Availability	_
175-3	29672-29681	Statement	_
175-4	29682-29685	for	_
175-5	29686-29689	the	_
175-6	29690-29697	current	_
175-7	29698-29703	study	_
175-8	29704-29707	The	_
175-9	29708-29712	data	_
175-10	29713-29721	analyzed	_
175-11	29722-29725	for	_
175-12	29726-29730	this	_
175-13	29731-29738	article	_
175-14	29739-29741	is	_
175-15	29742-29751	available	_
175-16	29752-29759	through	_
175-17	29760-29763	the	_
175-18	29764-29775	psychENCODE	_
175-19	29776-29785	Knowledge	_
175-20	29786-29792	Portal	_
175-21	29793-29794	(	_
175-22	29795-29810	psychencode.org	_
175-23	29811-29812	)	_
175-24	29813-29814	.	_

Text=Access to the data is controlled by the NIMH Repository and Genomics Resources (NRGR) https: //www.nimhgenetics.org.
176-1	29815-29821	Access	_
176-2	29822-29824	to	_
176-3	29825-29828	the	_
176-4	29829-29833	data	_
176-5	29834-29836	is	_
176-6	29837-29847	controlled	_
176-7	29848-29850	by	_
176-8	29851-29854	the	_
176-9	29855-29859	NIMH	_
176-10	29860-29870	Repository	_
176-11	29871-29874	and	_
176-12	29875-29883	Genomics	_
176-13	29884-29893	Resources	_
176-14	29894-29895	(	_
176-15	29896-29900	NRGR	_
176-16	29901-29902	)	_
176-17	29903-29908	https	_
176-18	29909-29910	:	_
176-19	29911-29933	//www.nimhgenetics.org	_
176-20	29934-29935	.	_

Text=See instructions for in the PsychENCODE Knowledge Portal: https: //www.synapse.org/ #! Synapse: syn4921369.
177-1	29936-29939	See	_
177-2	29940-29952	instructions	_
177-3	29953-29956	for	_
177-4	29957-29959	in	_
177-5	29960-29963	the	_
177-6	29964-29975	PsychENCODE	_
177-7	29976-29985	Knowledge	_
177-8	29986-29992	Portal	_
177-9	29993-29994	:	_
177-10	29995-30000	https	_
177-11	30001-30002	:	_
177-12	30003-30021	//www.synapse.org/	_
177-13	30022-30023	#	_
177-14	30024-30025	!	_
177-15	30026-30033	Synapse	_
177-16	30034-30035	:	_
177-17	30036-30046	syn4921369	_
177-18	30047-30048	.	_

Text=Data and results are at https: //www.synapse.org/ #! Synapse: syn4566010.
178-1	30049-30053	Data	_
178-2	30054-30057	and	_
178-3	30058-30065	results	_
178-4	30066-30069	are	_
178-5	30070-30072	at	_
178-6	30073-30078	https	_
178-7	30079-30080	:	_
178-8	30081-30099	//www.synapse.org/	_
178-9	30100-30101	#	_
178-10	30102-30103	!	_
178-11	30104-30111	Synapse	_
178-12	30112-30113	:	_
178-13	30114-30124	syn4566010	_
178-14	30125-30126	.	_

Text=The site includes link to UCSC browser visualizations.
179-1	30127-30130	The	_
179-2	30131-30135	site	_
179-3	30136-30144	includes	_
179-4	30145-30149	link	_
179-5	30150-30152	to	_
179-6	30153-30157	UCSC	_
179-7	30158-30165	browser	_
179-8	30166-30180	visualizations	_
179-9	30181-30182	.	_

Text=URLs Data access instructions (for ChIP-seq data presented in our paper): https: //www.synapse.org/ #! Synapse: syn4921369/wiki/235539 Data, results and visualizations (for ChIP-seq data presented in our paper): https: //www.synapse.org/ #! Synapse: syn4566010 Psychiatric Genomics Consortium: med.unc.edu/pgc International Genomics of Alzheimer ’ s Project: web.pasteur-lille.fr/en/recherche/u744 The Social Science Genetic Association Consortium: ssgac.org Sleep phenotypes: www.t2diabetesgenes.org/data Genetic Investigation of ANthropometric Traits: portals.broadinstitute.org/collaboration/giant Coronary Artery Disease: cardiogramplusc4d.org International Inflammatory Bowel Disease Genetics Consortium: ibdgenetics.org CommonMind Consortium: commonmind.org Roadmap Epigenomics Project: roadmapepigenomics.org Grubert, et al.
180-1	30183-30187	URLs	_
180-2	30188-30192	Data	_
180-3	30193-30199	access	_
180-4	30200-30212	instructions	_
180-5	30213-30214	(	_
180-6	30215-30218	for	_
180-7	30219-30227	ChIP-seq	_
180-8	30228-30232	data	_
180-9	30233-30242	presented	_
180-10	30243-30245	in	_
180-11	30246-30249	our	_
180-12	30250-30255	paper	_
180-13	30256-30257	)	_
180-14	30258-30259	:	_
180-15	30260-30265	https	_
180-16	30266-30267	:	_
180-17	30268-30286	//www.synapse.org/	_
180-18	30287-30288	#	_
180-19	30289-30290	!	_
180-20	30291-30298	Synapse	_
180-21	30299-30300	:	_
180-22	30301-30323	syn4921369/wiki/235539	_
180-23	30324-30328	Data	_
180-24	30329-30330	,	_
180-25	30331-30338	results	_
180-26	30339-30342	and	_
180-27	30343-30357	visualizations	_
180-28	30358-30359	(	_
180-29	30360-30363	for	_
180-30	30364-30372	ChIP-seq	_
180-31	30373-30377	data	_
180-32	30378-30387	presented	_
180-33	30388-30390	in	_
180-34	30391-30394	our	_
180-35	30395-30400	paper	_
180-36	30401-30402	)	_
180-37	30403-30404	:	_
180-38	30405-30410	https	_
180-39	30411-30412	:	_
180-40	30413-30431	//www.synapse.org/	_
180-41	30432-30433	#	_
180-42	30434-30435	!	_
180-43	30436-30443	Synapse	_
180-44	30444-30445	:	_
180-45	30446-30456	syn4566010	_
180-46	30457-30468	Psychiatric	_
180-47	30469-30477	Genomics	_
180-48	30478-30488	Consortium	_
180-49	30489-30490	:	_
180-50	30491-30506	med.unc.edu/pgc	_
180-51	30507-30520	International	_
180-52	30521-30529	Genomics	_
180-53	30530-30532	of	_
180-54	30533-30542	Alzheimer	_
180-55	30543-30544	’	_
180-56	30545-30546	s	_
180-57	30547-30554	Project	_
180-58	30555-30556	:	_
180-59	30557-30595	web.pasteur-lille.fr/en/recherche/u744	_
180-60	30596-30599	The	_
180-61	30600-30606	Social	_
180-62	30607-30614	Science	_
180-63	30615-30622	Genetic	_
180-64	30623-30634	Association	_
180-65	30635-30645	Consortium	_
180-66	30646-30647	:	_
180-67	30648-30657	ssgac.org	_
180-68	30658-30663	Sleep	_
180-69	30664-30674	phenotypes	_
180-70	30675-30676	:	_
180-71	30677-30705	www.t2diabetesgenes.org/data	_
180-72	30706-30713	Genetic	_
180-73	30714-30727	Investigation	_
180-74	30728-30730	of	_
180-75	30731-30745	ANthropometric	_
180-76	30746-30752	Traits	_
180-77	30753-30754	:	_
180-78	30755-30801	portals.broadinstitute.org/collaboration/giant	_
180-79	30802-30810	Coronary	_
180-80	30811-30817	Artery	_
180-81	30818-30825	Disease	_
180-82	30826-30827	:	_
180-83	30828-30849	cardiogramplusc4d.org	_
180-84	30850-30863	International	_
180-85	30864-30876	Inflammatory	_
180-86	30877-30882	Bowel	_
180-87	30883-30890	Disease	_
180-88	30891-30899	Genetics	_
180-89	30900-30910	Consortium	_
180-90	30911-30912	:	_
180-91	30913-30928	ibdgenetics.org	_
180-92	30929-30939	CommonMind	_
180-93	30940-30950	Consortium	_
180-94	30951-30952	:	_
180-95	30953-30967	commonmind.org	_
180-96	30968-30975	Roadmap	_
180-97	30976-30987	Epigenomics	_
180-98	30988-30995	Project	_
180-99	30996-30997	:	_
180-100	30998-31020	roadmapepigenomics.org	_
180-101	31021-31028	Grubert	_
180-102	31029-31030	,	_
180-103	31031-31033	et	_
180-104	31034-31036	al	_
180-105	31037-31038	.	_

Text=(Cell 2015) histone QTLs: http: //chromovar3d.stanford.edu/
181-1	31039-31040	(	_
181-2	31041-31045	Cell	_
181-3	31046-31050	2015	_
181-4	31051-31052	)	_
181-5	31053-31060	histone	_
181-6	31061-31065	QTLs	_
181-7	31066-31067	:	_
181-8	31068-31072	http	_
181-9	31073-31074	:	_
181-10	31075-31102	//chromovar3d.stanford.edu/	_

